[
  {
    "author": [
      {
        "family": "Wardell",
        "given": "William M."
      },
      {
        "family": "Lasagna",
        "given": "Louis"
      }
    ],
    "citation-number": [
      "1."
    ],
    "date": [
      "1975"
    ],
    "location": [
      "Washington, DC"
    ],
    "pages": [
      "30"
    ],
    "publisher": [
      "American Enterprise Institute for Public Policy"
    ],
    "title": [
      "Regulation and Drug Development"
    ],
    "type": "book"
  },
  {
    "citation-number": [
      "2."
    ],
    "container-title": [
      "The conference took place in"
    ],
    "date": [
      "1973",
      "1972"
    ],
    "editor": [
      {
        "family": "Lasagna",
        "given": "Louis"
      },
      {
        "family": "discussion",
        "given": "in Joseph D.Cooper"
      }
    ],
    "location": [
      "Washington, DC"
    ],
    "pages": [
      "156"
    ],
    "publisher": [
      "Smithsonian Institution"
    ],
    "title": [
      "The Efficacy of Self-Medication, Philosophy and Technology of Drug Assessment 4"
    ],
    "type": "paper-conference",
    "volume": [
      "168"
    ]
  },
  {
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Oct"
    ],
    "date": [
      "1986"
    ],
    "note": [
      "accessed July 4, 2002)."
    ],
    "title": [
      "United States Food and Drug Administration, FDA Oral History Program, “Interview with William W. Goodrich, Office of the General Counsel, 1939–1971 (Part 2"
    ],
    "type": "article-journal",
    "url": [
      "www.fda.gov/oc/history/oralhistories/goodrich/ part2.html"
    ],
    "volume": [
      "15"
    ]
  },
  {
    "location": [
      "London"
    ],
    "note": [
      "3. Société Suisse de Psychiatrie, “Comptes-rendus des séances, 21–22 juin"
    ],
    "title": [
      "Notes to Chapter 2 1. Shakespeare, Cymbeline, act III, scene 2. 2. Casebook of Frederick Parkes-Weber, 1913–, 77, Contemporary Medical Archives Center, Wellcome Library"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Adair",
        "given": "James M."
      }
    ],
    "container-title": [
      "appeared in the announcement in Annales Médico-psychologiques",
      "The Letters of Doctor George Cheyne to Samuel Richardson (1733–1743",
      "Schweizer Archiv für Neurologie und Psychiatrie"
    ],
    "date": [
      "1930",
      "1930",
      "1786",
      "1943"
    ],
    "editor": [
      {
        "family": "Mullett",
        "given": "Charles F."
      }
    ],
    "issue": [
      "1931",
      "ser., 88"
    ],
    "location": [
      "Bath",
      "Columbia"
    ],
    "note": [
      "47, letter of Feb. 3, 1738."
    ],
    "pages": [
      "174–183",
      "186 4",
      "13 5"
    ],
    "publisher": [
      "Cruttwell",
      "University of Missouri"
    ],
    "title": [
      "à Neuchâtel et à Perreux",
      "Hans Walther gave the lecture on “Pharmacologie und Psychiatrie,” summary, 175, but many other contributions touched on this theme; the title of the meeting, “Pharmakologie et Psychiatrie",
      "Medical Cautions for the Consideration of Invalids"
    ],
    "type": "article-journal",
    "volume": [
      "27"
    ]
  },
  {
    "author": [
      {
        "family": "Mayer",
        "given": "L.]"
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Beiträge zur Geburtshilfe und Gynäkologie"
    ],
    "date": [
      "1872",
      "quote 127"
    ],
    "pages": [
      "111–134,"
    ],
    "title": [
      "Menstruation im Zusammenhange mit psychischen Störungen"
    ],
    "type": "article-journal",
    "volume": [
      "1"
    ]
  },
  {
    "citation-number": [
      "7."
    ],
    "container-title": [
      "American Journal of Insanity"
    ],
    "date": [
      "1889"
    ],
    "pages": [
      "28–47, 29"
    ],
    "title": [
      "On the impact of the isolation of hyoscyamine, see Henry Wetherill, “The Modern Hypnotics"
    ],
    "type": "article-journal",
    "volume": [
      "46"
    ]
  },
  {
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Wellcome Witnesses to Twentieth Century Medicine"
    ],
    "date": [
      "1998"
    ],
    "editor": [
      {
        "family": "E. M. Tansey",
        "particle": "ed."
      }
    ],
    "location": [
      "London"
    ],
    "note": [
      "The green medicine also contained a barbiturate."
    ],
    "pages": [
      "169"
    ],
    "publisher": [
      "Wellcome Institute for the History of Medicine"
    ],
    "title": [
      "Ian Tait, discussion"
    ],
    "type": "chapter",
    "volume": [
      "2"
    ]
  },
  {
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Psychotropic Drugs"
    ],
    "date": [
      "1957"
    ],
    "editor": [
      {
        "family": "Belloni",
        "given": "Luigi"
      },
      {
        "family": "introduction",
        "given": "to S.] Garattini"
      },
      {
        "others": true
      }
    ],
    "location": [
      "Amsterdam"
    ],
    "pages": [
      "–"
    ],
    "publisher": [
      "Elsevier"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Elvehjem",
        "given": "Conrad Arnold"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "Journal of Biological Chemistry"
    ],
    "date": [
      "1938"
    ],
    "pages": [
      "137–149"
    ],
    "title": [
      "The Isolation and Identification of the Anti-Black Tongue Factor"
    ],
    "type": "article-journal",
    "volume": [
      "123"
    ]
  },
  {
    "author": [
      {
        "family": "Stokes",
        "given": "John H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "11."
    ],
    "container-title": [
      "JAMA"
    ],
    "date": [
      "1944-09-09"
    ],
    "pages": [
      "74–79"
    ],
    "title": [
      "The Action of Penicillin in Late Syphilis Including Neurosyphilis"
    ],
    "type": "article-journal",
    "volume": [
      "126"
    ]
  },
  {
    "author": [
      {
        "family": "Wardener",
        "given": "H.] E.]",
        "particle": "De"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "12."
    ],
    "container-title": [
      "see, on this, Edward Shorter, Historical Dictionary of Psychiatry",
      "Lancet"
    ],
    "date": [
      "1947-01-04",
      "2005"
    ],
    "location": [
      "New York"
    ],
    "pages": [
      "303–304"
    ],
    "publisher": [
      "Oxford University Press"
    ],
    "title": [
      "Cerebral Beriberi (Wernicke’s Encephalopathy): Review of 52 Cases in a Singapore Prisoner-of-War Hospital"
    ],
    "type": "article-journal",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "Bridger",
        "given": "A.] E."
      }
    ],
    "citation-number": [
      "13."
    ],
    "date": [
      "1892"
    ],
    "location": [
      "London"
    ],
    "pages": [
      "51–52"
    ],
    "publisher": [
      "Hogg"
    ],
    "title": [
      "Depression: What It Is and How to Cure It"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Carlsson",
        "given": "Arvid"
      }
    ],
    "citation-number": [
      "14."
    ],
    "container-title": [
      "interview, in The Psychopharmacologists"
    ],
    "date": [
      "1996"
    ],
    "editor": [
      {
        "family": "David Healy",
        "particle": "ed."
      }
    ],
    "location": [
      "London"
    ],
    "pages": [
      "51–80",
      "77"
    ],
    "publisher": [
      "Chapman and Hall"
    ],
    "title": [
      "Rise of Neuropsychopharmacology"
    ],
    "type": "chapter",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "opium",
        "given": "On",
        "particle": "the pharmacology of"
      },
      {
        "family": "Louis S. Goodman",
        "particle": "see"
      },
      {
        "family": "Gilman",
        "given": "Alfred"
      }
    ],
    "citation-number": [
      "15."
    ],
    "container-title": [
      "this classic textbook contain a discussion of opium"
    ],
    "date": [
      "1955"
    ],
    "edition": [
      "2nd",
      "All editions"
    ],
    "location": [
      "New York"
    ],
    "note": [
      "yet this edition provides probably the most extensive."
    ],
    "pages": [
      "216–217"
    ],
    "publisher": [
      "Macmillan"
    ],
    "title": [
      "The Pharmacological Basis of Therapeutics"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Matthias M. Weber",
        "particle": "see"
      }
    ],
    "citation-number": [
      "16."
    ],
    "container-title": [
      "Sudhoffs Archiv"
    ],
    "date": [
      "1987"
    ],
    "pages": [
      "31–61"
    ],
    "title": [
      "On the history of opium in psychiatry",
      "Die ‘Opiumkur’ in der Psychiatrie: Ein Beitrag zur Geschichte der Psychopharmakologie"
    ],
    "type": "article-journal",
    "volume": [
      "71"
    ]
  },
  {
    "author": [
      {
        "family": "Engelken",
        "given": "See Hermann E.E."
      }
    ],
    "citation-number": [
      "17."
    ],
    "container-title": [
      "Deutsche Irrenärzte"
    ],
    "date": [
      "1921"
    ],
    "editor": [
      {
        "family": "Theodor Kirchhoff",
        "particle": "ed."
      }
    ],
    "location": [
      "Berlin"
    ],
    "pages": [
      "223–227"
    ],
    "publisher": [
      "Springer"
    ],
    "title": [
      "Familie Engelken, 1742–1919"
    ],
    "type": "chapter",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "Benning",
        "given": "See Geert"
      }
    ],
    "citation-number": [
      "18."
    ],
    "date": [
      "1936"
    ],
    "genre": [
      "Jahrhunderts (Göttingen doctoral diss.,"
    ],
    "note": [
      "The author was a family member."
    ],
    "pages": [
      "13–14"
    ],
    "title": [
      "Das Opium in der deutschen Psychiatrie des 19"
    ],
    "type": "thesis"
  },
  {
    "author": [
      {
        "family": "Krafft-Ebing",
        "given": "R.]",
        "particle": "von"
      }
    ],
    "citation-number": [
      "19."
    ],
    "date": [
      "1879"
    ],
    "location": [
      "Stuttgart"
    ],
    "pages": [
      "255"
    ],
    "publisher": [
      "Enke"
    ],
    "title": [
      "Lehrbuch der Psychiatrie"
    ],
    "type": "book",
    "volume": [
      "1"
    ]
  },
  {
    "citation-number": [
      "20."
    ],
    "container-title": [
      "Günter Elsässer [autobiographical account], Psychiatrie in Selbstdarstellungen"
    ],
    "date": [
      "1977",
      "quote 62"
    ],
    "editor": [
      {
        "family": "Pongratz",
        "given": "Ludwig J."
      }
    ],
    "location": [
      "Berne"
    ],
    "pages": [
      "54–81,"
    ],
    "publisher": [
      "Huber"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "psycho-pharm@psycom.net",
        "given": "Post",
        "particle": "to"
      }
    ],
    "citation-number": [
      "21."
    ],
    "container-title": [
      "Mar"
    ],
    "date": [
      "2007"
    ],
    "title": [
      "The members of this listserv did not necessarily realize they were posting for attribution, and I am preserving their anonymity"
    ],
    "type": "article-journal",
    "volume": [
      "13"
    ]
  },
  {
    "author": [
      {
        "family": "Issekutz",
        "given": "See Bela"
      }
    ],
    "citation-number": [
      "22."
    ],
    "date": [
      "1971"
    ],
    "location": [
      "Budapest"
    ],
    "pages": [
      "68"
    ],
    "publisher": [
      "Kiado"
    ],
    "title": [
      "Die Geschichte der Arzneimittelforschung"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Turner",
        "given": "Trevor"
      }
    ],
    "citation-number": [
      "23."
    ],
    "container-title": [
      "Psychological Medicine Monograph"
    ],
    "title": [
      "A Diagnostic Analysis of the Casebooks of Ticehurst House Asylum, 1845–1890"
    ],
    "type": "article-journal",
    "volume": [
      "Supplement 21"
    ]
  },
  {
    "author": [
      {
        "family": "Böttger",
        "given": "Heinrich"
      }
    ],
    "container-title": [
      "Deutsche Klinik (Feb"
    ],
    "date": [
      "1992",
      "quote 80"
    ],
    "location": [
      "Cambridge"
    ],
    "pages": [
      "12 24",
      "79–80,"
    ],
    "publisher": [
      "Cambridge University Press"
    ],
    "title": [
      "Bericht über die Heil- und Pflegeanstalt für Gemüthsund Nervenkranke Asyl Carlsfeld bei Halle a. S"
    ],
    "type": "article-journal",
    "volume": [
      "59",
      "25, 1865"
    ]
  },
  {
    "author": [
      {
        "family": "Cloetta",
        "given": "Max"
      },
      {
        "family": "A. Ulrich",
        "particle": "discussion comment following"
      }
    ],
    "citation-number": [
      "25."
    ],
    "container-title": [
      "Correspondenz-Blatt für Schweizer Aerzte"
    ],
    "date": [
      "1916"
    ],
    "pages": [
      "505"
    ],
    "title": [
      "Ueber die psychischen Wirkungen des Broms und über die Brombehandlung von melancholischen Verstimmungen"
    ],
    "type": "article-journal",
    "volume": [
      "46",
      "504"
    ]
  },
  {
    "author": [
      {
        "family": "Mutch",
        "given": "N."
      }
    ],
    "citation-number": [
      "26."
    ],
    "container-title": [
      "BMJ"
    ],
    "date": [
      "1934-02-24",
      "see 322, table 5"
    ],
    "pages": [
      "319–322,"
    ],
    "title": [
      "Proprietary Remedies, with Special Reference to Hypnotics"
    ],
    "type": "article-journal",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "Liste",
        "given": "See Rote"
      }
    ],
    "citation-number": [
      "27."
    ],
    "date": [
      "1939",
      "1939"
    ],
    "edition": [
      "3rd"
    ],
    "location": [
      "Berlin"
    ],
    "pages": [
      "330"
    ],
    "publisher": [
      "Fachgruppe Pharmazeutische Erzeugnisse"
    ],
    "title": [
      "Preisverzeichnis deutscher pharmazeutischer Spezialpräparate"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Gay",
        "given": "See Peter"
      }
    ],
    "citation-number": [
      "28."
    ],
    "date": [
      "1988"
    ],
    "location": [
      "New York"
    ],
    "pages": [
      "43–44"
    ],
    "publisher": [
      "Norton"
    ],
    "title": [
      "Freud: A Life for Our Time"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Musto",
        "given": "David F."
      }
    ],
    "citation-number": [
      "29."
    ],
    "date": [
      "1973"
    ],
    "location": [
      "New Haven"
    ],
    "pages": [
      "7"
    ],
    "publisher": [
      "Yale University Press"
    ],
    "title": [
      "The American Disease: Origins of Narcotics Control"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "testimony",
        "given": "Leo Alexander"
      }
    ],
    "citation-number": [
      "30."
    ],
    "note": [
      "Docket No. FDA-DAC-1, Aug. 5, 1966: 2742 (“Meprobamate Hearings”). Obtained from FDA through the Freedom of Information Act."
    ],
    "title": [
      "Before the Secretary, Department of Health, Education and Welfare, Food and Drug Administration. In the Matter of: Depressant and Stimulant Drugs"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Matussek",
        "given": "Norbert"
      }
    ],
    "citation-number": [
      "31."
    ],
    "container-title": [
      "The Neurotransmitter Era in Neuropsychopharmacology"
    ],
    "date": [
      "2006"
    ],
    "editor": [
      {
        "family": "Thomas A. Ban",
        "particle": "ed."
      },
      {
        "family": "Udabe",
        "given": "Ronaldo Ucha"
      }
    ],
    "location": [
      "Buenos Aires"
    ],
    "pages": [
      "195"
    ],
    "publisher": [
      "Polemos"
    ],
    "title": [
      "The Neurotransmittter Era in Neuropsychopharmacology: Reflections of a Neuropsychopharmacologist",
      "193–200"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Cervello",
        "given": "Vincenzo"
      }
    ],
    "citation-number": [
      "32."
    ],
    "container-title": [
      "Archivio per le Scienze Mediche"
    ],
    "date": [
      "1882"
    ],
    "pages": [
      "177–214"
    ],
    "title": [
      "Sull’azione fisiologica della paraldeide"
    ],
    "type": "article-journal",
    "volume": [
      "6"
    ]
  },
  {
    "author": [
      {
        "family": "urethane",
        "given": "Henry McIlwain",
        "particle": "considers"
      }
    ],
    "citation-number": [
      "33."
    ],
    "container-title": [
      "Henry McIlwain, Chemotherapy and the Central Nervous System"
    ],
    "date": [
      "1885",
      "1957"
    ],
    "location": [
      "Boston"
    ],
    "pages": [
      "24–25"
    ],
    "publisher": [
      "Little, Brown"
    ],
    "title": [
      "among the first “attempt[s] to design a therapeutic agent.” Yet urethane was quickly displaced by the less toxic barbiturates"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Fischer",
        "given": "Emil"
      },
      {
        "family": "Mering",
        "given": "J.]",
        "particle": "von"
      }
    ],
    "citation-number": [
      "34."
    ],
    "container-title": [
      "Therapie der Gegenwart"
    ],
    "date": [
      "1903"
    ],
    "note": [
      "For details, see"
    ],
    "pages": [
      "97–101"
    ],
    "title": [
      "Ueber eine neue Klasse von Schlafmitteln"
    ],
    "type": "article-journal",
    "volume": [
      "44"
    ]
  },
  {
    "author": [
      {
        "family": "Shorter",
        "given": "Edward"
      },
      {
        "family": "Cardoni",
        "given": "Alex A."
      }
    ],
    "container-title": [
      "Connecticut Medicine"
    ],
    "date": [
      "1997",
      "1991",
      "quote 409. 36",
      "1972"
    ],
    "editor": [
      {
        "family": "Cooper",
        "given": "Joseph D."
      }
    ],
    "location": [
      "New York",
      "Washington, DC"
    ],
    "note": [
      "For details see Shorter, Historical Dictionary of Psychiatry, 37. 38. See The People of the State of New York, Respondent v. William Esposito and Anthony Esposito, Appellants, Court of Appeals of New York, 287 N.Y. 389; 39"
    ],
    "pages": [
      "202–207 35",
      "409–411,",
      "78 37"
    ],
    "publisher": [
      "Wiley",
      "Interdisciplinary Communication Associates"
    ],
    "title": [
      "History of Psychiatry",
      "Fifty Years of Psychopharmacology: An Interview with Benjamin Wiesel",
      "Louis Lasagna, discussion",
      "The Philosophy of Evidence, Philosophy and Technology of Drug Assessment 3"
    ],
    "type": "article-journal",
    "volume": [
      "37",
      "55"
    ]
  },
  {
    "author": [
      {
        "family": "Curran",
        "given": "Frank J."
      }
    ],
    "container-title": [
      "LEXIS",
      "Journal of Nervous and Mental Disease",
      "BMJ"
    ],
    "date": [
      "1942",
      "1100",
      "1942-01-22",
      "1944",
      "see 143. 40",
      "1934-10-06",
      "quote 621"
    ],
    "pages": [
      "142 956,",
      "4 39",
      "142–169,",
      "619–621,"
    ],
    "title": [
      "N.Y",
      "Current Views on Neuropsychiatric Effects of Barbiturates and Bromides",
      "Lord Horder, “Use of Narcotics in the Treatment of Nervous and Mental Patients"
    ],
    "type": "article-journal",
    "volume": [
      "N.E.2d 925",
      "100",
      "2"
    ]
  },
  {
    "author": [
      {
        "family": "Vita Sackville-West",
        "given": "See Virginia Woolf",
        "particle": "to"
      },
      {
        "given": "Feb"
      }
    ],
    "citation-number": [
      "41."
    ],
    "container-title": [
      "The Letters of Virginia Woolf"
    ],
    "date": [
      "1929",
      "1978"
    ],
    "editor": [
      {
        "family": "Nicolson",
        "given": "Nigel"
      },
      {
        "others": true
      }
    ],
    "location": [
      "New York"
    ],
    "pages": [
      "1929–1931",
      "13"
    ],
    "publisher": [
      "Harvest/ HBJ"
    ],
    "type": "chapter",
    "volume": [
      "4"
    ]
  },
  {
    "author": [
      {
        "family": "Bleckwenn",
        "given": "W.] J."
      }
    ],
    "citation-number": [
      "42."
    ],
    "container-title": [
      "Wisconsin Medical Journal"
    ],
    "date": [
      "1930"
    ],
    "pages": [
      "693–696, 694"
    ],
    "title": [
      "Sodium Amytal in Certain Nervous and Mental Conditions"
    ],
    "type": "article-journal",
    "volume": [
      "20"
    ]
  },
  {
    "author": [
      {
        "family": "Lindemann",
        "given": "Erich"
      }
    ],
    "citation-number": [
      "43."
    ],
    "container-title": [
      "Journal of the Society for Experimental Study of Biology and Medicine"
    ],
    "date": [
      "1931",
      "quote 865"
    ],
    "pages": [
      "864–866,"
    ],
    "title": [
      "The Psychopathological Effect of Sodium Amytal"
    ],
    "type": "article-journal",
    "volume": [
      "28"
    ]
  },
  {
    "author": [
      {
        "family": "Lindemann",
        "given": "Erich"
      }
    ],
    "citation-number": [
      "44."
    ],
    "container-title": [
      "AJP"
    ],
    "date": [
      "1932"
    ],
    "pages": [
      "1083–1091"
    ],
    "title": [
      "Psychological Changes in Normal and Abnormal Individuals Under the Influence of Sodium Amytal"
    ],
    "type": "article-journal",
    "volume": [
      "88"
    ]
  },
  {
    "author": [
      {
        "family": "Lindemann",
        "given": "Erich"
      }
    ],
    "citation-number": [
      "45."
    ],
    "container-title": [
      "AJP"
    ],
    "date": [
      "1944"
    ],
    "pages": [
      "141–148"
    ],
    "title": [
      "Symptomatology and Management of Acute Grief"
    ],
    "type": "article-journal",
    "volume": [
      "101"
    ]
  },
  {
    "author": [
      {
        "family": "Fort",
        "given": "Joel"
      }
    ],
    "citation-number": [
      "46."
    ],
    "container-title": [
      "Bulletin on Narcotics"
    ],
    "date": [
      "1964-01",
      "quote 18"
    ],
    "pages": [
      "17–35,"
    ],
    "title": [
      "The Problem of Barbiturates in the United States of America"
    ],
    "type": "article-journal",
    "volume": [
      "16"
    ]
  },
  {
    "author": [
      {
        "family": "advertisement",
        "given": "Eskaphen B.Elixir"
      }
    ],
    "citation-number": [
      "47."
    ],
    "container-title": [
      "New York State Journal of Medicine"
    ],
    "date": [
      "1950"
    ],
    "pages": [
      "1897"
    ],
    "type": "article-journal",
    "volume": [
      "50"
    ]
  },
  {
    "author": [
      {
        "family": "Laporte",
        "given": "Joan-Ramon"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "48."
    ],
    "container-title": [
      "Clinical Pharmacology in Psychiatry: Bridging the Experimental-Therapeutic Gap"
    ],
    "date": [
      "1983"
    ],
    "editor": [
      {
        "family": "Lars F. Gram",
        "particle": "ed."
      },
      {
        "others": true
      }
    ],
    "location": [
      "London"
    ],
    "pages": [
      "18–31",
      "24"
    ],
    "publisher": [
      "Macmillan"
    ],
    "title": [
      "Patterns of Use of Psychotropic Drugs in Spain in an International Perspective"
    ],
    "type": "chapter"
  },
  {
    "citation-number": [
      "49."
    ],
    "date": [
      "1929"
    ],
    "location": [
      "Paris"
    ],
    "pages": [
      "66"
    ],
    "publisher": [
      "Editions Émile-Paul Frères"
    ],
    "title": [
      "Marcel Proust to Natalie Barney, undated letter, in Natalie Clifford Barney, Aventures de l’esprit"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Weber",
        "given": "Matthias M."
      }
    ],
    "citation-number": [
      "50."
    ],
    "date": [
      "1999"
    ],
    "location": [
      "Munich"
    ],
    "pages": [
      "110"
    ],
    "publisher": [
      "Urban"
    ],
    "title": [
      "Die Entwicklung der Psychopharmakologie im Zeitalter der naturwissenschaftlichen Medizin"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Gillespie",
        "given": "R.] D.]"
      },
      {
        "given": "discussion"
      }
    ],
    "citation-number": [
      "51."
    ],
    "container-title": [
      "BMJ"
    ],
    "date": [
      "1933-12-30",
      "1214"
    ],
    "pages": [
      "1213–1214,"
    ],
    "title": [
      "Hypnotic Drugs: Uses and Dangers"
    ],
    "type": "article-journal",
    "volume": [
      "2"
    ]
  },
  {
    "author": [
      {
        "family": "Castleden",
        "given": "L.I.M."
      }
    ],
    "citation-number": [
      "52."
    ],
    "container-title": [
      "The Practitioner"
    ],
    "date": [
      "1936"
    ],
    "pages": [
      "358–368, 364–367"
    ],
    "title": [
      "Hypnotic Drugs"
    ],
    "type": "article-journal",
    "volume": [
      "137"
    ]
  },
  {
    "author": [
      {
        "family": "Hambourger",
        "given": "W.E."
      }
    ],
    "citation-number": [
      "53."
    ],
    "container-title": [
      "JAMA"
    ],
    "date": [
      "1939-04-08"
    ],
    "pages": [
      "1340–1343"
    ],
    "title": [
      "A Study of the Promiscuous Use of the Barbiturates: Their Use in Suicides"
    ],
    "type": "article-journal",
    "volume": [
      "112"
    ]
  },
  {
    "author": [
      {
        "family": "Ohberg",
        "given": "Annakatri"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "54."
    ],
    "container-title": [
      "BJP"
    ],
    "date": [
      "1996"
    ],
    "note": [
      "in defined daily doses (DDD) per 1,000 population in 1987, the barbiturates had a relative suicide risk of 105.3, the benzodiazepines 0.3."
    ],
    "pages": [
      "75–80"
    ],
    "title": [
      "Alcohol and Drugs in Suicides"
    ],
    "type": "article-journal",
    "volume": [
      "169"
    ]
  },
  {
    "author": [
      {
        "family": "Lasagna",
        "given": "Louis"
      }
    ],
    "citation-number": [
      "55."
    ],
    "container-title": [
      "Medical Clinics of North America"
    ],
    "date": [
      "1957",
      "quote 365"
    ],
    "pages": [
      "359–368,"
    ],
    "title": [
      "The Newer Hypnotics"
    ],
    "type": "article-journal",
    "volume": [
      "41"
    ]
  },
  {
    "author": [
      {
        "family": "Simmons",
        "given": "Harold"
      },
      {
        "given": "discussion"
      }
    ],
    "citation-number": [
      "56."
    ],
    "container-title": [
      "BMJ"
    ],
    "date": [
      "1934-08-04"
    ],
    "pages": [
      "223"
    ],
    "title": [
      "BMA] Section of Neurology, Psychological Medicine and Mental Diseases"
    ],
    "type": "article-journal",
    "volume": [
      "2"
    ]
  },
  {
    "citation-number": [
      "57."
    ],
    "container-title": [
      "See Drug Abuse Control Amendments of 1965. Hearings Before the Committee on Interstate and Foreign Commerce, House of Representatives"
    ],
    "note": [
      "89th Congress, 1st Session, on H.R. 2. Jan."
    ],
    "title": [
      "Goldberg had prepared the table at the request of Gerhard Zbinden, Hoffmann-La Roche’s vice president for research"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Edward",
        "given": "G."
      }
    ],
    "citation-number": [
      "27–Feb."
    ],
    "container-title": [
      "table at",
      "Education and Welfare, Feb"
    ],
    "date": [
      "1965",
      "1966",
      "1964"
    ],
    "genre": [
      "13th Report, WHO Technical Report Series 273"
    ],
    "location": [
      "Washington, DC",
      "College Park, MD",
      "Geneva"
    ],
    "note": [
      "NARA), RG 88 (Records of the Food and Drug Administration), 88–74–2, (hearing material, 1965–1966), box. 50. 59. WHO Expert Committee on Addiction-Producing Drugs,"
    ],
    "pages": [
      "58",
      "9"
    ],
    "publisher": [
      "U.S. Government Printing Office",
      "World Health Organization"
    ],
    "title": [
      "10, 1965",
      "Egan (Gane’s Chemical Works) to Hearing Clerk, Department of Health",
      "National Archives and Records Administration"
    ],
    "type": "article-journal",
    "volume": [
      "293",
      "14"
    ]
  },
  {
    "author": [
      {
        "family": "Fink",
        "given": "Max"
      },
      {
        "family": "Edward Shorter",
        "particle": "interview with"
      },
      {
        "family": "Healy",
        "given": "David"
      }
    ],
    "citation-number": [
      "62."
    ],
    "date": [
      "2002-10-25"
    ],
    "location": [
      "Nissequogue, New York"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Angst",
        "given": "Jules"
      }
    ],
    "citation-number": [
      "63."
    ],
    "container-title": [
      "interview, in The Psychopharmacologists"
    ],
    "date": [
      "1996"
    ],
    "editor": [
      {
        "family": "David Healy",
        "particle": "ed."
      }
    ],
    "location": [
      "London"
    ],
    "pages": [
      "287–307",
      "296"
    ],
    "publisher": [
      "Chapman and Hall"
    ],
    "title": [
      "Myths of Psychopharmacology"
    ],
    "type": "chapter",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "Edeleano",
        "given": "L.]"
      }
    ],
    "citation-number": [
      "64."
    ],
    "container-title": [
      "Berichte der Deutschen Chemischen Gesellschaft"
    ],
    "date": [
      "1887"
    ],
    "editor": [
      {
        "family": "Smith",
        "given": "See"
      },
      {
        "given": "Kline"
      },
      {
        "family": "Clark",
        "given": "French Laboratories",
        "particle": "v."
      },
      {
        "given": "Clark"
      },
      {
        "others": true
      }
    ],
    "issue": [
      "9048"
    ],
    "note": [
      "United States Circuit Court of Appeals, Third Circuit. 157 F.2d 725; U.S. App. LEXIS 3910; 70 U.S.P.Q."
    ],
    "pages": [
      "616–622"
    ],
    "title": [
      "Ueber einige Derivate der Phenylmethacrylsäure und der Phenylisobuttersäure",
      "In retrospect, it is not exactly clear what compound Edeleano synthesized, and this was agonized over long in court"
    ],
    "type": "article-journal",
    "volume": [
      "20"
    ]
  },
  {
    "author": [
      {
        "family": "Miura",
        "given": "See Kinnosuke"
      },
      {
        "given": "G."
      },
      {
        "family": "Chen",
        "given": "See K.K."
      },
      {
        "family": "Schmidt",
        "given": "Carl F."
      },
      {
        "family": "Carl F. Schmidt",
        "given": "See",
        "particle": "also"
      },
      {
        "family": "Sneader",
        "given": "Walter"
      },
      {
        "family": "Takamine",
        "given": "Jokichi"
      },
      {
        "family": "Dale",
        "given": "H."
      },
      {
        "family": "Mannich",
        "given": "C.]"
      },
      {
        "family": "Jacobsohn",
        "given": "W."
      }
    ],
    "citation-number": [
      "66."
    ],
    "container-title": [
      "1885",
      "Berliner Klinische Wochenschrift",
      "JAMA",
      "Annual Review of Physiology",
      "Therapeutic Gazette",
      "Journal of Physiology",
      "Berichte der Deutschen Chemischen Gesellschaft"
    ],
    "date": [
      "1946-08-06",
      "Sept. 19",
      "1926-09-11",
      "1985",
      "1901",
      "1910",
      "1910"
    ],
    "issue": [
      "1961"
    ],
    "location": [
      "Chichester"
    ],
    "note": [
      "BNA) 382,",
      "G[eorge] Barger and H[enry",
      "70. For a guide to PEA derivatives, see Lundbeck Institute, Psychotropics"
    ],
    "pages": [
      "65",
      "836–842",
      "1–14, 5",
      "100 67",
      "221–224 68",
      "19–59 69",
      "189–197"
    ],
    "publisher": [
      "Wiley"
    ],
    "title": [
      "Aus der chirurgisch-ophthalmologischen Universitätsklinik in Tokio (Japan): Vorläufige Mittheilung über Ephedrin, ein neues Mydriaticum",
      "1887): 707, reporting the work of “Prof. Dr. Nagai",
      "Yamanashi had isolated an impure form of the alkaloid",
      "Action and Clinical Use of Ephedrine",
      "Pharmacology in a Changing World",
      "Drug Discovery: The Evolution of Modern Medicines",
      "The Blood-Pressure-Raising Principle of the Suprarenal Glands—A Preliminary Report",
      "Chemical Structure and Sympathomimetic Action of Amines",
      "Ueber Oxyphenyl-alkylamine und Dioxyphenyl-alkylamine"
    ],
    "type": "article-journal",
    "volume": [
      "2",
      "24",
      "87",
      "23",
      "25",
      "41",
      "43"
    ]
  },
  {
    "citation-number": [
      "2002/03"
    ],
    "date": [
      "2003"
    ],
    "location": [
      "Copenhagen"
    ],
    "pages": [
      "385–400"
    ],
    "publisher": [
      "Lundbeck Institute"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Burnat",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "71."
    ],
    "container-title": [
      "Presse Médicale"
    ],
    "date": [
      "1996-09-14"
    ],
    "pages": [
      "1208–1212"
    ],
    "title": [
      "L’Ecstasy: Psychostimulant, hallucinogène et toxique"
    ],
    "type": "article-journal",
    "volume": [
      "25"
    ]
  },
  {
    "citation-number": [
      "72."
    ],
    "container-title": [
      "Neurology and the Neurosciences"
    ],
    "date": [
      "2000"
    ],
    "edition": [
      "2nd"
    ],
    "location": [
      "Philadelphia"
    ],
    "pages": [
      "595–598"
    ],
    "publisher": [
      "Lippincott"
    ],
    "title": [
      "For a helpful summary of both drugs, and of almost all other drugs discussed in this book, the reader is referred to Frank Ayd, Jr., Lexicon of Psychiatry"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "J",
        "given": "S."
      }
    ],
    "citation-number": [
      "73."
    ],
    "date": [
      "1991"
    ],
    "editor": [
      {
        "family": "Sandler",
        "given": "Merton"
      },
      {
        "others": true
      }
    ],
    "location": [
      "Oxford"
    ],
    "pages": [
      "20"
    ],
    "publisher": [
      "Oxford University Press"
    ],
    "title": [
      "Peroutka, discussion",
      "5-Hydroxytryptamine in Psychiatry: A Spectrum of Ideas"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "advertisement",
        "given": "Desoxyn"
      },
      {
        "family": "New York",
        "particle": "in"
      }
    ],
    "citation-number": [
      "74."
    ],
    "container-title": [
      "State Journal of Medicine",
      "Annals of Internal Medicine"
    ],
    "date": [
      "1947",
      "2005"
    ],
    "pages": [
      "380–385"
    ],
    "title": [
      "On 1943 as the launch year of methamphetamine, see Eric Colman, “Anorectics on Trial: A Half Century of Federal Regulation of Prescription Appetite Suppressants"
    ],
    "type": "article-journal",
    "volume": [
      "47",
      "143"
    ]
  },
  {
    "author": [
      {
        "family": "Späth",
        "given": "Ernst"
      }
    ],
    "citation-number": [
      "75."
    ],
    "container-title": [
      "Monatshefte für Chemie"
    ],
    "date": [
      "1919"
    ],
    "pages": [
      "129–154"
    ],
    "title": [
      "Ueber die Anhalonium–Alkaloide: I. Anhalin und Mezcalin"
    ],
    "type": "article-journal",
    "volume": [
      "40"
    ]
  },
  {
    "author": [
      {
        "family": "Mitchell",
        "given": "S.Weir"
      },
      {
        "given": "Heffter"
      }
    ],
    "citation-number": [
      "76."
    ],
    "container-title": [
      "BMJ",
      "Berichte der Deutschen Chemischen Gesellschaft"
    ],
    "date": [
      "Dec. 5",
      "1896"
    ],
    "note": [
      "On its isolation, see A."
    ],
    "pages": [
      "1625–1629",
      "216–227"
    ],
    "title": [
      "Remarks on the Effects of Anhelonium Lewinii (the Mescal Button",
      "Ueber Cacteenalkaloide"
    ],
    "type": "article-journal",
    "volume": [
      "2",
      "1896",
      "29"
    ]
  },
  {
    "author": [
      {
        "family": "Ellis",
        "given": "Havelock"
      }
    ],
    "citation-number": [
      "77."
    ],
    "container-title": [
      "Contemporary Review"
    ],
    "date": [
      "1898",
      "quote 141"
    ],
    "pages": [
      "130–141,"
    ],
    "title": [
      "Mescal: A New Artificial Paradise"
    ],
    "type": "article-journal",
    "volume": [
      "73"
    ]
  },
  {
    "author": [
      {
        "family": "Piness",
        "given": "George"
      },
      {
        "family": "Miller",
        "given": "Hyman"
      },
      {
        "family": "Alles",
        "given": "Gordon A."
      }
    ],
    "citation-number": [
      "78."
    ],
    "container-title": [
      "JAMA"
    ],
    "date": [
      "1930-03-15"
    ],
    "pages": [
      "790–791"
    ],
    "title": [
      "Clinical Observations on Phenylaminoethanol Sulphate"
    ],
    "type": "article-journal",
    "volume": [
      "94"
    ]
  },
  {
    "author": [
      {
        "given": "Smith"
      }
    ],
    "citation-number": [
      "79."
    ],
    "pages": [
      "8"
    ],
    "publisher": [
      "Clark & Clark"
    ],
    "title": [
      "Kline & French v"
    ],
    "type": "book"
  },
  {
    "citation-number": [
      "80."
    ],
    "container-title": [
      "Amphetamine in American Medicine"
    ],
    "date": [
      "1929"
    ],
    "title": [
      "The details in this section are based on Nicolas Rasmussen, “Making the First Anti-Depressant"
    ],
    "type": "article-journal"
  },
  {
    "date": [
      "2006"
    ],
    "pages": [
      "288–314"
    ],
    "title": [
      "Journal of the History of Medicine and Allied Sciences 61"
    ],
    "type": null
  },
  {
    "author": [
      {
        "literal": "Rasmussen had access to the Alles papers; further details are also in Smith, Kline & French v. Clark & Clark."
      }
    ],
    "date": [
      "1979-07-12"
    ],
    "genre": [
      "RG 88,"
    ],
    "note": [
      "General Subject Files, 88-85-49, box 33. 81. Council on Pharmacy and Chemistry, “Reports of the Council,” JAMA 111"
    ],
    "title": [
      "On 1932 as the marketing date for the first amphetamines, see Sherwin Gardner to the secretary",
      "National Archives and Records Administration"
    ],
    "type": "report"
  },
  {
    "author": [
      {
        "family": "Smith",
        "given": "See",
        "particle": "also"
      },
      {
        "given": "Kline"
      },
      {
        "family": "Clark",
        "given": "French Laboratories",
        "particle": "v."
      },
      {
        "given": "Clark"
      },
      {
        "others": true
      },
      {
        "family": "LEXIS",
        "given": "U.S.Dist"
      },
      {
        "family": "Prinzmetal",
        "given": "Myron"
      },
      {
        "family": "Bloomberg",
        "given": "Wilfred"
      },
      {
        "family": "Peoples",
        "given": "A.S."
      },
      {
        "family": "Guttmann",
        "given": "E.]"
      },
      {
        "family": "Guttmann",
        "given": "Erich"
      },
      {
        "family": "Sargant",
        "given": "William"
      },
      {
        "family": "Myerson",
        "given": "Abraham"
      },
      {
        "family": "Nathanson",
        "given": "M.] H."
      },
      {
        "family": "Wilbur",
        "given": "Dwight L."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Supp",
      "JAMA",
      "Lancet",
      "BMJ",
      "AMA Archives of Neurology and Psychiatry",
      "JAMA",
      "JAMA"
    ],
    "date": [
      "1938-07-02",
      "1945",
      "1899",
      "1945",
      "1935-12-21",
      "1014",
      "1936",
      "1937-08-21"
    ],
    "genre": [
      "quotes 1108–1109. 84.",
      "quote 817. 86."
    ],
    "issue": [
      "May 16, 1936",
      "May 15, 1937",
      "Feb. 13, 1937"
    ],
    "pages": [
      "27",
      "2 82",
      "2051–2054 83",
      "1107–1109,",
      "1013–1015,",
      "85",
      "816–822,",
      "528–531, 531 87",
      "549–554"
    ],
    "title": [
      "C-2311; United States District Court for the District of New Jersey, 62 F",
      "The Use of Benzedrine for the Treatment of Narcolepsy",
      "Hypertension Produced with Benzedrine: Its Psychological Accompaniments",
      "Observations on Benzedrine",
      "Effect of Benzedrine Sulfate on Mood and Fatigue in Normal and in Neurotic Persons",
      "The Central Action of Beta-aminopropylbenzene (Benzedrine",
      "Clinical Observations on the Effect of Benzedrine Sulfate: A Study of Patients with States of Chronic Exhaustion, Depression and Psychoneurosis"
    ],
    "type": "article-journal",
    "volume": [
      "971",
      "66 U.S.P.Q. (BNA) 440, Sept. 1",
      "105",
      "1",
      "1",
      "36",
      "108",
      "109"
    ]
  },
  {
    "author": [
      {
        "family": "Sollmann",
        "given": "Torald"
      }
    ],
    "citation-number": [
      "88."
    ],
    "date": [
      "1948"
    ],
    "edition": [
      "7th"
    ],
    "location": [
      "Philadelphia"
    ],
    "pages": [
      "385"
    ],
    "publisher": [
      "Saunders"
    ],
    "title": [
      "A Manual of Pharmacology"
    ],
    "type": "book"
  },
  {
    "citation-number": [
      "89."
    ],
    "date": [
      "1942-03-17"
    ],
    "genre": [
      "Patent 2,276,508,"
    ],
    "title": [
      "United States Patent Office"
    ],
    "type": "patent"
  },
  {
    "citation-number": [
      "90."
    ],
    "note": [
      "267 (Benzedrine), 1883 (Dexedrine)."
    ],
    "title": [
      "Compare the numbers of Benzedrine and Dexedrine advertisements in the New York State Journal of Medicine in 1946"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "advertisement",
        "given": "Benzedrine"
      }
    ],
    "citation-number": [
      "91."
    ],
    "container-title": [
      "New York State Journal of Medicine"
    ],
    "date": [
      "1941-01-15"
    ],
    "pages": [
      "185"
    ],
    "type": "article-journal",
    "volume": [
      "41"
    ]
  },
  {
    "citation-number": [
      "92."
    ],
    "container-title": [
      "see New York State Journal of Medicine"
    ],
    "title": [
      "Advertisement for Benzedrine"
    ],
    "type": "article-journal",
    "volume": [
      "47"
    ]
  },
  {
    "author": [
      {
        "family": "Rasmussen",
        "given": "Nicolas"
      }
    ],
    "date": [
      "1947",
      "1948",
      "93",
      "2005",
      "2006"
    ],
    "pages": [
      "2193",
      "20–21"
    ],
    "title": [
      "2082; advertisement for Dexedrine, see New York State Journal of Medicine 48",
      "Among the historians to pick up on the amphetamines as the “first generation” of antidepressants are Shorter, Historical Dictionary of Psychiatry",
      "First Anti-Depressant Amphetamine"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "advertisement",
        "given": "Desoxyn"
      }
    ],
    "citation-number": [
      "94."
    ],
    "container-title": [
      "New York State Journal of Medicine"
    ],
    "date": [
      "1947"
    ],
    "pages": [
      "1473"
    ],
    "type": "article-journal",
    "volume": [
      "47"
    ]
  },
  {
    "author": [
      {
        "family": "Delay",
        "given": "Jean"
      }
    ],
    "container-title": [
      "Proceedings of the Royal Society of Medicine 42",
      "Medical Record",
      "New York State Journal of Medicine"
    ],
    "date": [
      "1943",
      "1950"
    ],
    "pages": [
      "422–424",
      "2750 96"
    ],
    "title": [
      "The factual basis of the claim was probably Eugene Davidoff, “A Comparison of the Stimulating Effect of Amphetamine, Dextroamphetamine and Dextro-N-Methyl Amphetamine (Dextro-Desoxyephedrine",
      "Davidoff had conducted several trials of amphetamines. 95. Advertisement for Methedrine",
      "Pharmacological Explorations of the Personality: Narco-Analysis and Methedrine Shock"
    ],
    "type": "article-journal",
    "volume": [
      "156",
      "50"
    ]
  },
  {
    "date": [
      "1949"
    ],
    "pages": [
      "491–496, 491–492"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "M] Rudolf",
        "given": "G.]",
        "particle": "de"
      }
    ],
    "citation-number": [
      "97."
    ],
    "container-title": [
      "The Practitioner"
    ],
    "date": [
      "1955"
    ],
    "pages": [
      "180–183"
    ],
    "title": [
      "Treatment of Depression with Sympathomimetic Preparations"
    ],
    "type": "article-journal",
    "volume": [
      "174"
    ]
  },
  {
    "citation-number": [
      "98."
    ],
    "container-title": [
      "Lancet"
    ],
    "date": [
      "1955-05-21"
    ],
    "pages": [
      "1065"
    ],
    "title": [
      "Editorial “Drugs in the Treatment of Depression"
    ],
    "type": "article-journal",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "Simon",
        "given": "John L."
      },
      {
        "family": "Taube",
        "given": "Harry"
      }
    ],
    "citation-number": [
      "99."
    ],
    "container-title": [
      "Journal of Nervous and Mental Disease"
    ],
    "date": [
      "1946"
    ],
    "pages": [
      "593–596"
    ],
    "title": [
      "A Preliminary Study on the Use of Methedrine in Psychiatric Diagnosis"
    ],
    "type": "article-journal",
    "volume": [
      "104"
    ]
  },
  {
    "author": [
      {
        "family": "Ling",
        "given": "T.M."
      },
      {
        "family": "Davies",
        "given": "L.S."
      },
      {
        "family": "John T. Hutchinson",
        "given": "See",
        "particle": "also"
      }
    ],
    "citation-number": [
      "100."
    ],
    "container-title": [
      "AJP",
      "British Journal of Clinical Practice"
    ],
    "date": [
      "1952",
      "1956"
    ],
    "pages": [
      "38–39",
      "541–544, 543"
    ],
    "title": [
      "The Use of Methedrine in the Diagnosis and Treatment of the Psychoneuroses",
      "The Value of Drugs in the Treatment of Neuroses"
    ],
    "type": "article-journal",
    "volume": [
      "109",
      "10"
    ]
  },
  {
    "author": [
      {
        "family": "McNulty",
        "given": "Sheila"
      }
    ],
    "citation-number": [
      "101."
    ],
    "container-title": [
      "Financial Times Weekend"
    ],
    "date": [
      "2005-08-20"
    ],
    "pages": [
      "1"
    ],
    "title": [
      "Needles and Haystacks"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Cohen",
        "given": "Benjamin"
      },
      {
        "family": "Myerson",
        "given": "Abraham"
      }
    ],
    "citation-number": [
      "102."
    ],
    "container-title": [
      "AJP"
    ],
    "date": [
      "1938",
      "quote 387"
    ],
    "pages": [
      "371–393,"
    ],
    "title": [
      "The Effective Use of Phenobarbital and Benzedrine Sulfate (Amphetamine Sulfate) in the Treatment of Epilepsy"
    ],
    "type": "article-journal",
    "volume": [
      "95"
    ]
  },
  {
    "author": [
      {
        "family": "Reifenstein",
        "given": "Edward C."
      },
      {
        "family": "Davidoff",
        "given": "Eugene"
      }
    ],
    "citation-number": [
      "103."
    ],
    "container-title": [
      "New York State Journal of Medicine"
    ],
    "date": [
      "1939",
      "quote 52"
    ],
    "pages": [
      "42–57,"
    ],
    "title": [
      "Benzedrine Sulfate Therapy"
    ],
    "type": "article-journal",
    "volume": [
      "39"
    ]
  },
  {
    "author": [
      {
        "family": "Myerson",
        "given": "Abraham"
      }
    ],
    "citation-number": [
      "104."
    ],
    "container-title": [
      "NEJM",
      "NEJM"
    ],
    "date": [
      "1939-10-12",
      "quotes 562",
      "1939-12-28"
    ],
    "note": [
      "Paredrine is hydroxyamphetamine."
    ],
    "pages": [
      "561–564,",
      "1015–1019"
    ],
    "title": [
      "The Reciprocal Pharmacologic Effects of Amphetamine (Benzedrine) Sulfate and the Barbiturates",
      "The article referred to in the quote was Myerson et al., “The Effect of Amphetamine (Benzedrine) Sulfate and Paredrine Hydrobromide on Sodium Amytal Narcosis"
    ],
    "type": "article-journal",
    "volume": [
      "221",
      "221"
    ]
  },
  {
    "author": [
      {
        "family": "Gottlieb",
        "given": "Jacques S."
      },
      {
        "family": "Coburn",
        "given": "Frank E."
      }
    ],
    "citation-number": [
      "105."
    ],
    "container-title": [
      "AMA Archives of Neurology and Psychiatry"
    ],
    "date": [
      "1944"
    ],
    "pages": [
      "260–263"
    ],
    "title": [
      "Psychopharmacologic Study of Schizophrenia and Depressions: Intravenous Administration of Sodium Amytal and Amphetamine Sulfate Separately and in Various Combinations"
    ],
    "type": "article-journal",
    "volume": [
      "51"
    ]
  },
  {
    "author": [
      {
        "family": "Gottlieb",
        "given": "Jacques S."
      }
    ],
    "citation-number": [
      "106."
    ],
    "container-title": [
      "Diseases of the Nervous System"
    ],
    "date": [
      "1949"
    ],
    "pages": [
      "50–52, 50–51"
    ],
    "title": [
      "The Use of Sodium Amytal and Benzedrine Sulfate in the Symptomatic Treatment of Depressions"
    ],
    "type": "article-journal",
    "volume": [
      "10"
    ]
  },
  {
    "author": [
      {
        "family": "Legge",
        "given": "D."
      },
      {
        "family": "Steinberg",
        "given": "Hannah"
      }
    ],
    "citation-number": [
      "107."
    ],
    "container-title": [
      "British Journal of Pharmacology"
    ],
    "date": [
      "1962"
    ],
    "pages": [
      "490–500, 499"
    ],
    "title": [
      "Actions of a Mixture of Amphetamine and a Barbiturate in Man"
    ],
    "type": "article-journal",
    "volume": [
      "18"
    ]
  },
  {
    "citation-number": [
      "108."
    ],
    "container-title": [
      "New York State Journal of Medicine"
    ],
    "date": [
      "1950"
    ],
    "pages": [
      "1897"
    ],
    "title": [
      "Benzebar advertisement"
    ],
    "type": "article-journal",
    "volume": [
      "48"
    ]
  },
  {
    "author": [
      {
        "family": "Pennes",
        "given": "Harry H."
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Bulletin of the New York Academy of Medicine"
    ],
    "date": [
      "1957",
      "quote 81"
    ],
    "pages": [
      "81–88,"
    ],
    "title": [
      "The Nature of Drugs with Mental Actions and Their Relation to Cerebral Function"
    ],
    "type": "article-journal",
    "volume": [
      "33"
    ]
  },
  {
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Psiquiatria Biol"
    ],
    "date": [
      "1999"
    ],
    "pages": [
      "177–189"
    ],
    "title": [
      "The term “first drug set” was coined by Thomas Ban in the 1960s, then revived in his “Selective Drugs Versus Heterogeneous Diagnoses: Towards a New Methodology in Psychopharmacologic Research"
    ],
    "type": "article-journal",
    "volume": [
      "7"
    ]
  },
  {
    "citation-number": [
      "3."
    ],
    "date": [
      "1962-01-15"
    ],
    "genre": [
      "F-D-C Reports/Pink Sheet,"
    ],
    "pages": [
      "20"
    ],
    "title": [
      "Wyeth’s Spartase Came from ‘Entirely New Development in Therapy,’"
    ],
    "type": "report"
  },
  {
    "author": [
      {
        "family": "Robert",
        "given": "S."
      }
    ],
    "citation-number": [
      "4."
    ],
    "date": [
      "1958-10-28"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "pages": [
      "2534"
    ],
    "publisher": [
      "General Subject Files"
    ],
    "title": [
      "Roe (director, BPS) to commissioner"
    ],
    "type": null
  },
  {
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Mar"
    ],
    "date": [
      "1965"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "note": [
      "General Subject Files, box 4248."
    ],
    "title": [
      "Joseph Sadusk (head of Bureau of Medicine) to George Larrick (commissioner"
    ],
    "type": "article-journal",
    "volume": [
      "17"
    ]
  },
  {
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Depression: Proceedings of the Symposium Held at Cambridge 22 to 26 September 1959"
    ],
    "date": [
      "1964"
    ],
    "editor": [
      {
        "family": "Fish",
        "given": "Frank"
      },
      {
        "family": "discussion",
        "given": "in E.Beresford Davies"
      }
    ],
    "location": [
      "Cambridge"
    ],
    "pages": [
      "349"
    ],
    "publisher": [
      "Cambridge University Press"
    ],
    "type": "paper-conference"
  },
  {
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Anxiety: The Proceedings of the 39th Annual Meeting of the American Psycho-Pathological Association, Held in New York City, June, 1949"
    ],
    "date": [
      "1950"
    ],
    "editor": [
      {
        "family": "Hoch",
        "given": "Paul"
      },
      {
        "family": "Zubin",
        "given": "Joseph"
      }
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "Grune & Stratton"
    ],
    "type": "paper-conference"
  },
  {
    "author": [
      {
        "family": "Berger",
        "given": "F.] M."
      },
      {
        "family": "Bradley",
        "given": "W."
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "British Journal of Pharmacology",
      "Monatshefte"
    ],
    "date": [
      "1946"
    ],
    "pages": [
      "265–272"
    ],
    "title": [
      "The Pharmacological Properties of Dihydroxy (2-Methylphenoxy)-Propane (Myanesin",
      "Myanesin is a brand name for the generic mephenesin. For the synthesis of mephenesin see Petar Zivkovic, “Ueber eine neue Bildungsart von Äethern des Glyzerins mit Phenolen"
    ],
    "type": "article-journal",
    "volume": [
      "1"
    ]
  },
  {
    "title": [
      "für Chemie 29 (1908): 951–958; for the history of the glycerol ethers see Louis"
    ],
    "type": null
  },
  {
    "container-title": [
      "The Pharmacological Basis of Therapeutics"
    ],
    "date": [
      "1955"
    ],
    "edition": [
      "2nd"
    ],
    "editor": [
      {
        "given": "Goodman"
      },
      {
        "family": "Gilman",
        "given": "Alfred"
      }
    ],
    "location": [
      "New York"
    ],
    "pages": [
      "206–207"
    ],
    "publisher": [
      "Macmillan"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "interview",
        "given": "Frank Berger"
      },
      {
        "family": "Edward Shorter",
        "particle": "by"
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Aug"
    ],
    "date": [
      "2006"
    ],
    "location": [
      "in New York"
    ],
    "type": "article-journal",
    "volume": [
      "10"
    ]
  },
  {
    "author": [
      {
        "family": "Berger",
        "given": "F.] M."
      },
      {
        "family": "Bradley",
        "given": "W."
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "Lancet"
    ],
    "date": [
      "1947-01-18"
    ],
    "note": [
      "Berger interview."
    ],
    "pages": [
      "97 11"
    ],
    "title": [
      "Muscle-Relaxing Action of Myanesin"
    ],
    "type": "article-journal",
    "volume": [
      "252"
    ]
  },
  {
    "author": [
      {
        "family": "anxiety",
        "given": "On",
        "particle": "mephenesin in"
      },
      {
        "family": "Louis S. Schlan",
        "particle": "see"
      },
      {
        "family": "Unna",
        "given": "Klaus R."
      }
    ],
    "citation-number": [
      "12."
    ],
    "container-title": [
      "JAMA"
    ],
    "date": [
      "1949-06-25"
    ],
    "pages": [
      "672–673"
    ],
    "title": [
      "Some Effects of Myanesin in Psychiatric Patients"
    ],
    "type": "article-journal",
    "volume": [
      "140"
    ]
  },
  {
    "citation-number": [
      "13."
    ],
    "date": [
      "1951"
    ],
    "pages": [
      "2"
    ],
    "title": [
      "Tolserol advertisement, Diseases of the Nervous System 12"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "advertisement",
        "given": "Serpasil"
      }
    ],
    "citation-number": [
      "19."
    ],
    "container-title": [
      "New York State Journal of Medicine"
    ],
    "date": [
      "1953"
    ],
    "pages": [
      "3076"
    ],
    "type": "article-journal",
    "volume": [
      "53"
    ]
  },
  {
    "author": [
      {
        "family": "advertisement",
        "given": "Rauwiloid"
      }
    ],
    "citation-number": [
      "20."
    ],
    "container-title": [
      "New York State Journal of Medicine"
    ],
    "date": [
      "1953"
    ],
    "pages": [
      "1628–1629"
    ],
    "type": "article-journal",
    "volume": [
      "53"
    ]
  },
  {
    "author": [
      {
        "family": "Wilkins",
        "given": "Robert W."
      }
    ],
    "citation-number": [
      "21."
    ],
    "container-title": [
      "Annals of the New York Academy of Sciences"
    ],
    "date": [
      "1954"
    ],
    "pages": [
      "36–44, 43"
    ],
    "title": [
      "Clinical Usage of Rauwolfia Alkaloids, Including Reserpine (Serpasil"
    ],
    "type": "chapter",
    "volume": [
      "59"
    ]
  },
  {
    "author": [
      {
        "family": "advertisement",
        "given": "Rauwidrine"
      }
    ],
    "citation-number": [
      "22."
    ],
    "container-title": [
      "New York State Journal of Medicine"
    ],
    "date": [
      "1954"
    ],
    "pages": [
      "915"
    ],
    "type": "article-journal",
    "volume": [
      "54"
    ]
  },
  {
    "citation-number": [
      "23."
    ],
    "date": [
      "1957-03-04"
    ],
    "genre": [
      "F-D-C Reports/Pink Sheet,"
    ],
    "pages": [
      "11–12"
    ],
    "title": [
      "FDA Seizes ‘Tranquil,’"
    ],
    "type": "report"
  },
  {
    "citation-number": [
      "24."
    ],
    "container-title": [
      "F-D-C Reports/Pink Sheet, Apr"
    ],
    "date": [
      "1957"
    ],
    "pages": [
      "7–8"
    ],
    "title": [
      "Tranquilizer Classifications"
    ],
    "type": "article-journal",
    "volume": [
      "1"
    ]
  },
  {
    "citation-number": [
      "25."
    ],
    "container-title": [
      "State Journal of Medicine"
    ],
    "date": [
      "1951"
    ],
    "note": [
      "2213; Alexandre Blondeau, Histoire des laboratoires"
    ],
    "title": [
      "For the first Dormison advertisement, see New York"
    ],
    "type": "article-journal",
    "volume": [
      "51"
    ]
  },
  {
    "date": [
      "1994",
      "1976",
      "1957"
    ],
    "edition": [
      "9th"
    ],
    "editor": [
      {
        "family": "Efron",
        "given": "Daniel E."
      }
    ],
    "issue": [
      "5671, 5672"
    ],
    "location": [
      "Paris",
      "Rahway, NJ",
      "Psychopharmacology"
    ],
    "pages": [
      "167–168",
      "26"
    ],
    "publisher": [
      "Cherche Midi",
      "Merck",
      "A Review of Progress"
    ],
    "title": [
      "pharmaceutiques en France et de leurs médicaments",
      "On sorting out methylparfynol (meparfynol) and its congeners, see The Merck Index",
      "On scientific use of the term antineurotic, see, for example, Karl Rickels, chair of session on “Antineurotic Agents",
      "Public Health Service Pub"
    ],
    "type": "book",
    "volume": [
      "2",
      "5666"
    ]
  },
  {
    "author": [
      {
        "family": "Weber",
        "given": "Renate"
      }
    ],
    "date": [
      "1968"
    ],
    "issue": [
      "1836"
    ],
    "location": [
      "Washington, DC"
    ],
    "pages": [
      "137 27",
      "141"
    ],
    "publisher": [
      "GPO",
      "Deutsche Apotheker Zeitung"
    ],
    "title": [
      "Die Ritalin-Story"
    ],
    "type": "book",
    "volume": []
  },
  {
    "author": [
      {
        "family": "Leandro Panizzon",
        "given": "See",
        "particle": "also"
      },
      {
        "family": "Meier",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Helvetica Chimica Acta",
      "Klinische Wochenschrift"
    ],
    "date": [
      "2001",
      "1944",
      "1954-05-15"
    ],
    "pages": [
      "1091–1093",
      "1748–1756",
      "445–450"
    ],
    "title": [
      "La Preparazione di Piridil-e Piperidil-arilacetonitrili",
      "Ritalin, eine neuartige synthetische Verbindung mit spezifischer zentralerregender Wirkungskomponente"
    ],
    "type": "article-journal",
    "volume": [
      "27",
      "32"
    ]
  },
  {
    "citation-number": [
      "28."
    ],
    "date": [
      "1956"
    ],
    "pages": [
      "68"
    ],
    "title": [
      "Ritalin advertisement, Diseases of the Nervous System 17"
    ],
    "type": null
  },
  {
    "citation-number": [
      "29."
    ],
    "container-title": [
      "JAMA"
    ],
    "date": [
      "1957-04-13"
    ],
    "pages": [
      "4–5"
    ],
    "title": [
      "Ritalin advertisement"
    ],
    "type": "article-journal",
    "volume": [
      "163"
    ]
  },
  {
    "author": [
      {
        "family": "Cole",
        "given": "J."
      },
      {
        "family": "Glees",
        "given": "P."
      }
    ],
    "citation-number": [
      "30."
    ],
    "container-title": [
      "Lancet"
    ],
    "date": [
      "1956-03-24"
    ],
    "pages": [
      "338"
    ],
    "title": [
      "Ritalin as an Antagonist to Reserpine in Monkeys"
    ],
    "type": "article-journal",
    "volume": [
      "270"
    ]
  },
  {
    "author": [
      {
        "family": "Drassdo",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "31."
    ],
    "container-title": [
      "Medizinische Klinik"
    ],
    "date": [
      "1954-05-28"
    ],
    "pages": [
      "892–893"
    ],
    "title": [
      "Untersuchungen über ein neuartiges, zentrales Stimulans (Ritalin"
    ],
    "type": "article-journal",
    "volume": [
      "49"
    ]
  },
  {
    "citation-number": [
      "32."
    ],
    "date": [
      "1956-07-30"
    ],
    "genre": [
      "F-D-C Reports/Pink Sheet,"
    ],
    "pages": [
      "6"
    ],
    "title": [
      "Other Interesting Figures Disclosed by the Import Tabulation"
    ],
    "type": "report"
  },
  {
    "author": [
      {
        "family": "Ferguson",
        "given": "John T."
      }
    ],
    "citation-number": [
      "33."
    ],
    "container-title": [
      "Annals of the New York Academy of Sciences"
    ],
    "date": [
      "1955"
    ],
    "pages": [
      "101–107"
    ],
    "title": [
      "Treatment of Reserpine-Induced Depression with a New Analeptic: Phenidylate [sic"
    ],
    "type": "chapter",
    "volume": [
      "61"
    ]
  },
  {
    "author": [
      {
        "family": "Natenshon",
        "given": "Adolph L."
      },
      {
        "family": "A. B. Kerenyi",
        "given": "See",
        "particle": "also"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "34."
    ],
    "container-title": [
      "Diseases of the Nervous System",
      "Canadian Medical Association Journal"
    ],
    "date": [
      "1956",
      "quote 395"
    ],
    "pages": [
      "392–396,"
    ],
    "title": [
      "Clinical Evaluation of Ritalin",
      "The 39 fatigued, depressed patients were a subset of the 89 in this open trial",
      "Depressive States and Drugs—III. Use of Methylphenidate (Ritalin) in Open Psychiatric Settings and in Office Practice"
    ],
    "type": "article-journal",
    "volume": [
      "17"
    ]
  },
  {
    "citation-number": [
      "83"
    ],
    "date": [
      "1960-12-10"
    ],
    "pages": [
      "1249–1254"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Siegler",
        "given": "Peter E."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "35."
    ],
    "container-title": [
      "Current Therapeutic Research"
    ],
    "date": [
      "1960"
    ],
    "note": [
      "see 550, table 5."
    ],
    "pages": [
      "543–553,"
    ],
    "title": [
      "A Comparative Study of the Effects of Methylphenidate and a New Piperidine Compound (SCH 5472"
    ],
    "type": "article-journal",
    "volume": [
      "2"
    ]
  },
  {
    "author": [
      {
        "family": "Rickels",
        "given": "Karl"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "36."
    ],
    "container-title": [
      "Clinical Pharmacology and Therapeutics"
    ],
    "date": [
      "1970"
    ],
    "pages": [
      "698–710, 709"
    ],
    "title": [
      "Pemoline and Methylphenidate in Mildly Depressed Outpatients"
    ],
    "type": "article-journal",
    "volume": [
      "11"
    ]
  },
  {
    "author": [
      {
        "family": "Drugs",
        "given": "Council",
        "particle": "on"
      }
    ],
    "citation-number": [
      "37."
    ],
    "container-title": [
      "JAMA"
    ],
    "date": [
      "1957-04-20"
    ],
    "pages": [
      "1479–1480"
    ],
    "title": [
      "American Medical Association, “New and Nonofficial Drugs"
    ],
    "type": "article-journal",
    "volume": [
      "163"
    ]
  },
  {
    "author": [
      {
        "family": "Robin",
        "given": "A."
      },
      {
        "family": "Wiseberg",
        "given": "S."
      }
    ],
    "citation-number": [
      "38."
    ],
    "title": [
      "A placebo-controlled trial finding Ritalin ineffective in hospital depression was A",
      "A Controlled Trial of Methylphenidate"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "advertisement",
        "given": "Miltown"
      }
    ],
    "citation-number": [
      "43."
    ],
    "container-title": [
      "New York State Journal of Medicine"
    ],
    "date": [
      "1956"
    ],
    "pages": [
      "5"
    ],
    "type": "article-journal",
    "volume": [
      "56"
    ]
  },
  {
    "citation-number": [
      "44."
    ],
    "container-title": [
      "Evaluated by the AMA Council on Drugs"
    ],
    "date": [
      "1971"
    ],
    "location": [
      "Chicago"
    ],
    "pages": [
      "229"
    ],
    "publisher": [
      "AMA"
    ],
    "title": [
      "For hostility to Deprol, see the testimony of Heinz Lehmann and Fritz Freyhan at the Senate’s Kefauver Hearings Report, 178–179, and AMA Drug Evaluations"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "example",
        "given": "For"
      },
      {
        "family": "Karliner",
        "given": "William"
      },
      {
        "family": "Edward Shorter",
        "particle": "interview by"
      },
      {
        "family": "Fink",
        "given": "Max"
      }
    ],
    "citation-number": [
      "45."
    ],
    "container-title": [
      "Apr"
    ],
    "date": [
      "2004"
    ],
    "location": [
      "New York"
    ],
    "type": "article-journal",
    "volume": [
      "6"
    ]
  },
  {
    "author": [
      {
        "family": "Frank Ayd",
        "given": "interview by David Healy",
        "suffix": "Jr."
      }
    ],
    "citation-number": [
      "46."
    ],
    "date": [
      "1998-12-13"
    ],
    "note": [
      "American College of Neuropsychopharmacology (ACNP), Oral History Project; I am grateful to Thomas Ban for making the transcript available."
    ],
    "pages": [
      "10–11,"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Selling",
        "given": "Lowell S."
      }
    ],
    "citation-number": [
      "47."
    ],
    "container-title": [
      "JAMA"
    ],
    "issue": [
      "Apr. 30, 1955"
    ],
    "pages": [
      "1594–1596"
    ],
    "title": [
      "Clinical Study of a New Tranquilizing Drug: Use of Miltown"
    ],
    "type": "article-journal",
    "volume": [
      "157"
    ]
  },
  {
    "author": [
      {
        "family": "Hollister",
        "given": "Leo E."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "48."
    ],
    "title": [
      "Meprobamate in Chronic Psychiatric Patients"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Koteen",
        "given": "Herbert"
      }
    ],
    "container-title": [
      "BMJ",
      "Annals of Internal Medicine"
    ],
    "date": [
      "1957-07-13",
      "1957"
    ],
    "pages": [
      "63–66",
      "978–989"
    ],
    "title": [
      "Tranquilizing Drugs in Psychoneurosis",
      "Use of a ‘Double-Blind’ Study Investigating the Clinical Merits of a New Tranquilizing Agent"
    ],
    "type": "article-journal",
    "volume": [
      "2",
      "47"
    ]
  },
  {
    "author": [
      {
        "family": "Tucker",
        "given": "Weatherall",
        "particle": "cited"
      },
      {
        "family": "Tucker",
        "given": "Kenneth"
      },
      {
        "family": "Wilensky",
        "given": "Harold"
      }
    ],
    "container-title": [
      "AJP"
    ],
    "date": [
      "1957",
      "1957"
    ],
    "note": [
      "For a positive early trial beating placebo, see E. D."
    ],
    "pages": [
      "698–703"
    ],
    "title": [
      "to demonstrate the inadequacy of meprobamate in chronic schizophrenics",
      "A Clinical Evaluation of Meprobamate Therapy in a Chronic Schizophrenic Population"
    ],
    "type": "article-journal",
    "volume": [
      "113"
    ]
  },
  {
    "author": [
      {
        "given": "West"
      },
      {
        "others": true
      },
      {
        "family": "Greenblatt",
        "given": "David J."
      },
      {
        "family": "Shader",
        "given": "Richard I."
      },
      {
        "family": "Food",
        "given": "U.S."
      },
      {
        "family": "Administration",
        "given": "Drug"
      },
      {
        "family": "Borrus",
        "given": "Joseph C."
      },
      {
        "family": "Ayd",
        "given": "Frank J.",
        "suffix": "Jr"
      }
    ],
    "citation-number": [
      "50."
    ],
    "container-title": [
      "49. FDA, “In the Matter of Depressant and Stimulant Drugs,” docket no. FDA-DAC-1",
      "Medical Clinics of North America",
      "These statistics were entered as evidence in congressional hearings; Drug Abuse Control Amendments of 1965. Hearings Before the Committee on Interstate and Foreign Commerce, House of Representatives",
      "BMJ",
      "AJP"
    ],
    "date": [
      "1956-11-24",
      "1971",
      "1966-08-18",
      "1957",
      "1965",
      "1965"
    ],
    "issue": [
      "89-1"
    ],
    "location": [
      "Washington, DC"
    ],
    "note": [
      "89th Congress, First Session, on H.R. 2, Feb. 9,",
      "Berger interview. 53."
    ],
    "pages": [
      "1206–1209",
      "3519–3521,",
      "327–337, 334 51",
      "293 52"
    ],
    "publisher": [
      "GPO"
    ],
    "title": [
      "Controlled Trial of Meprobamate",
      "An interesting exercise in toting up these underpowered and relatively meaningless trials is",
      "Meprobamate: A Study of Irrational Drug Use",
      "1297–1303, who concluded the benzodiazepines were superior. This is possible, but does not necessarily mean that meprobamate was a bad drug",
      "Division of Dockets Management, Rockland, MD; obtained through the Freedom of Information Act (FOIA). Hereafter cited as “Meprobamate Hearings",
      "Meprobamate in Psychiatric Disorders",
      "The Early History of Psychopharmacology"
    ],
    "type": "article-journal",
    "volume": [
      "2",
      "127",
      "41",
      "l"
    ]
  },
  {
    "container-title": [
      "Neuropsychopharmacology"
    ],
    "date": [
      "1991"
    ],
    "pages": [
      "71–84, 73–74"
    ],
    "type": "article-journal",
    "volume": [
      "5"
    ]
  },
  {
    "citation-number": [
      "54."
    ],
    "container-title": [
      "Wolins Pharmacal Corp",
      "Supp",
      "Dist. LEXIS"
    ],
    "date": [
      "1299"
    ],
    "issue": [
      "70 C"
    ],
    "pages": [
      "168"
    ],
    "title": [
      "Information Carter-Wallace supplied for Carter-Wallace, Inc. v",
      "45; United States District Court for the Eastern District of New York, 326 F",
      "U.S"
    ],
    "type": "article-journal",
    "volume": [
      "14734"
    ]
  },
  {
    "author": [
      {
        "given": "U.S.P.Q."
      }
    ],
    "date": [
      "1971"
    ],
    "note": [
      "CCH) P73,488. Filed Feb. 5,"
    ],
    "pages": [
      "1"
    ],
    "title": [
      "566; 1971 Trade Cas"
    ],
    "type": null
  },
  {
    "author": [
      {
        "literal": "Carter became Carter-Wallace in"
      }
    ],
    "date": [
      "1965",
      "1957-06-10",
      "1956-11-05"
    ],
    "genre": [
      "F-D-C Reports/Pink Sheet,"
    ],
    "note": [
      "Estes Kefauver, in Kefauver Hearings (Tranquilizers), 9145. 57. See, for example, “New Tranquilizer Market Strategy,”"
    ],
    "pages": [
      "56",
      "11–12"
    ],
    "publisher": [
      "F-D-C Reports/Pink Sheet"
    ],
    "title": [
      "55. “AM Psychiatric Assn’s Kline Hits Unfavorable Tranquilizer Publicity at Senate Hearing"
    ],
    "type": "report",
    "volume": [
      "10"
    ]
  },
  {
    "author": [
      {
        "family": "testimony",
        "given": "Frank Ayd"
      }
    ],
    "citation-number": [
      "58."
    ],
    "container-title": [
      "Meprobamate Hearings"
    ],
    "date": [
      "1966-07-29"
    ],
    "pages": [
      "2084–2085"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Delay",
        "given": "Jean"
      }
    ],
    "citation-number": [
      "59."
    ],
    "date": [
      "1955-10-20",
      "1956"
    ],
    "editor": [
      {
        "given": "Delay"
      }
    ],
    "location": [
      "Paris",
      "Paris"
    ],
    "pages": [
      "3–6"
    ],
    "publisher": [
      "Doin"
    ],
    "title": [
      "Introduction au colloque international",
      "Colloque international sur la chlorpromazine"
    ],
    "type": "book"
  },
  {
    "citation-number": [
      "60."
    ],
    "container-title": [
      "Psychopharmacology Frontiers: Proceedings of the Psychopharmacology Symposium, Second International Congress of Psychiatry, Zurich, 1957"
    ],
    "date": [
      "1958"
    ],
    "editor": [
      {
        "family": "Deniker",
        "given": "Pierre"
      },
      {
        "family": "discussion",
        "given": "in Nathan S.Kline"
      }
    ],
    "location": [
      "Boston"
    ],
    "note": [
      "424; Deniker meant signs of Parkinsonism."
    ],
    "publisher": [
      "Little, Brown"
    ],
    "type": "paper-conference"
  },
  {
    "author": [
      {
        "family": "Organization",
        "given": "World Health"
      }
    ],
    "citation-number": [
      "61."
    ],
    "container-title": [
      "Technical Report Series"
    ],
    "issue": [
      "152"
    ],
    "location": [
      "Geneva"
    ],
    "title": [
      "Ataractic and Hallucinogenic Drugs in Psychiatry Report of a Study Group"
    ],
    "type": "article-journal",
    "volume": []
  },
  {
    "author": [
      {
        "family": "Charpentier",
        "given": "Paul"
      }
    ],
    "citation-number": [
      "65."
    ],
    "container-title": [
      "Comptes Rendus Hebdomadaires des Séances de l’Académie des Sciences 225"
    ],
    "date": [
      "1947"
    ],
    "pages": [
      "–",
      "306–308"
    ],
    "title": [
      "Sur la constitution d’une diméthylamino-propyl-N-phénothiazine"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "See",
        "given": "for example"
      }
    ],
    "citation-number": [
      "66."
    ],
    "date": [
      "1981",
      "1999"
    ],
    "genre": [
      "repr."
    ],
    "location": [
      "London"
    ],
    "pages": [
      "32"
    ],
    "publisher": [
      "Dunitz"
    ],
    "title": [
      "Jean Thuillier, Ten Years That Changed the Face of Mental Illness"
    ],
    "translator": [
      {
        "family": "Hickish",
        "given": "Gordon"
      }
    ],
    "type": null
  },
  {
    "citation-number": [
      "67."
    ],
    "container-title": [
      "Apr"
    ],
    "date": [
      "2007"
    ],
    "title": [
      "Thomas Ban, personal communication"
    ],
    "type": "article-journal",
    "volume": [
      "9"
    ]
  },
  {
    "citation-number": [
      "68."
    ],
    "date": [
      "2002"
    ],
    "location": [
      "Cambridge"
    ],
    "publisher": [
      "Harvard University Press"
    ],
    "title": [
      "For an authoritative account, see David Healy, The Creation of Psychopharmacology"
    ],
    "type": "book"
  },
  {
    "citation-number": [
      "69."
    ],
    "date": [
      "1955"
    ],
    "pages": [
      "227"
    ],
    "title": [
      "Thorazine advertisement, Diseases of the Nervous System 16"
    ],
    "type": null
  },
  {
    "citation-number": [
      "70."
    ],
    "date": [
      "2007-10-08"
    ],
    "genre": [
      "Thomas Ban, personal communication,"
    ],
    "type": "personal_communication"
  },
  {
    "author": [
      {
        "family": "M] Lacomme",
        "given": "See",
        "particle": "for example"
      },
      {
        "family": "Laborit",
        "given": "H.]"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "71."
    ],
    "container-title": [
      "Bulletin de la Féderation des Sociétés de Gynécologie et d’Obstétrique de Langue Française"
    ],
    "date": [
      "1952"
    ],
    "pages": [
      "558–562"
    ],
    "title": [
      "Note sur un essai d’analgésie obstétricale potentialisée par association de dolosal et de 45–50 R. P. en perfusion intra-veineuse. Étude de 175 cas"
    ],
    "type": "article-journal",
    "volume": [
      "4"
    ]
  },
  {
    "author": [
      {
        "family": "Delay",
        "given": "J.]"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "72."
    ],
    "container-title": [
      "Colloque international sur la chlorpromazine"
    ],
    "date": [
      "1955-10-20",
      "1956"
    ],
    "editor": [
      {
        "given": "Delay"
      }
    ],
    "location": [
      "Paris",
      "Paris"
    ],
    "pages": [
      "228–235"
    ],
    "publisher": [
      "Doin"
    ],
    "title": [
      "Etude de 300 dossiers de malades psychotiques traités par la chlorpromazine en service fermé depuis 1952"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Shorter",
        "given": "See Edward"
      },
      {
        "family": "Healy",
        "given": "David"
      }
    ],
    "citation-number": [
      "73."
    ],
    "date": [
      "2007"
    ],
    "location": [
      "New Brunswick, NJ"
    ],
    "publisher": [
      "Rutgers University Press"
    ],
    "title": [
      "Shock Therapy: The History of Electroconvulsive Treatment in Mental Illness"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Sigwald",
        "given": "J.]"
      },
      {
        "family": "Bouttier",
        "given": "D.]"
      }
    ],
    "citation-number": [
      "74."
    ],
    "container-title": [
      "Presse médicale"
    ],
    "date": [
      "1953-04-25",
      "quote 608"
    ],
    "pages": [
      "607–609,"
    ],
    "title": [
      "L’utilisation des propriétés neuroplégiques du chlorhydrate de chloro-3(diméthylamino-3’-propyl)-phénothiazine en thérapeutique neuro-psychiatrique"
    ],
    "type": "article-journal",
    "volume": [
      "61"
    ]
  },
  {
    "author": [
      {
        "family": "Sigwald",
        "given": "J.]"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "75."
    ],
    "container-title": [
      "Journal of Clinical and Experimental Psychopathology and Quarterly Review of Psychiatry and Neurology"
    ],
    "date": [
      "1956",
      "quote 68"
    ],
    "pages": [
      "57–69,"
    ],
    "title": [
      "‘Ambulatory’ Treatment with Chlorpromazine"
    ],
    "type": "article-journal",
    "volume": [
      "17"
    ]
  },
  {
    "author": [
      {
        "family": "Hutchinson",
        "given": "John T."
      }
    ],
    "citation-number": [
      "76."
    ],
    "container-title": [
      "British Journal of Clinical Practice"
    ],
    "date": [
      "1956",
      "quote 541"
    ],
    "pages": [
      "541–544,"
    ],
    "title": [
      "The Value of Drugs in the Treatment of Neuroses"
    ],
    "type": "article-journal",
    "volume": [
      "10"
    ]
  },
  {
    "author": [
      {
        "family": "Kielholz",
        "given": "P.]"
      }
    ],
    "citation-number": [
      "77."
    ],
    "container-title": [
      "Schweizer Archiv für Neurologie und Psychiatrie"
    ],
    "date": [
      "1954"
    ],
    "pages": [
      "291–309"
    ],
    "title": [
      "Über die Largactilwirkung bei depressiven Zuständen und Manien sowie bei der Entziehung von Morphin- und Barbitursüchtigen"
    ],
    "type": "article-journal",
    "volume": [
      "73"
    ]
  },
  {
    "author": [
      {
        "family": "Lehmann",
        "given": "Heinz"
      }
    ],
    "citation-number": [
      "78."
    ],
    "container-title": [
      "interview, in The Psychopharmacologists"
    ],
    "date": [
      "1996"
    ],
    "editor": [
      {
        "family": "David Healy",
        "particle": "ed."
      }
    ],
    "location": [
      "London"
    ],
    "pages": [
      "159–186",
      "160"
    ],
    "publisher": [
      "Chapman and Hall"
    ],
    "title": [
      "Psychopharmacotherapy"
    ],
    "type": "chapter",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "Goldman",
        "given": "Douglas"
      }
    ],
    "citation-number": [
      "79."
    ],
    "container-title": [
      "Chlorpromazine and Mental Health: Proceedings of the Symposium Held"
    ],
    "date": [
      "1955-06-06"
    ],
    "editor": [
      {
        "literal": "ed."
      }
    ],
    "location": [
      "Warwick Hotel, Philadelphia, Pennsylvania"
    ],
    "title": [
      "The Effect of Chlorpromazine on Severe Mental and Emotional Disturbances"
    ],
    "type": "paper-conference"
  },
  {
    "author": [
      {
        "family": "Smith",
        "given": "Kline"
      },
      {
        "family": "Laboratories",
        "given": "French"
      },
      {
        "family": "Fink",
        "given": "Max"
      },
      {
        "family": "Klein",
        "given": "Donald F."
      },
      {
        "family": "Raskin",
        "given": "Allen"
      },
      {
        "others": true
      },
      {
        "given": "Ban"
      },
      {
        "family": "Schwarz",
        "given": "L."
      }
    ],
    "container-title": [
      "Depression: Proceedings of the Symposium Held at Cambridge 22 to 26 September 1959",
      "Archives of General Psychiatry",
      "AJP",
      "Archives of General Psychiatry"
    ],
    "date": [
      "1955",
      "1962",
      "quotes 454",
      "1962",
      "81",
      "1970",
      "82"
    ],
    "editor": [
      {
        "family": "E. Beresford Davies",
        "particle": "ed."
      }
    ],
    "location": [
      "Philadelphia"
    ],
    "note": [
      "Cambridge; Cambridge University Press, 1964), quote 215. 83. Deniker must have misspoken. There is no levopromazine. On levomepromazine (methotrimeprazine, Nozinan) as an antimelancholic, see T[homas"
    ],
    "pages": [
      "32–33 80",
      "449–459,",
      "432–438",
      "164–173",
      "214–215"
    ],
    "publisher": [
      "Lea & Febiger"
    ],
    "title": [
      "19–40",
      "Behavioral Reaction Patterns with Phenothiazines",
      "A simultaneous analysis of the patients randomized to imipramine showed that the relationship did not run the other way: The depressed patients responded well, the schizophrenic significantly less so. Klein and Fink, “Psychiatric Reaction Patterns to Imipramine",
      "A word of caution: Precisely as a result of a large, early RCT sponsored by the Psychopharmacology Research Branch of the National Institute for Mental Health, imipramine was found in general superior to chlorpromazine as an antidepressant",
      "Differential Response to Chlorpromazine, Imipramine, and Placebo",
      "Pierre Deniker and T[herèse] Lemperière, “Drug Treatment of Depression",
      "Systematic Studies with Levomepromazine"
    ],
    "type": "article-journal",
    "volume": [
      "7",
      "119",
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Baruk",
        "given": "H.]"
      }
    ],
    "container-title": [
      "Journal of Neuropsychiatry",
      "Annales Moreau de Tours"
    ],
    "date": [
      "1963",
      "1965"
    ],
    "pages": [
      "112–117",
      "71–73"
    ],
    "title": [
      "Principes et direction pratique de la thérapeutique des états dépressifs"
    ],
    "type": "article-journal",
    "volume": [
      "5",
      "2"
    ]
  },
  {
    "author": [
      {
        "family": "Overall",
        "given": "John E."
      },
      {
        "family": "Hollister",
        "given": "Leo E."
      },
      {
        "family": "Johnson",
        "given": "Merlin"
      },
      {
        "family": "Pennington",
        "given": "Veronica"
      }
    ],
    "citation-number": [
      "89."
    ],
    "container-title": [
      "JAMA"
    ],
    "issue": [
      "Mar. 14, 1966"
    ],
    "note": [
      "On Pennington, see Edward Shorter, Historical Dictionary of"
    ],
    "pages": [
      "946–948"
    ],
    "title": [
      "Nosology of Depression and Differential Response to Drugs"
    ],
    "type": "article-journal",
    "volume": [
      "195"
    ]
  },
  {
    "author": [
      {
        "family": "Mary M. Robertson",
        "given": "For",
        "particle": "an overview see"
      },
      {
        "family": "Trimble",
        "given": "M.] R."
      },
      {
        "family": "Parker",
        "given": "Gordon"
      },
      {
        "family": "Malhi",
        "given": "Gin"
      }
    ],
    "container-title": [
      "“A Double-Blind Comparison of Thioridazine (Mellaril) Versus Diazepam (Valium) in Patients with Chronic Mixed Anxiety and Depressive Symptoms,” Current Therapeutic Research 15",
      "Journal of Affective Disorders",
      "Australian and New Zealand Journal of Psychiatry"
    ],
    "date": [
      "2005",
      "1982",
      "2001"
    ],
    "editor": [
      {
        "family": "Rosenthal",
        "given": "Saul H."
      },
      {
        "family": "Bowden",
        "given": "Charles L."
      }
    ],
    "location": [
      "New York"
    ],
    "pages": [
      "310 90",
      "173–193",
      "631–638 91"
    ],
    "publisher": [
      "Oxford University Press"
    ],
    "title": [
      "Psychiatry",
      "Major Tranquillisers Used as Antidepressants",
      "Are Atypical Antipsychotic Drugs Also Atypical Antidepressants?"
    ],
    "type": "article-journal",
    "volume": [
      "4",
      "35"
    ]
  },
  {
    "date": [
      "1973",
      "quote 261"
    ],
    "pages": [
      "261–267,"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "advertisement",
        "given": "Marsilid"
      }
    ],
    "citation-number": [
      "92."
    ],
    "container-title": [
      "New York State Journal of Medicine"
    ],
    "date": [
      "1957"
    ],
    "pages": [
      "2036–2037"
    ],
    "type": "article-journal",
    "volume": [
      "57"
    ]
  },
  {
    "author": [
      {
        "family": "Gaddum",
        "given": "J.] H."
      },
      {
        "family": "Kwiatkowski",
        "given": "H."
      }
    ],
    "citation-number": [
      "93."
    ],
    "container-title": [
      "Journal of Physiology"
    ],
    "date": [
      "1938"
    ],
    "pages": [
      "87–100"
    ],
    "title": [
      "The Action of Ephedrine"
    ],
    "type": "article-journal",
    "volume": [
      "94"
    ]
  },
  {
    "citation-number": [
      "94."
    ],
    "container-title": [
      "Journal of Neural Transmission"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "707–716, 709"
    ],
    "title": [
      "Thomas Ban calls the evidence on behalf of the hypothesis “tenuous.” “Pharmacotherapy of Depression: A Historical Analysis"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Sandler",
        "given": "Merton"
      }
    ],
    "citation-number": [
      "95."
    ],
    "container-title": [
      "Journal of Psychopharmacology"
    ],
    "date": [
      "1990"
    ],
    "pages": [
      "136–139"
    ],
    "title": [
      "Monoamine Oxidase Inhibitors in Depression: History and Mythology"
    ],
    "type": "article-journal",
    "volume": [
      "4"
    ]
  },
  {
    "author": [
      {
        "family": "Selikoff",
        "given": "Irving J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "96."
    ],
    "container-title": [
      "Quarterly Bulletin of Sea View Hospital"
    ],
    "date": [
      "1952"
    ],
    "pages": [
      "17–26"
    ],
    "title": [
      "Toxicity of Hydrazine Derivatives of Isonicotinic Acid in the Chemotherapy of Human Tuberculosis"
    ],
    "type": "article-journal",
    "volume": [
      "13"
    ]
  },
  {
    "author": [
      {
        "family": "Selikoff",
        "given": "Irving J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "97."
    ],
    "container-title": [
      "JAMA"
    ],
    "date": [
      "1952-11-08",
      "quote 977"
    ],
    "pages": [
      "973–980,"
    ],
    "title": [
      "Treatment of Pulmonary Tuberculosis with Hydrazine Derivatives of Isonicotinic Acid"
    ],
    "type": "article-journal",
    "volume": [
      "150"
    ]
  },
  {
    "author": [
      {
        "family": "Robert G. Bloch",
        "particle": "see"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "98."
    ],
    "container-title": [
      "Annals of Internal Medicine"
    ],
    "date": [
      "1954"
    ],
    "pages": [
      "881–900"
    ],
    "title": [
      "For a more discouraging view of the psychiatric side effects of iproniazid",
      "The Clinical Effect of Isoniazid and Iproniazid in the Treatment of Pulmonary Tuberculosis"
    ],
    "type": "article-journal",
    "volume": [
      "40"
    ]
  },
  {
    "author": [
      {
        "family": "Zeller",
        "given": "E.A.]"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "99."
    ],
    "container-title": [
      "Experientia"
    ],
    "date": [
      "1952-09-15"
    ],
    "pages": [
      "349–350"
    ],
    "title": [
      "Influence of Isonicotinic Acid Hydrazide (INH) and 1-Isonicotinyl-2-isopropyl Hydrazide (IIH) on Bacterial and Mammalian Enzymes"
    ],
    "type": "article-journal",
    "volume": [
      "8"
    ]
  },
  {
    "author": [
      {
        "family": "Kamman",
        "given": "Gordon R."
      },
      {
        "others": true
      },
      {
        "family": "Jackson A. Smith",
        "particle": "see"
      }
    ],
    "citation-number": [
      "100."
    ],
    "container-title": [
      "Journal of Nervous and Mental Diseases",
      "American Practitioner Digest of Treatment"
    ],
    "date": [
      "1953",
      "1953"
    ],
    "pages": [
      "391–407",
      "519–520"
    ],
    "title": [
      "The Effect of 1-Isonicotynl 2-Isopropyl Hydrazide (IIH) on the Behavior of Long-Term Mental Patients",
      "For another early negative report",
      "The Use of the Isopropyl Derivative of Isonicotinylhydrazine (Marsilid) in the Treatment of Mental Disease"
    ],
    "type": "article-journal",
    "volume": [
      "118",
      "4"
    ]
  },
  {
    "author": [
      {
        "family": "Crane",
        "given": "George E."
      }
    ],
    "citation-number": [
      "101."
    ],
    "container-title": [
      "AJP"
    ],
    "date": [
      "1956",
      "quote 499"
    ],
    "pages": [
      "494–501,"
    ],
    "title": [
      "The Psychiatric Side-Effects of Iproniazid"
    ],
    "type": "article-journal",
    "volume": [
      "112"
    ]
  },
  {
    "author": [
      {
        "family": "Saunders",
        "given": "John C."
      },
      {
        "family": "discussion",
        "given": "in E."
      }
    ],
    "citation-number": [
      "102."
    ],
    "container-title": [
      "Annals of the New York Academy of Sciences 80 (1959): 551–1038, quote 719. The conference was in"
    ],
    "date": [
      "1958"
    ],
    "editor": [
      {
        "given": "Zeller"
      }
    ],
    "title": [
      "A",
      "Amine Oxidase Inhibitors"
    ],
    "type": "paper-conference"
  },
  {
    "author": [
      {
        "family": "said",
        "given": "Frank Ayd"
      },
      {
        "given": "Ayd"
      }
    ],
    "citation-number": [
      "103."
    ],
    "container-title": [
      "Healy"
    ],
    "date": [
      "quote 93"
    ],
    "issue": [
      "opharmacologists 1"
    ],
    "pages": [
      "81–110,"
    ],
    "title": [
      "Nate persuaded Saunders to leave Ciba and join him at Rockland State",
      "The Discovery of Antidepressants"
    ],
    "type": "article-journal",
    "volume": []
  },
  {
    "citation-number": [
      "104."
    ],
    "container-title": [
      "At the 1958 conference (720), Saunders gave",
      "the proceedings of the 1955 conference as the source for his contribution. The 1955 reference: Jacques S. Gotttlieb",
      "Pharmacologic Products Recently Introduced in the"
    ],
    "editor": [
      {
        "literal": "ed."
      }
    ],
    "pages": [
      "152"
    ],
    "type": "paper-conference"
  },
  {
    "author": [
      {
        "family": "Loomer",
        "given": "Harry P."
      },
      {
        "family": "Saunders",
        "given": "John C."
      },
      {
        "family": "Kline",
        "given": "Nathan S."
      }
    ],
    "citation-number": [
      "106."
    ],
    "container-title": [
      "Research in Affects, American Psychiatric Association, Psychiatric Research Reports 8"
    ],
    "editor": [
      {
        "literal": "ed."
      }
    ],
    "title": [
      "A Clinical and Psychodynamic Evaluation of Iproniazid as a Psychic Energizer"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Marc",
        "given": "H."
      }
    ],
    "date": [
      "1957"
    ],
    "location": [
      "Washington, DC"
    ],
    "pages": [
      "138"
    ],
    "publisher": [
      "APA"
    ],
    "title": [
      "Hollender"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Simpson",
        "given": "George"
      }
    ],
    "citation-number": [
      "107."
    ],
    "container-title": [
      "interview, in Healy"
    ],
    "date": [
      "see 292"
    ],
    "issue": [
      "opharmacologists 2"
    ],
    "pages": [
      "285–305,"
    ],
    "title": [
      "Clinical Psychopharmacology"
    ],
    "type": "article-journal",
    "volume": []
  },
  {
    "author": [
      {
        "family": "Ayd",
        "given": "Frank J.",
        "suffix": "Jr"
      },
      {
        "family": "Verteuil",
        "given": "See",
        "particle": "also R. L. de"
      },
      {
        "family": "Lehmann",
        "given": "H.] E."
      }
    ],
    "citation-number": [
      "108."
    ],
    "container-title": [
      "AJP",
      "Canadian Medical Association Journal"
    ],
    "date": [
      "1957",
      "1958-01-15"
    ],
    "note": [
      "About a third of patients"
    ],
    "pages": [
      "459",
      "131–133"
    ],
    "title": [
      "A Preliminary Report on Marsilid",
      "Therapeutic Trial of Iproniazid (Marsilid) in Depressed and Apathetic Patients"
    ],
    "type": "article-journal",
    "volume": [
      "114",
      "78"
    ]
  },
  {
    "author": [
      {
        "family": "Breitner",
        "given": "Carl"
      },
      {
        "family": "discussion",
        "given": "in Zeller"
      }
    ],
    "citation-number": [
      "114."
    ],
    "container-title": [
      "AJP"
    ],
    "date": [
      "1958"
    ],
    "pages": [
      "941"
    ],
    "title": [
      "Amine Oxidase Inhibitors,” 742–744; Breitner, “Marsilid in Catatonic Schizophrenia"
    ],
    "type": "article-journal",
    "volume": [
      "114"
    ]
  },
  {
    "author": [
      {
        "family": "English",
        "given": "David C."
      },
      {
        "family": "discussion",
        "given": "in Zeller"
      }
    ],
    "citation-number": [
      "115."
    ],
    "container-title": [
      "Psychotic Depression"
    ],
    "date": [
      "807",
      "2007"
    ],
    "editor": [
      {
        "family": "Swartz",
        "given": "Conrad M."
      },
      {
        "family": "Shorter",
        "given": "Edward"
      }
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "Cambridge University Press"
    ],
    "title": [
      "Amine Oxidase Inhibitors",
      "On the drug treatment of psychotic depression see"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Yanof",
        "given": "Zale A."
      },
      {
        "family": "discussion",
        "given": "in Zeller"
      }
    ],
    "citation-number": [
      "116."
    ],
    "pages": [
      "752"
    ],
    "title": [
      "Amine Oxidase Inhibitors"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Kline",
        "given": "Nathan S."
      }
    ],
    "citation-number": [
      "117."
    ],
    "container-title": [
      "Journal of Clinical and Experimental Psychopathology and Quarterly Review of Psychiatry and Neurology"
    ],
    "date": [
      "1958"
    ],
    "issue": [
      "1"
    ],
    "pages": [
      "72–79, 73"
    ],
    "title": [
      "Clinical Experience with Iproniazid (Marsilid"
    ],
    "type": "article-journal",
    "volume": [
      "19"
    ]
  },
  {
    "author": [
      {
        "family": "Joel",
        "given": "Samuel W."
      },
      {
        "given": "al"
      }
    ],
    "citation-number": [
      "118."
    ],
    "container-title": [
      "Diseases of the Nervous System",
      "J. Guyotat et",
      "Journal de Médecine de Lyon"
    ],
    "date": [
      "1959",
      "quote 524",
      "1960"
    ],
    "pages": [
      "521–524,",
      "367–375"
    ],
    "title": [
      "Twenty Month Study of Iproniazid Therapy",
      "Joel’s article appeared a year before the contribution that is thought to have initiated the modern era of OCD treatment",
      "L’imipramine en dehors des états dépressifs"
    ],
    "type": "article-journal",
    "volume": [
      "20",
      "41"
    ]
  },
  {
    "author": [
      {
        "family": "Kline",
        "given": "Nathan S."
      }
    ],
    "citation-number": [
      "119."
    ],
    "container-title": [
      "Journal of Clinical and Experimental Psychopathology and Quarterly Review of Psychiatry and Neurology"
    ],
    "date": [
      "1958",
      "quote 76"
    ],
    "issue": [
      "1"
    ],
    "pages": [
      "72–79,"
    ],
    "title": [
      "Clinical Experience with Iproniazid (Marsilid"
    ],
    "type": "article-journal",
    "volume": [
      "19"
    ]
  },
  {
    "author": [
      {
        "family": "Kline",
        "given": "Nathan"
      }
    ],
    "citation-number": [
      "120."
    ],
    "container-title": [
      "Psychopharmacology Frontiers"
    ],
    "date": [
      "1957"
    ],
    "editor": [
      {
        "family": "Nathan Kline",
        "particle": "ed."
      }
    ],
    "location": [
      "Boston"
    ],
    "pages": [
      "433"
    ],
    "publisher": [
      "Little, Brown"
    ],
    "title": [
      "discussion"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Joel",
        "given": "Samuel"
      }
    ],
    "citation-number": [
      "121."
    ],
    "date": [
      "1997-08-06"
    ],
    "genre": [
      "personal communication,"
    ],
    "type": "personal_communication"
  },
  {
    "author": [
      {
        "family": "Robie",
        "given": "Theodore R."
      }
    ],
    "citation-number": [
      "122."
    ],
    "container-title": [
      "AJP"
    ],
    "date": [
      "1958"
    ],
    "pages": [
      "402–409"
    ],
    "title": [
      "Iproniazid Chemotherapy in Melancholia"
    ],
    "type": "article-journal",
    "volume": [
      "115"
    ]
  },
  {
    "author": [
      {
        "family": "West",
        "given": "E.D."
      },
      {
        "family": "Dally",
        "given": "P.J."
      }
    ],
    "citation-number": [
      "123."
    ],
    "container-title": [
      "BMJ",
      "F-D-C Reports/Pink Sheet, Apr"
    ],
    "date": [
      "1491",
      "1958"
    ],
    "issue": [
      "June 13, 1959"
    ],
    "pages": [
      "1491–1494,",
      "19–20"
    ],
    "title": [
      "Effects of Iproniazid in Depressive Syndromes",
      "124. “Roche’s Marsilid Pick–Up Program"
    ],
    "type": "article-journal",
    "volume": [
      "1",
      "21"
    ]
  },
  {
    "author": [
      {
        "family": "Larrick",
        "given": "See George"
      }
    ],
    "citation-number": [
      "125."
    ],
    "date": [
      "1959-07-27"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "note": [
      "General Subject Files, box 2698."
    ],
    "title": [
      "FDA) to Louis Gershenfeld (Philadelphia College of Pharmacy and Science"
    ],
    "type": null
  },
  {
    "citation-number": [
      "126."
    ],
    "container-title": [
      "F-D-C Reports/Pink Sheet, Apr"
    ],
    "date": [
      "1958"
    ],
    "pages": [
      "2"
    ],
    "title": [
      "Hoffmann-La Roche Marsilid"
    ],
    "type": "article-journal",
    "volume": [
      "14"
    ]
  },
  {
    "citation-number": [
      "127."
    ],
    "container-title": [
      "Agency Coordination Study"
    ],
    "date": [
      "1962",
      "1963"
    ],
    "genre": [
      "Part 1"
    ],
    "location": [
      "Washington, DC"
    ],
    "pages": [
      "518–521"
    ],
    "publisher": [
      "GPO"
    ],
    "title": [
      "On these events, see Interagency Coordination in Drug Research and Regulation. Hearings Before the Subcommittee on Reorganization and International Organizations of the Committee on Government Operations, United States Senate, 87th Congress, 2nd Session"
    ],
    "type": "article-journal",
    "volume": [
      "Aug 1 and 9"
    ]
  },
  {
    "author": [
      {
        "family": "B. S. Mansueto",
        "given": "Guy Walters",
        "particle": "to"
      },
      {
        "given": "Sept"
      }
    ],
    "citation-number": [
      "128."
    ],
    "date": [
      "1965",
      "1964/65"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "pages": [
      "3755"
    ],
    "publisher": [
      "General Subject Files"
    ],
    "type": null
  },
  {
    "citation-number": [
      "129."
    ],
    "date": [
      "1959-06-08"
    ],
    "genre": [
      "F-D-C Reports/Pink Sheet,"
    ],
    "pages": [
      "18"
    ],
    "title": [
      "M-A-O-I New Drug Era"
    ],
    "type": "report"
  },
  {
    "citation-number": [
      "130."
    ],
    "date": [
      "1959-11-30"
    ],
    "genre": [
      "F-D-C Reports/Pink Sheet,"
    ],
    "pages": [
      "18"
    ],
    "title": [
      "Lakeside’s Catron"
    ],
    "type": "report"
  },
  {
    "author": [
      {
        "family": "Alexander",
        "given": "Leo"
      },
      {
        "family": "Berkeley",
        "given": "Austin W."
      }
    ],
    "citation-number": [
      "131."
    ],
    "container-title": [
      "Annals of the New York Academy of Sciences"
    ],
    "date": [
      "1959"
    ],
    "pages": [
      "669–679"
    ],
    "title": [
      "The Inert Psychasthenic Reaction (Anhedonia) as Differentiated from Classic Depression and Its Response to Iproniazid"
    ],
    "type": "chapter",
    "volume": [
      "80"
    ]
  },
  {
    "author": [
      {
        "family": "Roth",
        "given": "Martin"
      }
    ],
    "citation-number": [
      "132."
    ],
    "container-title": [
      "Proceedings of the Royal Society of Medicine"
    ],
    "date": [
      "1959",
      "quote 594"
    ],
    "pages": [
      "587–596,"
    ],
    "title": [
      "The Phobic Anxiety-Depersonalization Syndrome"
    ],
    "type": "paper-conference",
    "volume": [
      "52"
    ]
  },
  {
    "citation-number": [
      "133."
    ],
    "date": [
      "2002-08-20"
    ],
    "genre": [
      "Thomas Ban, personal communication,"
    ],
    "type": "personal_communication"
  },
  {
    "author": [
      {
        "family": "Pletscher",
        "given": "Alfred"
      }
    ],
    "citation-number": [
      "134."
    ],
    "container-title": [
      "Experientia"
    ],
    "date": [
      "1991"
    ],
    "pages": [
      "4–8, 6"
    ],
    "title": [
      "The Discovery of Antidepressants: A Winding Path"
    ],
    "type": "article-journal",
    "volume": [
      "47"
    ]
  },
  {
    "citation-number": [
      "135."
    ],
    "date": [
      "1959-06-15"
    ],
    "genre": [
      "F-D-C Reports/Pink Sheet,"
    ],
    "title": [
      "New Drug Developments"
    ],
    "type": "report",
    "volume": [
      "16"
    ]
  },
  {
    "author": [
      {
        "family": "Bernthsen",
        "given": "August"
      }
    ],
    "citation-number": [
      "136."
    ],
    "container-title": [
      "Chemische Berichte (Berichte der Deutschen Chemischen Gesellschaft"
    ],
    "date": [
      "1883"
    ],
    "pages": [
      "2896–2904"
    ],
    "title": [
      "Zur Kenntnis des Methylenblau und verwandter Farbstoffe"
    ],
    "type": "chapter",
    "volume": [
      "16"
    ]
  },
  {
    "citation-number": [
      "137."
    ],
    "container-title": [
      "Wellcome Witnesses to Twentieth Century Medicine"
    ],
    "date": [
      "1998"
    ],
    "editor": [
      {
        "family": "E. M. Tansey",
        "particle": "ed."
      },
      {
        "others": true
      }
    ],
    "location": [
      "London"
    ],
    "pages": [
      "138–139"
    ],
    "publisher": [
      "Wellcome Trust"
    ],
    "title": [
      "Alan Broadhurst, discussion"
    ],
    "type": "chapter",
    "volume": [
      "2"
    ]
  },
  {
    "citation-number": [
      "138."
    ],
    "container-title": [
      "From Psychopharmacology to Neuropsychopharmacology in the 1980s"
    ],
    "date": [
      "2002"
    ],
    "editor": [
      {
        "family": "Thomas A. Ban",
        "particle": "ed."
      },
      {
        "others": true
      }
    ],
    "location": [
      "Budapest"
    ],
    "pages": [
      "282–352"
    ],
    "publisher": [
      "Animula"
    ],
    "title": [
      "The following account is based on “The Imipramine Dossier"
    ],
    "type": "chapter"
  },
  {
    "citation-number": [
      "139."
    ],
    "container-title": [
      "Psychiatrie in Selbstdarstellungen"
    ],
    "date": [
      "1977"
    ],
    "editor": [
      {
        "family": "Ludwig J. Pongratz",
        "particle": "ed."
      }
    ],
    "location": [
      "Berne"
    ],
    "pages": [
      "219–257",
      "236"
    ],
    "publisher": [
      "Huber"
    ],
    "title": [
      "Roland Kuhn [autobiographical essay"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "given": "Ban"
      }
    ],
    "citation-number": [
      "140."
    ],
    "title": [
      "Imipramine Dossier"
    ],
    "type": null,
    "volume": [
      "311–312, 325. 141. Ibid., 301"
    ]
  },
  {
    "author": [
      {
        "family": "Swartz",
        "given": "See Conrad M."
      },
      {
        "family": "Shorter",
        "given": "Edward"
      }
    ],
    "citation-number": [
      "160."
    ],
    "date": [
      "2007"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "Cambridge University Press"
    ],
    "title": [
      "Psychotic Depression"
    ],
    "type": "book"
  },
  {
    "citation-number": [
      "161."
    ],
    "date": [
      "1969"
    ],
    "location": [
      "Baltimore"
    ],
    "pages": [
      "270–289"
    ],
    "publisher": [
      "Williams & Wilkins"
    ],
    "title": [
      "For a balanced view of the risks and benefits of the tricyclic antidepressants, see Thomas Ban, Psychopharmacology"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Mitchell",
        "given": "S.Weir"
      },
      {
        "family": "use",
        "given": "See",
        "particle": "also for early lithium"
      },
      {
        "family": "Hammond",
        "given": "William A."
      }
    ],
    "citation-number": [
      "164."
    ],
    "container-title": [
      "American Journal of the Medical Sciences"
    ],
    "date": [
      "1870",
      "1871"
    ],
    "location": [
      "New York"
    ],
    "note": [
      "Lithium-rich springs (“crazy water”) in the United States had offered what was essentially lithium treatment for decades."
    ],
    "pages": [
      "443–445",
      "381"
    ],
    "publisher": [
      "Appleton"
    ],
    "title": [
      "On the Use of Bromide of Lithium",
      "A Treatise on Diseases of the Nervous System"
    ],
    "type": "article-journal",
    "volume": [
      "60"
    ]
  },
  {
    "author": [
      {
        "family": "F. Neil Johnson",
        "given": "Accounts",
        "particle": "may be found in"
      }
    ],
    "citation-number": [
      "165."
    ],
    "container-title": [
      "Australian and New Zealand Journal of Psychiatry"
    ],
    "date": [
      "1984",
      "1997",
      "1999"
    ],
    "location": [
      "London",
      "New York"
    ],
    "pages": [
      "255–257"
    ],
    "publisher": [
      "Macmillan",
      "Wiley"
    ],
    "title": [
      "The History of Lithium Therapy",
      "Edward Shorter, History of Psychiatry",
      "see also “Fifty Years of Treatments for Bipolar Disorder: A Celebration of John Cade’s Discovery"
    ],
    "type": "article-journal",
    "volume": [
      "33, suppl"
    ]
  },
  {
    "author": [
      {
        "family": "Cade",
        "given": "John F.J."
      }
    ],
    "citation-number": [
      "166."
    ],
    "container-title": [
      "Medical Journal of Australia"
    ],
    "date": [
      "1949-09-03"
    ],
    "pages": [
      "349–352"
    ],
    "title": [
      "Lithium Salts in the Treatment of Psychotic Excitement"
    ],
    "type": "article-journal",
    "volume": [
      "2"
    ]
  },
  {
    "author": [
      {
        "family": "See",
        "given": "for example"
      },
      {
        "family": "Plichet",
        "given": "A.]"
      }
    ],
    "citation-number": [
      "167."
    ],
    "container-title": [
      "Presse Médicale",
      "Annales Médico-Psychologiques"
    ],
    "date": [
      "1954-06-05",
      "744",
      "1954"
    ],
    "pages": [
      "869–870",
      "737–743"
    ],
    "title": [
      "Le traitement des états maniaques par les sels de lithium",
      "see also the comments of Paris psychiatrist S. Follin, discussion, who prescribes lithium for its “action remarquable sur les états d’excitation maniaque",
      "The comment follows H[ans] Steck, “Le syndrome extrapyramidal et diencéphalique au cours des traitements au largactil et au serpasil"
    ],
    "type": "article-journal",
    "volume": [
      "62",
      "112"
    ]
  },
  {
    "author": [
      {
        "family": "Shorter",
        "given": "See"
      }
    ],
    "citation-number": [
      "168."
    ],
    "container-title": [
      "Historical Dictionary"
    ],
    "type": "article-journal",
    "volume": [
      "162"
    ]
  },
  {
    "author": [
      {
        "family": "Schou",
        "given": "Mogens"
      }
    ],
    "citation-number": [
      "169."
    ],
    "container-title": [
      "Psychiatric Journal of the University of Ottawa"
    ],
    "date": [
      "1989",
      "see 261"
    ],
    "pages": [
      "260–262,"
    ],
    "title": [
      "Lithium: Personal Reminiscences"
    ],
    "type": "article-journal",
    "volume": [
      "14"
    ]
  },
  {
    "author": [
      {
        "family": "Schou",
        "given": "M.]"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "170."
    ],
    "container-title": [
      "Journal of Neurology, Neurosurgery and Psychiatry"
    ],
    "date": [
      "1954",
      "quote 255"
    ],
    "pages": [
      "250–260,"
    ],
    "title": [
      "The Treatment of Manic Psychoses by the Administration of Lithium Salts"
    ],
    "type": "article-journal",
    "volume": [
      "17"
    ]
  },
  {
    "citation-number": [
      "171."
    ],
    "container-title": [
      "Talking About Psychiatry"
    ],
    "date": [
      "1993"
    ],
    "editor": [
      {
        "family": "Greg Wilkinson",
        "particle": "ed."
      }
    ],
    "location": [
      "London"
    ],
    "pages": [
      "157–177",
      "167"
    ],
    "publisher": [
      "Gaskell"
    ],
    "title": [
      "Felix Post [interview"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Shepherd",
        "given": "M.]"
      }
    ],
    "citation-number": [
      "174."
    ],
    "container-title": [
      "Principles and Practice of Clinical Trials"
    ],
    "date": [
      "1970"
    ],
    "editor": [
      {
        "family": "E. L. Harris",
        "particle": "ed."
      },
      {
        "others": true
      }
    ],
    "location": [
      "Edinburgh"
    ],
    "pages": [
      "208–216",
      "214–216"
    ],
    "publisher": [
      "Livingstone"
    ],
    "title": [
      "Evaluation of Psychotropic Drugs (2): Depression, Part II—1969"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Coppen",
        "given": "Alec"
      }
    ],
    "citation-number": [
      "175."
    ],
    "container-title": [
      "interview, in Healy"
    ],
    "issue": [
      "opharmacologists 1"
    ],
    "pages": [
      "265–286, 274"
    ],
    "title": [
      "Biological Psychiatry in Britain"
    ],
    "type": "article-journal",
    "volume": []
  },
  {
    "citation-number": [
      "176."
    ],
    "date": [
      "1973"
    ],
    "editor": [
      {
        "family": "Sutter",
        "given": "Jean-M."
      }
    ],
    "issue": [
      "ale 62, suppl. "
    ],
    "note": [
      "“Les lithinés du docteur Gustin.”"
    ],
    "pages": [
      "68"
    ],
    "title": [
      "Reyss Brion, discussion",
      "Psychopharmacologie"
    ],
    "type": null,
    "volume": []
  },
  {
    "author": [
      {
        "family": "Gershon",
        "given": "Samuel"
      },
      {
        "family": "Yuwiler",
        "given": "Arthur"
      },
      {
        "literal": "Eddie [sic] Kingstone"
      }
    ],
    "citation-number": [
      "177."
    ],
    "container-title": [
      "Journal of Neuropsychiatry",
      "Comprehensive Psychiatry"
    ],
    "date": [
      "1960",
      "1960"
    ],
    "note": [
      "The paper had been rejected by the American Journal of Psychiatry."
    ],
    "pages": [
      "229–241",
      "317–320"
    ],
    "title": [
      "Lithium Ion: A Specific Pharmacological Approach to the Treatment of Mania",
      "The Lithium Treatment of Hypomanic and Manic States"
    ],
    "type": "article-journal",
    "volume": [
      "1",
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "Fieve",
        "given": "Ronald R."
      }
    ],
    "citation-number": [
      "178."
    ],
    "container-title": [
      "The Triumph of Psychopharmacology and the Story of CINP"
    ],
    "date": [
      "2000"
    ],
    "editor": [
      {
        "family": "Thomas Ban",
        "particle": "ed."
      },
      {
        "others": true
      }
    ],
    "location": [
      "Budapest"
    ],
    "pages": [
      "258–260",
      "259"
    ],
    "publisher": [
      "Animula"
    ],
    "title": [
      "Lithium: From Introduction to Public Awareness"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Wharton",
        "given": "Ralph N."
      },
      {
        "family": "Fieve",
        "given": "Ronald R."
      }
    ],
    "citation-number": [
      "179."
    ],
    "container-title": [
      "AJP"
    ],
    "date": [
      "1966"
    ],
    "pages": [
      "706–712"
    ],
    "title": [
      "The Use of Lithium in the Affective Psychoses"
    ],
    "type": "article-journal",
    "volume": [
      "123"
    ]
  },
  {
    "author": [
      {
        "family": "Fieve",
        "given": "Ronald R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "180."
    ],
    "container-title": [
      "AJP"
    ],
    "date": [
      "1968"
    ],
    "pages": [
      "487–491"
    ],
    "title": [
      "The Use of Lithium in Affective Disorders: I. Acute Endogenous Depression"
    ],
    "type": "article-journal",
    "volume": [
      "125"
    ]
  },
  {
    "author": [
      {
        "family": "Cole",
        "given": "Jonathan"
      },
      {
        "family": "interview",
        "particle": "telephone"
      }
    ],
    "citation-number": [
      "181."
    ],
    "date": [
      "2002-07-17",
      "1970-02-23"
    ],
    "genre": [
      "F-D-C Reports/Pink Sheet,"
    ],
    "pages": [
      "1"
    ],
    "title": [
      "See also “FDA to Approve Lithium"
    ],
    "type": "report"
  },
  {
    "citation-number": [
      "182."
    ],
    "container-title": [
      "FDA, Psychopharmacological Drugs Advisory Committee, 31st Meeting"
    ],
    "title": [
      "Discussion comment of Robert Prien at NIMH"
    ],
    "type": "paper-conference",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "Arehart-Treichel",
        "given": "Joan"
      }
    ],
    "container-title": [
      "Psychiatric News"
    ],
    "date": [
      "2007-06-15"
    ],
    "pages": [
      "8"
    ],
    "title": [
      "Kids’ Hospitalizations Have Researchers Puzzled"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Charney",
        "given": "Dennis"
      },
      {
        "family": "discussion",
        "given": "in F.D.A."
      }
    ],
    "citation-number": [
      "187."
    ],
    "container-title": [
      "Meeting"
    ],
    "date": [
      "1995"
    ],
    "issue": [
      "44, Feb. 6"
    ],
    "note": [
      "valproate in mania]: 135; obtained through FOIA."
    ],
    "title": [
      "Psychopharmacologic Drugs Advisory Committee"
    ],
    "type": "article-journal",
    "volume": []
  },
  {
    "author": [
      {
        "family": "Bowman",
        "given": "Robert L."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "188."
    ],
    "container-title": [
      "Science"
    ],
    "date": [
      "1955-07-01"
    ],
    "pages": [
      "32–33"
    ],
    "title": [
      "Spectrophotofluorometric Assay in the Visible and Ultraviolet"
    ],
    "type": "article-journal",
    "volume": [
      "122"
    ]
  },
  {
    "author": [
      {
        "family": "Vogt",
        "given": "Marthe"
      }
    ],
    "citation-number": [
      "189."
    ],
    "container-title": [
      "Journal of Physiology"
    ],
    "date": [
      "1954"
    ],
    "pages": [
      "451–481"
    ],
    "title": [
      "The Concentration of Sympathin in Different Parts of the Central Nervous System Under Normal Conditions and After the Administration of Drugs"
    ],
    "type": "article-journal",
    "volume": [
      "123"
    ]
  },
  {
    "author": [
      {
        "family": "Amin",
        "given": "A.H."
      },
      {
        "family": "Crawford",
        "given": "T.B.B."
      },
      {
        "family": "Gaddum",
        "given": "J.] H.]"
      }
    ],
    "citation-number": [
      "190."
    ],
    "container-title": [
      "Ciba Foundation Symposium on Hypertension",
      "Journal of Physiology"
    ],
    "date": [
      "1954",
      "1954"
    ],
    "editor": [
      {
        "family": "G. E. W. Wolstenholme",
        "particle": "ed."
      },
      {
        "others": true
      }
    ],
    "location": [
      "London"
    ],
    "note": [
      "quote 77; on Gaddum’s own LSD experiment, see Dick Barlow, “Receptors and the Chemist,” interview, in Healy, Psychopharmacologists"
    ],
    "pages": [
      "596–618",
      "75–77",
      "157–173, 162"
    ],
    "publisher": [
      "Churchill"
    ],
    "title": [
      "The Distribution of Substance P and 5–Hydroxytryptamine in the Central Nervous System of the Dog",
      "On Gaddum and serotonin keeping us sane, see Gaddum, “Drugs Antagonistic to 5–Hydroxytryptamine"
    ],
    "type": "article-journal",
    "volume": [
      "126",
      "3"
    ]
  },
  {
    "author": [
      {
        "family": "Woolley",
        "given": "D.W.]"
      },
      {
        "family": "Shaw",
        "given": "E."
      }
    ],
    "citation-number": [
      "191."
    ],
    "container-title": [
      "Proceedings, National Academy of Sciences"
    ],
    "date": [
      "1954",
      "quote 230"
    ],
    "pages": [
      "228–231,"
    ],
    "title": [
      "A Biochemical and Pharmacological Suggestion About Certain Mental Disorders"
    ],
    "type": "paper-conference",
    "volume": [
      "40"
    ]
  },
  {
    "author": [
      {
        "family": "Kanigel",
        "given": "See Robert"
      }
    ],
    "citation-number": [
      "192."
    ],
    "date": [
      "1986"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "Macmillan"
    ],
    "title": [
      "Apprentice to Genius: The Making of a Scientific Dynasty"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Pletscher",
        "given": "Alfred"
      },
      {
        "family": "Shore",
        "given": "Parkhurst A."
      },
      {
        "family": "Brodie",
        "given": "Bernard B."
      }
    ],
    "citation-number": [
      "193."
    ],
    "container-title": [
      "Science"
    ],
    "date": [
      "1955-08-26"
    ],
    "note": [
      "Carlsson interview by Healy and Shorter, Feb. 27, 2007, 8."
    ],
    "pages": [
      "374–375"
    ],
    "title": [
      "Serotonin Release as a Possible Mechanism of Reserpine Action",
      "According to Arvid Carlsson, it was Park Shore who had this idea first, but all three have now passed on and it will probably never be possible to sort out the exact credit for this epochal discovery"
    ],
    "type": "article-journal",
    "volume": [
      "122"
    ]
  },
  {
    "author": [
      {
        "family": "Sulser",
        "given": "Fridolin"
      }
    ],
    "citation-number": [
      "194."
    ],
    "container-title": [
      "The Neurotransmitter Era in Neuropsychopharmacology"
    ],
    "date": [
      "2006"
    ],
    "editor": [
      {
        "family": "Thomas A. Ban",
        "particle": "ed."
      },
      {
        "others": true
      }
    ],
    "location": [
      "Buenos Aires"
    ],
    "pages": [
      "56–64",
      "53"
    ],
    "publisher": [
      "Polemos"
    ],
    "title": [
      "The Noradrenergic Second Messenger Cascade: Switch from Presynaptic to Postsynaptic Receptor-Mediated Events"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Brodie",
        "given": "Bernard B."
      },
      {
        "family": "Shore",
        "given": "Parkhurst A."
      }
    ],
    "citation-number": [
      "195."
    ],
    "container-title": [
      "Annals of the New York Academy of Sciences"
    ],
    "date": [
      "1957"
    ],
    "pages": [
      "631–642, 635"
    ],
    "title": [
      "A Concept for a Role of Serotonin and Norepinephrine as Chemical Mediators in the Brain"
    ],
    "type": "chapter",
    "volume": [
      "66"
    ]
  },
  {
    "author": [
      {
        "family": "Axelrod",
        "given": "Julius"
      }
    ],
    "citation-number": [
      "196."
    ],
    "container-title": [
      "Ciba Foundation Symposium . . . On Adrenergic Mechanisms"
    ],
    "date": [
      "1960"
    ],
    "editor": [
      {
        "family": "R. Vane",
        "particle": "ed."
      },
      {
        "others": true
      }
    ],
    "location": [
      "Boston"
    ],
    "pages": [
      "28–39",
      "37"
    ],
    "publisher": [
      "Little, Brown"
    ],
    "title": [
      "The Fate of Adrenaline and Noradrenaline"
    ],
    "type": "paper-conference"
  },
  {
    "author": [
      {
        "family": "Axelrod",
        "given": "Julius"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "197."
    ],
    "container-title": [
      "Science"
    ],
    "issue": [
      "Feb. 10, 1961"
    ],
    "pages": [
      "383–384"
    ],
    "title": [
      "Effect of Psychotropic Drugs on the Uptake of H3-Norepinephrine by Tissues"
    ],
    "type": "article-journal",
    "volume": [
      "133"
    ]
  },
  {
    "author": [
      {
        "family": "Carlsson",
        "given": "Arvid"
      },
      {
        "family": "Lindqvist",
        "given": "Margit"
      }
    ],
    "citation-number": [
      "198."
    ],
    "container-title": [
      "Acta Pharmacologica et Toxicologica"
    ],
    "date": [
      "1963"
    ],
    "pages": [
      "140–144"
    ],
    "title": [
      "Effect of Chlorpromazine or Haloperidol on Formation of 3-Methoxytryptamine and Normetanephrine in Mouse Brain"
    ],
    "type": "article-journal",
    "volume": [
      "20"
    ]
  },
  {
    "author": [
      {
        "family": "Glowinski",
        "given": "Jacques"
      },
      {
        "family": "Axelrod",
        "given": "Julius"
      }
    ],
    "citation-number": [
      "199."
    ],
    "container-title": [
      "Nature"
    ],
    "date": [
      "1964-12-26"
    ],
    "pages": [
      "1318–1319"
    ],
    "title": [
      "Inhibition of Uptake of Tritiated-Noradrenaline in the Intact Rat Brain by Imipramine and Structurally Related Compounds"
    ],
    "type": "article-journal",
    "volume": [
      "204"
    ]
  },
  {
    "author": [
      {
        "family": "Swann",
        "given": "John P."
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "A Historical Guide to the U.S. Government",
      "George Thomas Kurian, 248–254"
    ],
    "date": [
      "2002",
      "1998"
    ],
    "editor": [
      {
        "literal": "ed."
      }
    ],
    "location": [
      "New York"
    ],
    "note": [
      "accessed July 13,"
    ],
    "publisher": [
      "Oxford University Press"
    ],
    "title": [
      "Surprisingly, there is no comprehensive history of the Food and Drug Administration. This paragraph is based on Donna Hamilton, “A Brief History of the Center for Drug Evaluation and Research",
      "Food and Drug Administration"
    ],
    "type": "chapter",
    "url": [
      "www.fda.gov/cder/about/ history/Histext.htm,"
    ]
  },
  {
    "citation-number": [
      "2."
    ],
    "container-title": [
      "F-D-C Reports/Pink Sheet Apr"
    ],
    "date": [
      "1956"
    ],
    "pages": [
      "6–8"
    ],
    "title": [
      "On the chronology of this reopening of the addiction discussion, see “What Is a Habit-Forming Drug?"
    ],
    "type": "article-journal",
    "volume": [
      "12"
    ]
  },
  {
    "citation-number": [
      "3."
    ],
    "title": [
      "A key early document, cited repeatedly in the coming years, was"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Essig",
        "given": "Carl F."
      },
      {
        "family": "Ainslie",
        "given": "John D."
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "JAMA"
    ],
    "date": [
      "1957-07-20"
    ],
    "pages": [
      "1382"
    ],
    "title": [
      "Addiction to Meprobamate (Equanil, Miltown"
    ],
    "type": "article-journal",
    "volume": [
      "164"
    ]
  },
  {
    "citation-number": [
      "7."
    ],
    "container-title": [
      "F-D-C Reports/Pink Sheet, Feb"
    ],
    "date": [
      "1957-08-26",
      "1957"
    ],
    "genre": [
      "F-D-C Reports/Pink Sheet,"
    ],
    "pages": [
      "8",
      "7"
    ],
    "title": [
      "Miltown-Equanil Habituation",
      "Tranquilizers Useful, Not Proved Addictive"
    ],
    "type": "article-journal",
    "volume": [
      "16",
      "25"
    ]
  },
  {
    "citation-number": [
      "9."
    ],
    "date": [
      "1960",
      "1957-06-10"
    ],
    "genre": [
      "F-D-C Reports/ Pink Sheet,"
    ],
    "location": [
      "Washington, DC"
    ],
    "note": [
      "Hereafter cited as Kefauver Hearings (Tranquilizers). 10."
    ],
    "pages": [
      "9028",
      "10–11"
    ],
    "publisher": [
      "GPO"
    ],
    "title": [
      "Hearings Before the Subcommittee on Antitrust and Monopoly of the Committee on the Judiciary, United States Senate, 86th Congress, 2nd Session, Part 16: Administered Prices in the Drug Industry (Tranquilizers",
      "Kline Defends Miltown Against Addiction Allegations"
    ],
    "type": "report",
    "volume": [
      "10. 11. Ibid"
    ]
  },
  {
    "author": [
      {
        "family": "Robert",
        "given": "H."
      }
    ],
    "citation-number": [
      "12."
    ],
    "container-title": [
      "Mar"
    ],
    "date": [
      "1958"
    ],
    "pages": [
      "19"
    ],
    "title": [
      "Felix testimony to Blatnik House subcommittee investigating tranquilizers, quoted in F-D-C Reports/Pink Sheet"
    ],
    "type": "article-journal",
    "volume": [
      "3"
    ]
  },
  {
    "author": [
      {
        "family": "Hearings",
        "given": "Kefauver"
      }
    ],
    "citation-number": [
      "13."
    ],
    "container-title": [
      "Hearings Before the Subcommittee on Reorganization and International Organizations of the Committee on Government Operations, United States Senate, 88th Congress, 1st session, Agency Coordination Study, Part 5",
      "Ibid"
    ],
    "date": [
      "1963-06-19",
      "1964"
    ],
    "location": [
      "Washington, DC"
    ],
    "pages": [
      "15",
      "2812–2832, 2821–2822"
    ],
    "publisher": [
      "GPO"
    ],
    "title": [
      "9145. 14",
      "Supplementary Statement by Senator Hubert H. Humphrey"
    ],
    "type": "article-journal",
    "volume": [
      "9119"
    ]
  },
  {
    "citation-number": [
      "16."
    ],
    "date": [
      "1960-06-02"
    ],
    "genre": [
      "F-D-C Reports/Pink Sheet,"
    ],
    "note": [
      "“Tranquilizer ‘Addicting,’” 8–10."
    ],
    "pages": [
      "11 17"
    ],
    "title": [
      "Fraternization-With-Industry and Other Charges v. FDA Splattered All Over Kefauver Hearing Room by Disgruntled Dr. Babs Moulton"
    ],
    "type": "report"
  },
  {
    "author": [
      {
        "family": "Ralph G",
        "given": "See Kenneth D.Campbell",
        "particle": "to"
      }
    ],
    "citation-number": [
      "18."
    ],
    "date": [
      "1960-07-25",
      "1959-11-02"
    ],
    "genre": [
      "See F-D-C Reports/Pink Sheet,"
    ],
    "pages": [
      "22–23"
    ],
    "title": [
      "Smith (acting medical director",
      "NARA RG 88, General Subject Files, box 2887, 511.09. The FDA did, however, begin a crackdown on street sales of amphetamine"
    ],
    "type": "report"
  },
  {
    "author": [
      {
        "family": "Louis M. Moore",
        "given": "C.E.Beisel",
        "particle": "to"
      },
      {
        "given": "Feb"
      }
    ],
    "citation-number": [
      "19."
    ],
    "date": [
      "1964",
      "1964"
    ],
    "genre": [
      "RG 88,",
      "E35,"
    ],
    "location": [
      "NARA"
    ],
    "publisher": [
      "UD-WW",
      "General Subject Files"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Hutt",
        "given": "See Peter Barton"
      }
    ],
    "citation-number": [
      "20."
    ],
    "container-title": [
      "Symposium on “Who Regulates the Regulator . . .” Institute of Food Technologists",
      "Series"
    ],
    "date": [
      "1976-06-07",
      "1976"
    ],
    "location": [
      "Anaheim, CA",
      "Rochester, NY"
    ],
    "note": [
      "Hutt was chief counsel for FDA, 1971–75."
    ],
    "publisher": [
      "Center for the Study of Drug Development, Departments of Pharmacology and Toxicology and of Medicine, University of Rochester Medical Center"
    ],
    "title": [
      "Balanced Government Regulation of Consumer Products",
      "Pub"
    ],
    "type": "article-journal",
    "volume": [
      "PS-7601: 5"
    ]
  },
  {
    "author": [
      {
        "given": "Food"
      },
      {
        "family": "Administration",
        "given": "Drug"
      }
    ],
    "citation-number": [
      "21."
    ],
    "container-title": [
      "Education, and Welfare"
    ],
    "date": [
      "1962-10",
      "1962",
      "22"
    ],
    "location": [
      "Washington, DC"
    ],
    "note": [
      "“No Bromide and Acetanilid-Bromide ‘Crusade’ for FDA,” F-D-C Reports/"
    ],
    "publisher": [
      "U.S. DHEW/FDA"
    ],
    "title": [
      "Report of Second Citizens Advisory Committee on the Food and Drug Administration to the Secretary of Health",
      "32.These statistics also include some personnel in the Bureau of Biological and Physical Sciences responsible for drug approvals"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Sheet",
        "given": "Pink"
      }
    ],
    "container-title": [
      "The Philosophy of Evidence",
      "93, the proceedings of a 1971 conference. 25. Louis Lasagna in discussion",
      "Drug Assessment in Ferment: Multinational Comparisons",
      "149, the proceedings of a 1973 conference",
      "Sept"
    ],
    "date": [
      "1957",
      "1972",
      "1976"
    ],
    "editor": [
      {
        "family": "Leong",
        "given": "George S."
      },
      {
        "family": "discussion",
        "particle": "in"
      },
      {
        "family": "Joseph D. Cooper",
        "particle": "in"
      },
      {
        "family": "Burrell",
        "given": "Craig D."
      }
    ],
    "location": [
      "Washington, DC",
      "Washington, DC"
    ],
    "pages": [
      "– – , 6–9 24",
      "– – , 10–11"
    ],
    "publisher": [
      "Interdisciplinary Communication Associates",
      "Interdisciplinary Communication Associates"
    ],
    "type": "article-journal",
    "volume": [
      "16",
      "6. 23",
      "26"
    ]
  },
  {
    "author": [
      {
        "family": "Kinney",
        "given": "J.Kenneth"
      }
    ],
    "citation-number": [
      "27."
    ],
    "container-title": [
      "Nov"
    ],
    "date": [
      "supervisory inspector",
      "1961"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "note": [
      "General Subject Files, box 3054, 515.04."
    ],
    "title": [
      "to Director, Seattle District"
    ],
    "type": "article-journal",
    "volume": [
      "29"
    ]
  },
  {
    "author": [
      {
        "family": "Ted M",
        "given": "Monte O.Rentz",
        "particle": "to"
      }
    ],
    "citation-number": [
      "28."
    ],
    "container-title": [
      "Oct"
    ],
    "title": [
      "Hopes (Inspector, San Francisco District"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "13,"
    ],
    "date": [
      "1960",
      "1963-11-19"
    ],
    "editor": [
      {
        "family": "Winton B. Rankin",
        "given": "Edward M.Grundlach",
        "particle": "to"
      }
    ],
    "genre": [
      "NARA RG 88,"
    ],
    "note": [
      "General Subject Files, box 3568, 505.5."
    ],
    "title": [
      "NARA RG 88, General Subject Files, box 2893, 515. 29"
    ],
    "type": null
  },
  {
    "citation-number": [
      "30."
    ],
    "date": [
      "1963-01-31"
    ],
    "genre": [
      "NARA RG 88,"
    ],
    "note": [
      "General Subject Files, box 3578, 515.04"
    ],
    "title": [
      "Arthur Ruskin to Office of the Commissioner"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "King",
        "given": "Rufus"
      }
    ],
    "citation-number": [
      "31."
    ],
    "container-title": [
      "see ch"
    ],
    "date": [
      "1972"
    ],
    "location": [
      "New York"
    ],
    "pages": [
      "229–239"
    ],
    "publisher": [
      "Norton"
    ],
    "title": [
      "The Drug Hang-Up: America’s Fifty-Year Folly"
    ],
    "type": "article-journal",
    "volume": [
      "22"
    ]
  },
  {
    "citation-number": [
      "32."
    ],
    "date": [
      "1966-08-03"
    ],
    "note": [
      "For a full citation, see below. He had, however, heard of Roger Egeberg, then medical director of the Los Angeles County Department of Charities, who"
    ],
    "pages": [
      "2437"
    ],
    "title": [
      "See the testimony at the meprobamate hearings of Samuel Kaim, chief of research at the Veterans Administration, Meprobamate Hearings"
    ],
    "type": null
  },
  {
    "note": [
      "de-emphasized the supposed dangers of marijuana). 33. The President’s Advisory Commission on Narcotic and Drug Abuse, Final Report"
    ],
    "title": [
      "had been a member of the White House Ad Hoc Panel on Drug Abuse in 1962 (Egeberg counted as a liberal and later, as Assistant Secretary for Health and Scientific Affairs"
    ],
    "type": "report"
  },
  {
    "author": [
      {
        "family": "Judge E. Barrett Prettyman",
        "given": "The",
        "particle": "members were"
      },
      {
        "family": "chair",
        "given": "James P.Dixon"
      },
      {
        "family": "MD",
        "given": "James S.Dumpson"
      },
      {
        "family": "Egeberg",
        "given": "Roger O."
      },
      {
        "family": "MD",
        "given": "Harry M.Kimball"
      },
      {
        "family": "MacCormick",
        "given": "Austin H."
      },
      {
        "family": "Rafael Sanchez-Ubeda",
        "given": "M.D."
      }
    ],
    "container-title": [
      "Amedeo Marrazzi, in discussion",
      "proceedings of a conference held in",
      "Annals of the New York Academy of Sciences"
    ],
    "date": [
      "1963-11",
      "1962",
      "1961-04"
    ],
    "editor": [
      {
        "family": "Sankar",
        "given": "D.V.Siva"
      }
    ],
    "location": [
      "Washington, DC"
    ],
    "pages": [
      "10"
    ],
    "publisher": [
      "GPO"
    ],
    "title": [
      "for list of addicting and nonaddicting drugs (“Exhibit I”",
      "34",
      "Some Biological Aspects of Schizophrenic Behavior"
    ],
    "type": "article-journal",
    "volume": [
      "96",
      "335"
    ]
  },
  {
    "author": [
      {
        "family": "Larrick",
        "given": "George P."
      },
      {
        "given": "testimony"
      }
    ],
    "citation-number": [
      "35."
    ],
    "container-title": [
      "Hearings Before the Committee on Interstate and Foreign Commerce, House of Representatives, 89th Congress, First Session, on H.R",
      "Feb"
    ],
    "date": [
      "2, Jan 27, 28",
      "1965"
    ],
    "title": [
      "Drug Control Amendments of 1965"
    ],
    "type": "article-journal",
    "volume": [
      "2, 9, and 10"
    ]
  },
  {
    "author": [
      {
        "family": "added",
        "given": "Larrick"
      }
    ],
    "container-title": [
      "Food and Drug Administration, Division of Dockets Management",
      "Ibid",
      "docket"
    ],
    "date": [
      "1965",
      "1966-01-18",
      "1966",
      "1966-06-27"
    ],
    "issue": [
      "FDA-DAC-1, June 27–Sept. 16"
    ],
    "location": [
      "Washington, DC",
      "Rockland, MD"
    ],
    "note": [
      "obtained through the Freedom of Information Act. On the background, see Meprobamate Hearings,",
      "The prehearing began June 14 and is part of the record. 42."
    ],
    "pages": [
      "24",
      "36",
      "250 37",
      "40",
      "2–5"
    ],
    "publisher": [
      "GPO",
      "Ibid"
    ],
    "title": [
      "My testimony today isn’t exclusively my testimony. I am speaking for the Department",
      "Depressant and Stimulant Drugs: Proposed Listing of Additional Drugs Subject to Control,” FDA 21 CFR Part 166, Federal Register 31",
      "565; this is also in NARA, RG 88–74–2 (Hearing Files), box 42, together with administrative correspondence. 41. The 39-volume transcript of the hearings, amounting to 4683 manuscript pages, is at FDA: “In the Matter of Depressant and Stimulant Drugs",
      "U.S",
      "FDA Rebuttal to Industry Drug Bill Testimony Before House Interstate"
    ],
    "type": "article-journal",
    "volume": [
      "89",
      "87. 38. Ibid., 346–347. 39. Ibid., 362"
    ]
  },
  {
    "author": [
      {
        "family": "Sheet",
        "given": "F.-D.-C.Reports/Pink"
      }
    ],
    "container-title": [
      "Sept"
    ],
    "date": [
      "1962",
      "quote S-4"
    ],
    "pages": [
      "–2– –8,"
    ],
    "type": "article-journal",
    "volume": [
      "3"
    ]
  },
  {
    "citation-number": [
      "43."
    ],
    "container-title": [
      "Yet its second meeting took place on April 25–26, 1966; FDA, Advisory Committee on Abuse of Depressant and Stimulant Drugs, Summary of Proceedings, Second Meeting"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "note": [
      "UD-WW, E9, Acc. 88–79–49."
    ],
    "title": [
      "It is unclear when this committee was actually struck. On the basis of other evidence, it was already in existence in 1965"
    ],
    "type": "paper-conference"
  },
  {
    "citation-number": [
      "44."
    ],
    "container-title": [
      "See also FDA, Advisory Committee on Abuse of Depressant and Stimulant Drugs, Summary of Proceedings, Third Meeting"
    ],
    "date": [
      "1966-06-29",
      "June 29–30"
    ],
    "pages": [
      "335"
    ],
    "title": [
      "On this committee, see Meprobamate Hearings, Henry Brill testimony"
    ],
    "type": "paper-conference"
  },
  {
    "author": [
      {
        "family": "Roche",
        "given": "Appendix B.”) See Hoffmann-La"
      },
      {
        "family": "Inc.",
        "given": "Petitioner v Richard G.Kleindienst"
      },
      {
        "family": "United States. No",
        "given": "Attorney General",
        "particle": "of the"
      }
    ],
    "container-title": [
      "App. LEXIS"
    ],
    "date": [
      "1299",
      "1973-03-28"
    ],
    "note": [
      "accessed Sept. 24, 2005)."
    ],
    "pages": [
      "20"
    ],
    "title": [
      "United States Court of Appeals for the Third Circuit, 478 F.2d I; 1973 U.S"
    ],
    "type": "article-journal",
    "url": [
      "http://web.lexis-nexis.com"
    ],
    "volume": [
      "10840",
      "14"
    ]
  },
  {
    "author": [
      {
        "family": "Paul",
        "given": "A."
      }
    ],
    "citation-number": [
      "46."
    ],
    "container-title": [
      "Advisory Committee on Abuse of Depressant and Stimulant Drugs, Summary of Proceedings, Third Meeting"
    ],
    "date": [
      "1966-06-13",
      "June 29–30, 1966"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "pages": [
      "88–79–49"
    ],
    "publisher": [
      "UD-WW"
    ],
    "title": [
      "Palmisano (acting director, Bureau of Medicine), memorandum, to Advisory Committee on the Abuse of Stimulant and Depressant Drugs",
      "Attached to FDA"
    ],
    "type": "paper-conference",
    "volume": [
      "E9"
    ]
  },
  {
    "author": [
      {
        "family": "Hearing Clerk",
        "given": "William L.Hanaway",
        "particle": "to"
      },
      {
        "family": "DHEW",
        "given": "Jan"
      }
    ],
    "citation-number": [
      "47."
    ],
    "date": [
      "1966",
      "box 50"
    ],
    "genre": [
      "RG 88–74–2,"
    ],
    "location": [
      "NARA"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "J. K",
        "given": "Frederick M.Garfield",
        "particle": "to"
      }
    ],
    "citation-number": [
      "48."
    ],
    "container-title": [
      "May"
    ],
    "date": [
      "1966"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "note": [
      "box 3891, 515."
    ],
    "title": [
      "Kirk (assistant commissioner for operations"
    ],
    "type": "article-journal",
    "volume": [
      "13"
    ]
  },
  {
    "citation-number": [
      "49."
    ],
    "note": [
      ". . .” James L. Trawick, Director (FDA Division of Consumer Education) to Nelson N."
    ],
    "title": [
      "When in 1964 an Indianapolis physician noted that Librium and meprobamate were much less harmful than the public feared, the FDA agreed with him: “This is admittedly a difficult public relations area"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Kaufman",
        "given": "Feb"
      }
    ],
    "date": [
      "1964",
      "1964"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "pages": [
      "– , –35"
    ],
    "publisher": [
      "General Subject Files"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Districts",
        "given": "Kenneth Lennington",
        "particle": "to Directors of"
      }
    ],
    "citation-number": [
      "50."
    ],
    "date": [
      "1966-05-17"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "note": [
      "General Subject Files, box 3891, 515."
    ],
    "type": null
  },
  {
    "citation-number": [
      "51."
    ],
    "date": [
      "1966-05-19"
    ],
    "edition": [
      "515. 52. Ibid. 53. Ibid. 54. Ibid"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "note": [
      "General Subject Files, box 3891,"
    ],
    "title": [
      "Bennie Moxness to file, memorandum of telephone conversation"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Merandino",
        "given": "John"
      }
    ],
    "citation-number": [
      "55."
    ],
    "container-title": [
      "memorandum of conference"
    ],
    "date": [
      "1966-05-23"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "note": [
      "box 3891, 515."
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Dennis McGrath",
        "given": "Margaret Milliken",
        "particle": "to"
      },
      {
        "given": "memorandum"
      }
    ],
    "citation-number": [
      "56."
    ],
    "date": [
      "1966-05-23"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "note": [
      "box 3891, 515."
    ],
    "type": null
  },
  {
    "citation-number": [
      "57."
    ],
    "container-title": [
      "docket",
      "box"
    ],
    "date": [
      "1966-10-06"
    ],
    "genre": [
      "RG 88–74–2 (Hearing material),"
    ],
    "issue": [
      "FDA-DAC-2"
    ],
    "location": [
      "Washington, DC",
      "NARA"
    ],
    "pages": [
      "3812–3814,",
      "3777–3778"
    ],
    "title": [
      "This evidence came out in Murphy’s testimony at the Librium-Valium Hearings: Before the Secretary, Department of Health, Education and Welfare, Food and Drug Administration, “In the Matter of: Depressant and Stimulant Drugs"
    ],
    "type": "article-journal",
    "volume": [
      "49"
    ]
  },
  {
    "citation-number": [
      "58."
    ],
    "container-title": [
      "Aug"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "1"
    ],
    "title": [
      "On Lasagna’s apparent role as informal advisor to the hearing examiner, see Frank Berger interview"
    ],
    "type": "article-journal",
    "volume": [
      "10"
    ]
  },
  {
    "citation-number": [
      "59."
    ],
    "date": [
      "1966-06-15"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "Goddard",
      "NARA"
    ],
    "note": [
      "General Subject Files, box 3891, 515."
    ],
    "title": [
      "John Finlator (director of Bureau of Drug Abuse Control), memorandum, to Commissioner James L"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Hearings",
        "given": "Meprobamate"
      }
    ],
    "citation-number": [
      "60."
    ],
    "date": [
      "1966-06-14"
    ],
    "pages": [
      "14"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "testimony",
        "given": "Melvin Sabshin"
      }
    ],
    "citation-number": [
      "61."
    ],
    "container-title": [
      "Meprobamate Hearings"
    ],
    "date": [
      "1966-08-01"
    ],
    "pages": [
      "2170–2196"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "testimony",
        "given": "Frank Ayd"
      }
    ],
    "citation-number": [
      "62."
    ],
    "container-title": [
      "Meprobamate Hearings"
    ],
    "date": [
      "1966-07-29"
    ],
    "pages": [
      "2017–2021"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "testimony",
        "given": "Herman Denber"
      }
    ],
    "citation-number": [
      "63."
    ],
    "container-title": [
      "Meprobamate Hearings"
    ],
    "date": [
      "1966-08-11"
    ],
    "pages": [
      "3102–3107"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "testimony",
        "given": "Leo Alexander"
      }
    ],
    "citation-number": [
      "64."
    ],
    "container-title": [
      "Meprobamate Hearings"
    ],
    "date": [
      "1966-08-05"
    ],
    "pages": [
      "2750"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "testimony",
        "given": "Edward Annis"
      }
    ],
    "citation-number": [
      "65."
    ],
    "container-title": [
      "Meprobamate Hearings"
    ],
    "date": [
      "1966-07-29"
    ],
    "pages": [
      "1978–1979"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "testimony",
        "given": "Joseph Bordenave"
      }
    ],
    "citation-number": [
      "66."
    ],
    "container-title": [
      "Meprobamate Hearings"
    ],
    "date": [
      "1966-08-01"
    ],
    "pages": [
      "2280"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "given": "Minutes"
      }
    ],
    "citation-number": [
      "67."
    ],
    "container-title": [
      "UD-WW"
    ],
    "date": [
      "1974-07-24",
      "RG88"
    ],
    "location": [
      "NARA"
    ],
    "note": [
      "Again at the meeting of Nov. 20–21,"
    ],
    "pages": [
      "88–80–3"
    ],
    "title": [
      "Controlled Substances Advisory Committee",
      "1974, members expressed concern about listing leading to underutilization of controlled drugs and to overutilization of noncontrolled drugs, particularly analgesics"
    ],
    "type": "article-journal",
    "volume": [
      "2",
      "E1"
    ]
  },
  {
    "author": [
      {
        "family": "Hearings",
        "given": "Meprobamate"
      }
    ],
    "citation-number": [
      "68."
    ],
    "date": [
      "1966-08-12"
    ],
    "pages": [
      "4112"
    ],
    "type": null,
    "volume": [
      "3325; Aug. 30"
    ]
  },
  {
    "author": [
      {
        "family": "N",
        "given": "N."
      }
    ],
    "citation-number": [
      "69."
    ],
    "container-title": [
      "May"
    ],
    "date": [
      "1966"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "note": [
      "General Subject Files, box 3891, 515."
    ],
    "title": [
      "Alberstadt, memorandum of telephone conversation with Carl Essig"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "given": "Ainslie"
      }
    ],
    "container-title": [
      "JAMA"
    ],
    "date": [
      "July 20"
    ],
    "note": [
      "1957): 1382, on the reactions of three patients taking very large doses following"
    ],
    "title": [
      "The basis of Essig’s expertise was a one-page research note cowritten with John D",
      "Addiction to Meprobamate"
    ],
    "type": "article-journal",
    "volume": [
      "164"
    ]
  },
  {
    "citation-number": [
      "5"
    ],
    "container-title": [
      "7, NARA RG 88, UD-WW",
      "See CSAC Minutes"
    ],
    "date": [
      "1964",
      "1974",
      "July 24–25, 1974"
    ],
    "pages": [
      "334–343",
      "88–80–3"
    ],
    "title": [
      "FDA’s own Controlled Substances Advisory Committee cast doubt on such animal tests as a means of determining the “dependence potential” of a drug"
    ],
    "type": "article-journal",
    "volume": [
      "E1"
    ]
  },
  {
    "citation-number": [
      "70."
    ],
    "container-title": [
      "New York Times"
    ],
    "date": [
      "1966-07-06"
    ],
    "pages": [
      "27"
    ],
    "title": [
      "Test Dogs Killed by Tranquilizer"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "testimony",
        "given": "Carl Essig"
      },
      {
        "family": "Hearings",
        "given": "Meprobamate"
      }
    ],
    "citation-number": [
      "71."
    ],
    "date": [
      "1966-07-05"
    ],
    "note": [
      "he showed the movie at 602–604."
    ],
    "pages": [
      "605"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "testimony",
        "given": "Carl Essig"
      }
    ],
    "citation-number": [
      "72."
    ],
    "container-title": [
      "Meprobamate Hearings"
    ],
    "date": [
      "1966-07-05"
    ],
    "pages": [
      "637"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "testimony",
        "given": "John Ewing"
      },
      {
        "family": "Hearings",
        "given": "Meprobamate"
      }
    ],
    "citation-number": [
      "73."
    ],
    "date": [
      "1966-06-27"
    ],
    "pages": [
      "647"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "testimony",
        "given": "Jefferson Davis Bulla"
      },
      {
        "family": "Hearings",
        "given": "Meprobamate"
      }
    ],
    "citation-number": [
      "74."
    ],
    "date": [
      "1966-08-10"
    ],
    "pages": [
      "3072"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Ewing",
        "given": "John"
      },
      {
        "given": "re-testimony"
      }
    ],
    "citation-number": [
      "75."
    ],
    "container-title": [
      "telephone memo, to Office of the General Counsel"
    ],
    "date": [
      "1966-08-22",
      "76",
      "1966-05-24"
    ],
    "editor": [
      {
        "family": "Dobbs",
        "given": "Dorothy S."
      }
    ],
    "genre": [
      "RG 88–74–2,"
    ],
    "location": [
      "NARA"
    ],
    "pages": [
      "3719",
      "46"
    ],
    "title": [
      "Meprobamate Hearings",
      "DSD"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "testimony",
        "given": "Jerome Jaffe"
      },
      {
        "family": "Hearings",
        "given": "Meprobamate"
      }
    ],
    "citation-number": [
      "77."
    ],
    "date": [
      "1966-07-01"
    ],
    "note": [
      "see, for example, 467."
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "re-testimony",
        "given": "Jerome Jaffe"
      }
    ],
    "citation-number": [
      "78."
    ],
    "container-title": [
      "Sept"
    ],
    "date": [
      "1966"
    ],
    "pages": [
      "4722–4767"
    ],
    "title": [
      "Meprobamate Hearings"
    ],
    "type": "article-journal",
    "volume": [
      "16"
    ]
  },
  {
    "author": [
      {
        "family": "Hearings",
        "given": "Meprobamate"
      }
    ],
    "citation-number": [
      "79."
    ],
    "container-title": [
      "Sept"
    ],
    "date": [
      "1966"
    ],
    "pages": [
      "4588"
    ],
    "type": "article-journal",
    "volume": [
      "15"
    ]
  },
  {
    "author": [
      {
        "family": "Hearings",
        "given": "Meprobamate"
      }
    ],
    "citation-number": [
      "80."
    ],
    "date": [
      "1966-08-26"
    ],
    "pages": [
      "4024–4025"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Hearings",
        "given": "Meprobamate"
      }
    ],
    "citation-number": [
      "81."
    ],
    "container-title": [
      "Sept"
    ],
    "date": [
      "1966"
    ],
    "pages": [
      "4344"
    ],
    "type": "article-journal",
    "volume": [
      "14"
    ]
  },
  {
    "author": [
      {
        "family": "Making",
        "given": "Proposed Rule"
      },
      {
        "family": "Health",
        "given": "Department",
        "particle": "of"
      },
      {
        "given": "Education"
      },
      {
        "family": "Welfare",
        "given": "Food"
      },
      {
        "family": "Administration",
        "given": "Drug"
      }
    ],
    "citation-number": [
      "82."
    ],
    "container-title": [
      "Federal Register"
    ],
    "date": [
      "1967-04-13"
    ],
    "pages": [
      "5933–5938"
    ],
    "title": [
      "Meprobamate: Proposed Findings of Fact and Conclusions and Tentative Order Regarding Listing Drug as Subject to Control"
    ],
    "type": "article-journal",
    "volume": [
      "32"
    ]
  },
  {
    "author": [
      {
        "family": "testimony",
        "given": "Alexander"
      }
    ],
    "citation-number": [
      "83."
    ],
    "container-title": [
      "Meprobamate Hearings"
    ],
    "date": [
      "1966-08-05"
    ],
    "pages": [
      "2745–2746"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "84."
    ],
    "title": [
      "An editorial in JAMA, apropos of the Essig note and similarly based on"
    ],
    "type": null
  },
  {
    "container-title": [
      "Advances in Pharmacology and Chemotherapy"
    ],
    "date": [
      "box 46",
      "1972"
    ],
    "editor": [
      {
        "family": "Garattini",
        "given": "Silvio"
      },
      {
        "others": true
      }
    ],
    "genre": [
      "NARA RG 88–74–2,"
    ],
    "location": [
      "New York"
    ],
    "pages": [
      "105–118"
    ],
    "publisher": [
      "Academic"
    ],
    "title": [
      "The data in table 3, “Suicide from Poisoning by Drugs in 1963,” were published in Frank Berger, “Social Implications of Psychotropic Drugs"
    ],
    "type": "chapter"
  },
  {
    "citation-number": [
      "86."
    ],
    "date": [
      "1958"
    ],
    "title": [
      "for example, a pharmacist in Milledgeville, GA, wrote the FDA to find out how much Benzedrine he could dispense without a prescription"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Answer",
        "given": "none"
      }
    ],
    "date": [
      "1958-06-25"
    ],
    "genre": [
      "NARA RG 88,"
    ],
    "note": [
      "General Subject Files, box 2535, 511.09.10."
    ],
    "title": [
      "See Cilver Kidd to FDA"
    ],
    "type": null
  },
  {
    "citation-number": [
      "87."
    ],
    "date": [
      "1957-07-01",
      "1957-08-26"
    ],
    "genre": [
      "F-D-C Reports/Pink Sheet,",
      "F-D-C Reports/Pink Sheet,"
    ],
    "pages": [
      "15"
    ],
    "title": [
      "Tranquilizer D-H Case",
      "15; “Tranquilizer D-H Violations"
    ],
    "type": "report"
  },
  {
    "author": [
      {
        "family": "Sullivan",
        "given": "See Walter"
      }
    ],
    "container-title": [
      "FDA Oral History Program, “Interview with William W. Goodrich, Office of the General Counsel",
      "News Along the Pike [FDA CDER newsletter",
      "New York Times"
    ],
    "date": [
      "1948",
      "1997-04",
      "Aug",
      "2006",
      "1966-03-19",
      "1939"
    ],
    "issue": [
      "4"
    ],
    "note": [
      "8 of 12 in printout,",
      "accessed July 4, 2002)."
    ],
    "pages": [
      "5 88",
      "89",
      "90"
    ],
    "publisher": [
      "Frank Berger interview"
    ],
    "title": [
      "According to FDA historian John Swann, FDA enforcement of prescription requirements in general began with a Supreme Court decision in",
      "Swann, “FDA’s Encounter with Goof Balls, Bennies Before DEA",
      "Drugs Approved Before ’62 Face Rescreening"
    ],
    "type": "article-journal",
    "url": [
      "http://www.fda."
    ],
    "volume": [
      "3",
      "10",
      "4",
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "manufacturer",
        "given": "The"
      },
      {
        "family": "Smith",
        "given": "Kline"
      },
      {
        "family": "French",
        "given": "had requested hearings on tranylcypromine"
      }
    ],
    "citation-number": [
      "91."
    ],
    "container-title": [
      "JAMA"
    ],
    "date": [
      "1964-09-07"
    ],
    "pages": [
      "766–767"
    ],
    "title": [
      "But in a sudden reversal under its new medical director Joseph Sadusk, the FDA returned Parnate to market before the hearings began. See editorial “Tranylcypromine Sulfate"
    ],
    "type": "article-journal",
    "volume": [
      "189"
    ]
  },
  {
    "author": [
      {
        "family": "Carter-Wallace",
        "given": "Inc"
      },
      {
        "family": "Petitioner",
        "given": "v John W.Gardner"
      },
      {
        "family": "Health",
        "given": "Secretary",
        "particle": "of"
      },
      {
        "family": "Education"
      },
      {
        "family": "Welfare"
      },
      {
        "family": "Goddard",
        "given": "James L."
      }
    ],
    "citation-number": [
      "92."
    ],
    "container-title": [
      "Respondents"
    ],
    "issue": [
      "12200"
    ],
    "note": [
      "United States Court of Appeals for the Fourth Circuit, 417 F.2d 1086; 1969 U.S. App. LEXIS 10181. Decided Nov. 4, 1969."
    ],
    "title": [
      "Commissioner of Food and Drugs"
    ],
    "type": "article-journal",
    "volume": []
  },
  {
    "citation-number": [
      "93."
    ],
    "date": [
      "1970-06-08"
    ],
    "genre": [
      "F-D-C Reports/ Pink Sheet,"
    ],
    "pages": [
      "18"
    ],
    "title": [
      "Meprobamate ‘Abuse’ Control by BNDD Begins July 6"
    ],
    "type": "report"
  },
  {
    "citation-number": [
      "94."
    ],
    "date": [
      "1962-11-05"
    ],
    "genre": [
      "F-D-C Reports/Pink Sheet,"
    ],
    "pages": [
      "7"
    ],
    "title": [
      "Meprobamate Sales by AMHO & Carter, 1961–56"
    ],
    "type": "report"
  },
  {
    "author": [
      {
        "family": "Paul A",
        "given": "Dorothy S.Dobbs",
        "particle": "to"
      }
    ],
    "citation-number": [
      "95."
    ],
    "container-title": [
      "Nov",
      "DESI files"
    ],
    "date": [
      "1969"
    ],
    "issue": [
      "1730"
    ],
    "note": [
      "obtained through the Freedom of Information Act (FOIA)."
    ],
    "title": [
      "Bryan (special assistant for DESI",
      "FDA"
    ],
    "type": "article-journal",
    "volume": [
      "26",
      "8"
    ]
  },
  {
    "citation-number": [
      "96."
    ],
    "note": [
      "John Jennings (acting director, Bureau of Medicine) to Charles C. Edwards (FDA commissioner), Feb. 2, 1970, DESI files, #9698."
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "John Jennings",
        "given": "William W.Goodrich",
        "particle": "to"
      },
      {
        "given": "Feb"
      }
    ],
    "citation-number": [
      "97."
    ],
    "date": [
      "1970"
    ],
    "pages": [
      "9698"
    ],
    "publisher": [
      "DESI files"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "director",
        "given": "Barrett Scoville",
        "particle": "to deputy"
      },
      {
        "family": "Drugs",
        "given": "Bureau",
        "particle": "of"
      },
      {
        "given": "Jan"
      },
      {
        "family": "Covi",
        "given": "See Lino"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "98."
    ],
    "container-title": [
      "Acta Psychiatrica Scandinavica"
    ],
    "date": [
      "1974",
      "1973"
    ],
    "pages": [
      "51–64"
    ],
    "title": [
      "NARA RG 88, General Subject Files, box 5035, 515",
      "Length of Treatment with Anxiolytic Sedatives and Response to Their Sudden Withdrawal"
    ],
    "type": "article-journal",
    "volume": [
      "49"
    ]
  },
  {
    "citation-number": [
      "99."
    ],
    "container-title": [
      "Sept"
    ],
    "date": [
      "2002"
    ],
    "title": [
      "Edward Kennedy and eight other congresspersons to Dockets Management Branch, FDA"
    ],
    "type": "article-journal",
    "url": [
      "http://www.fda.gov/ohrms/"
    ],
    "volume": [
      "13"
    ]
  },
  {
    "citation-number": [
      "dockets/dailys/102/Sep02/091802/80027f41.pdf"
    ],
    "note": [
      "accessed Aug. 2005)."
    ],
    "type": null
  },
  {
    "citation-number": [
      "100."
    ],
    "date": [
      "2002-08-20"
    ],
    "publisher": [
      "Thomas Ban"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "advertisement",
        "given": "Tybamate"
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "JAMA"
    ],
    "date": [
      "1965-09-06"
    ],
    "pages": [
      "252"
    ],
    "title": [
      "When only an antineurotic can help your patient"
    ],
    "type": "article-journal",
    "volume": [
      "193"
    ]
  },
  {
    "author": [
      {
        "family": "Secretary",
        "given": "Before",
        "particle": "the"
      }
    ],
    "citation-number": [
      "2."
    ],
    "date": [
      "1966-10-06"
    ],
    "genre": [
      "RG 88–74–2"
    ],
    "issue": [
      "FDA-DAC-2"
    ],
    "location": [
      "Washington, DC",
      "NARA"
    ],
    "note": [
      "Hearing materials), box 49. Hereafter cited as Librium-Valium Hearings."
    ],
    "pages": [
      "3812–3814,"
    ],
    "title": [
      "Department of Health, Education and Welfare, Food and Drug Administration, “In the Matter of: Depressant and Stimulant Drugs"
    ],
    "type": null,
    "volume": []
  },
  {
    "author": [
      {
        "family": "Kessel",
        "given": "Neil"
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "“The Medical Use of Psychotropic Drugs: A Report of a Symposium Sponsored by the Department of Health and Social Security"
    ],
    "date": [
      "1972-07"
    ],
    "note": [
      "Journal of the"
    ],
    "pages": [
      "1–2"
    ],
    "title": [
      "Psychiatric Morbidity in General Practice"
    ],
    "type": "paper-conference"
  },
  {
    "author": [
      {
        "family": "Rose",
        "given": "Andy J."
      }
    ],
    "container-title": [
      "Benzodiazepines Divided: A Multidisciplinary Review",
      "See the various contributions in the symposium Hoffmann-La Roche organized for Librium’s launch. Titus Harris",
      "“Symposium on Newer Antidepressant and Other Psychotherapeutic Drugs",
      "Royal College of General Practitioners"
    ],
    "date": [
      "1973",
      "1983",
      "1959"
    ],
    "editor": [
      {
        "family": "Michael Trimble",
        "particle": "ed."
      },
      {
        "literal": "ed."
      }
    ],
    "location": [
      "Chichester"
    ],
    "pages": [
      "11–15, 12 4",
      "61–64",
      "61 5",
      "13–14,"
    ],
    "publisher": [
      "Wiley"
    ],
    "title": [
      "Controversies in Practice"
    ],
    "type": "article-journal",
    "volume": [
      "23, suppl. 2"
    ]
  },
  {
    "author": [
      {
        "family": "gin",
        "given": "On"
      },
      {
        "family": "Librium",
        "given": "see M.Marinker"
      }
    ],
    "container-title": [
      "Diseases of the Nervous System 21",
      "Journal of the Royal College of General Practitioners 23",
      "Wellcome Witnesses to Twentieth Century Medicine",
      "Journal of the History of Medicine",
      "JAMA"
    ],
    "date": [
      "1960-03",
      "1973",
      "quote 27",
      "1997",
      "1960-11-05",
      "1247",
      "1998"
    ],
    "editor": [
      {
        "family": "Tobin",
        "given": "Joseph M."
      },
      {
        "family": "Lewis",
        "given": "Nolan D.C."
      },
      {
        "family": "Tansey",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "issue": [
      "2"
    ],
    "location": [
      "London"
    ],
    "note": [
      "7. Alec Jenner, discussion, in E."
    ],
    "pages": [
      "21",
      "26–30,",
      "338–376 6",
      "1242–49,",
      "152–153"
    ],
    "publisher": [
      "Wellcome Trust"
    ],
    "title": [
      "farmer’s frau",
      "The Doctor’s Role in Prescribing",
      "The symposium at which this paper was given rang with snooty talk about the barrenness of life on English housing estates. Historian Susan L. Speaker challenges the stereotype of a tranquilizer-addicted society passively consuming large quantities of psychoactive drugs. “From ‘Happiness Pills’ to ‘National Nightmare’: Changing Cultural Assessment of Minor Tranquilizers in America, 1955–1980",
      "New Psychotherapeutic Agent, Chlordiazepoxide: Use in Treatment of Anxiety States and Related Symptoms"
    ],
    "type": "article-journal",
    "volume": [
      "suppl",
      "l",
      "52",
      "174",
      "2"
    ]
  },
  {
    "author": [
      {
        "family": "report",
        "given": "For",
        "particle": "his original"
      },
      {
        "family": "F. A. Jenner",
        "particle": "see"
      },
      {
        "others": true
      },
      {
        "family": "Gerard",
        "given": "R.] W."
      }
    ],
    "container-title": [
      "Journal of Mental Science",
      "Science"
    ],
    "date": [
      "1961",
      "1957",
      "quote 201"
    ],
    "pages": [
      "575–582 8",
      "201–203,"
    ],
    "title": [
      "A Controlled Trial of Methaminodiazepoxide (Chlordiazepoxide, ‘Librium’) in the Treatment of Anxiety in Neurotic Patients",
      "Drugs for the Soul: The Rise of Psychopharmacology"
    ],
    "type": "article-journal",
    "volume": [
      "107",
      "125"
    ]
  },
  {
    "citation-number": [
      "9."
    ],
    "date": [
      "1960"
    ],
    "location": [
      "March"
    ],
    "pages": [
      "122–123"
    ],
    "title": [
      "Librium advertisement, Diseases of the Nervous System 21"
    ],
    "type": null
  },
  {
    "citation-number": [
      "10."
    ],
    "date": [
      "1960-10-17"
    ],
    "genre": [
      "F-D-C Reports/Pink Sheet,"
    ],
    "pages": [
      "19"
    ],
    "title": [
      "How’s Business?"
    ],
    "type": "report"
  },
  {
    "author": [
      {
        "family": "Buttle",
        "given": "Edgar A."
      },
      {
        "family": "Examiner",
        "given": "Hearing"
      }
    ],
    "citation-number": [
      "11."
    ],
    "container-title": [
      "44–45, FDA, docket no. FDA-DAC-2",
      "Apr"
    ],
    "date": [
      "1967",
      "box 51"
    ],
    "genre": [
      "RG 88–74–2,"
    ],
    "location": [
      "NARA"
    ],
    "title": [
      "Report Including Recommended Findings and Conclusions Re Potential for Abuse of the Drugs Librium and Valium"
    ],
    "type": "article-journal",
    "volume": [
      "7"
    ]
  },
  {
    "author": [
      {
        "family": "Health",
        "given": "U.S.Department",
        "particle": "of"
      },
      {
        "family": "Education"
      },
      {
        "family": "Welfare",
        "given": "Task Force on Prescription Drugs"
      }
    ],
    "citation-number": [
      "12."
    ],
    "date": [
      "1968-12"
    ],
    "location": [
      "Washington, DC"
    ],
    "note": [
      "App. A: 38."
    ],
    "publisher": [
      "Office of the Secretary"
    ],
    "title": [
      "Background Papers, The Drug Users"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "William Dworkin",
        "given": "Mrs Mae M.",
        "particle": "to"
      },
      {
        "family": "FDA",
        "given": "Sept"
      }
    ],
    "citation-number": [
      "13."
    ],
    "date": [
      "1973",
      "box 4866"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "title": [
      "She said she took Librium and Valium alike"
    ],
    "type": null
  },
  {
    "citation-number": [
      "14."
    ],
    "container-title": [
      "Journal of Clinical Psychiatry"
    ],
    "pages": [
      "31"
    ],
    "title": [
      "Carl Salzman, in discussion, special issue on “Innovative Treatment Strategies"
    ],
    "type": "article-journal",
    "volume": [
      "51, suppl. (Oct. 1990"
    ]
  },
  {
    "citation-number": [
      "15."
    ],
    "date": [
      "1963",
      "uncataloged"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "publisher": [
      "Ten-Year Trend"
    ],
    "title": [
      "National Prescription Audit, Therapeutic Category Report"
    ],
    "type": null
  },
  {
    "citation-number": [
      "16."
    ],
    "date": [
      "1971"
    ],
    "location": [
      "Chicago"
    ],
    "pages": [
      "227"
    ],
    "publisher": [
      "AMA"
    ],
    "title": [
      "American Medical Association, AMA Drug Evaluations"
    ],
    "type": "book"
  },
  {
    "citation-number": [
      "17."
    ],
    "title": [
      "International sales of meprobamate have remained robust to this day"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Altman",
        "given": "Lawrence K."
      }
    ],
    "container-title": [
      "2001",
      "International Narcotics Control Board (INCB), Psychotropic Substances, Statistics for 2002",
      "Schedule",
      "National Prescription Audit",
      "New York Times"
    ],
    "date": [
      "2004",
      "1974-05-19"
    ],
    "location": [
      "New York"
    ],
    "pages": [
      "174 18",
      "1"
    ],
    "publisher": [
      "United Nations"
    ],
    "title": [
      "252,000 kg (277 U.S. tons) of meprobamate were manufactured worldwide",
      "Valium, Most Prescribed Drug, Is Center of a Medical Dispute"
    ],
    "type": "article-journal",
    "volume": [
      "IV, D2",
      "19"
    ]
  },
  {
    "citation-number": [
      "20."
    ],
    "date": [
      "2003"
    ],
    "location": [
      "Skodsborg, Denmark"
    ],
    "pages": [
      "9–11"
    ],
    "publisher": [
      "Lundbeck"
    ],
    "title": [
      "For a list, see Lundbeck Institute, Psychotropics 2002/2003"
    ],
    "type": "book"
  },
  {
    "citation-number": [
      "21."
    ],
    "container-title": [
      "JAMA"
    ],
    "date": [
      "1969-04-28"
    ],
    "pages": [
      "644–645"
    ],
    "title": [
      "Valium advertisement"
    ],
    "type": "article-journal",
    "volume": [
      "208"
    ]
  },
  {
    "author": [
      {
        "family": "Use",
        "given": "See"
      },
      {
        "family": "Benzodiazepines",
        "given": "Misuse",
        "particle": "of"
      }
    ],
    "citation-number": [
      "22."
    ],
    "container-title": [
      "Sept"
    ],
    "date": [
      "1979",
      "1980"
    ],
    "location": [
      "Washington, DC"
    ],
    "pages": [
      "241–242"
    ],
    "publisher": [
      "GPO"
    ],
    "title": [
      "Hearing Before the Subcommittee on Health and Scientific Research of the Committee on Labor and Human Resources, United States Senate, 96th Congress, First Session"
    ],
    "type": "article-journal",
    "volume": [
      "10"
    ]
  },
  {
    "author": [
      {
        "family": "listing",
        "given": "For",
        "particle": "a"
      },
      {
        "family": "Donald F. Klein",
        "particle": "see"
      },
      {
        "family": "Davis",
        "given": "John M."
      }
    ],
    "citation-number": [
      "23."
    ],
    "container-title": [
      "“Hoffmann-La Roche’s Worldwide Drug"
    ],
    "date": [
      "1969",
      "1971-07-26"
    ],
    "genre": [
      "F-D-C Reports/Pink Sheet,"
    ],
    "location": [
      "Baltimore"
    ],
    "pages": [
      "33 24",
      "3–5"
    ],
    "publisher": [
      "Williams & Wilkins"
    ],
    "title": [
      "Diagnosis and Drug Treatment of Psychiatric Disorders"
    ],
    "type": "article-journal",
    "volume": [
      "380"
    ]
  },
  {
    "citation-number": [
      "25."
    ],
    "container-title": [
      "JAMA"
    ],
    "date": [
      "1965-09-06"
    ],
    "pages": [
      "64–65"
    ],
    "title": [
      "Serax advertisement"
    ],
    "type": "article-journal",
    "volume": [
      "193"
    ]
  },
  {
    "citation-number": [
      "26."
    ],
    "location": [
      "Philadelphia"
    ],
    "pages": [
      "31"
    ],
    "publisher": [
      "Chemical Heritage Foundation, Oral History Transcript"
    ],
    "title": [
      "Leo Sternbach, the Roche chemist who synthesized the first benzos, dilated upon this point in an interview. See “Leo H. Sternbach, interview by Tonja Koeppel, 12 March 1986"
    ],
    "type": "book",
    "volume": [
      "0043"
    ]
  },
  {
    "author": [
      {
        "family": "Tallman",
        "given": "John F."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "27."
    ],
    "container-title": [
      "Science"
    ],
    "date": [
      "1980-01-18"
    ],
    "pages": [
      "274–281"
    ],
    "title": [
      "Receptors for the Age of Anxiety: Pharmacology of the Benzodiazepines"
    ],
    "type": "article-journal",
    "volume": [
      "207"
    ]
  },
  {
    "citation-number": [
      "28."
    ],
    "container-title": [
      "Scrip"
    ],
    "date": [
      "1990-01-19"
    ],
    "pages": [
      "24 29",
      "18–19"
    ],
    "publisher": [
      "Lundbeck Institute, Psychotropics"
    ],
    "title": [
      "Top 20 Branded Products of 1988"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Ayd",
        "given": "Frank J.",
        "suffix": "Jr"
      }
    ],
    "citation-number": [
      "30."
    ],
    "container-title": [
      "Neuropsychopharmacology"
    ],
    "date": [
      "1991"
    ],
    "pages": [
      "71–84, 81"
    ],
    "title": [
      "The Early History of Modern Psychopharmacology"
    ],
    "type": "article-journal",
    "volume": [
      "5"
    ]
  },
  {
    "author": [
      {
        "given": "I.N.C.B."
      }
    ],
    "citation-number": [
      "31."
    ],
    "container-title": [
      "Psychotropic Substances"
    ],
    "type": "article-journal",
    "volume": [
      "174"
    ]
  },
  {
    "citation-number": [
      "32."
    ],
    "date": [
      "1966-10-05"
    ],
    "pages": [
      "3678–3679"
    ],
    "publisher": [
      "Librium-Valium Hearings"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "advertisement",
        "given": "Librium"
      }
    ],
    "citation-number": [
      "33."
    ],
    "container-title": [
      "JAMA"
    ],
    "date": [
      "1960-11-05"
    ],
    "issue": [
      "10"
    ],
    "pages": [
      "253–254"
    ],
    "type": "article-journal",
    "volume": [
      "174"
    ]
  },
  {
    "author": [
      {
        "family": "See",
        "given": "for example"
      },
      {
        "family": "Angst",
        "given": "Jules"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "34."
    ],
    "container-title": [
      "Journal of Clinical Psychiatry"
    ],
    "date": [
      "1990",
      "tables 10, 11",
      "1998"
    ],
    "editor": [
      {
        "family": "Jack D. Maser",
        "particle": "ed."
      },
      {
        "others": true
      },
      {
        "family": "Paula J. Clayton",
        "particle": "see"
      }
    ],
    "location": [
      "Washington, DC"
    ],
    "note": [
      "see 8, fig. 2."
    ],
    "pages": [
      "123–127",
      "134–135,",
      "5–12,"
    ],
    "publisher": [
      "American Psychiatric Press"
    ],
    "title": [
      "Co-morbidity of Anxiety and Depression in the Zurich Cohort Study of Young Adults, “ in Comorbidity of Mood and Anxiety Disorders",
      "On mixed anxiety-depression as the commonest form of depression",
      "Depression Subtyping: Treatment Implications"
    ],
    "type": "article-journal",
    "volume": [
      "59, suppl. 16"
    ]
  },
  {
    "author": [
      {
        "family": "W",
        "given": "D.] A."
      }
    ],
    "citation-number": [
      "35."
    ],
    "container-title": [
      "Benzodiazepines Divided"
    ],
    "date": [
      "1983"
    ],
    "editor": [
      {
        "family": "Trimble",
        "given": "Michael"
      }
    ],
    "location": [
      "Chichester"
    ],
    "pages": [
      "65"
    ],
    "publisher": [
      "Wiley"
    ],
    "title": [
      "Johnson in discussion"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Üstün",
        "given": "T.B."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "36."
    ],
    "container-title": [
      "Mental Illness in General Health Care: An International Study"
    ],
    "editor": [
      {
        "literal": "ed."
      }
    ],
    "title": [
      "Primary Mental Health Services: Access and Provision of Care"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "given": "Ustün"
      },
      {
        "family": "Sartorius",
        "given": "N."
      },
      {
        "family": "Bowes",
        "given": "H.Angus"
      },
      {
        "family": "Tobin",
        "given": "Joseph M."
      },
      {
        "family": "Lewis",
        "given": "Nolan D.C."
      },
      {
        "family": "Schatzberg",
        "given": "Alan F."
      },
      {
        "family": "Cole",
        "given": "Jonathan O."
      },
      {
        "family": "Birkenhäger",
        "given": "T.K."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "39."
    ],
    "container-title": [
      "Dr. Rathbone in discussion, “Symposium on Chlordiazepoxide: A Scientific Meeting",
      "Diseases of the Nervous System",
      "JAMA",
      "Archives of General Psychiatry",
      "International Clinical Psychopharmacology",
      "Diseases of the Nervous System"
    ],
    "date": [
      "1995",
      "quote 20–21. 38",
      "1981-12-04",
      "1978",
      "1364",
      "1995",
      "1961-01-14"
    ],
    "genre": [
      "quote 1247. 40."
    ],
    "issue": [
      "Nov. 5, 1960"
    ],
    "location": [
      "Chichester"
    ],
    "note": [
      "T. A. Furukawa et al., “Antidepressant and Benzodiazepine for Major Depression (Cochrane Review),” Cochrane Library 3 (Oxford: Update Software, 2002), quote at 8 of 18. [Oct. 22, 2002]."
    ],
    "pages": [
      "6 37",
      "20–22,",
      "1242–1249,",
      "1359–1365,",
      "41",
      "42",
      "34–35 43"
    ],
    "publisher": [
      "Wiley"
    ],
    "title": [
      "The Role of Librium in an Out-Patient Psychiatric Setting",
      "Bernard Carroll, discussion, FDA, Psychopharmacologic Drugs Advisory Committee, Transcript [dothiepin/antidepressant labeling",
      "II-98–99; obtained from FDA through the Freedom of Information Act",
      "New Psychotherapeutic Agent, Chlordiazepoxide: Use in Treatment of Anxiety States and Related Symptoms",
      "Benzodiazepines in Depressive Disorders",
      "Benzodiazepines for Depression? A Review of the Literature"
    ],
    "type": "article-journal",
    "volume": [
      "358",
      "21, suppl. (Mar. 1960",
      "2",
      "174",
      "35",
      "10",
      "22, suppl. (1961"
    ]
  },
  {
    "citation-number": [
      "44."
    ],
    "container-title": [
      "Mar"
    ],
    "date": [
      "2007"
    ],
    "title": [
      "Thomas Ban, personal communication"
    ],
    "type": "article-journal",
    "volume": [
      "3"
    ]
  },
  {
    "citation-number": [
      "45."
    ],
    "container-title": [
      "21 CFR Part 166, Federal Register"
    ],
    "date": [
      "1966-01-18"
    ],
    "pages": [
      "565"
    ],
    "title": [
      "Depressant and Stimulant Drugs"
    ],
    "type": "chapter",
    "volume": [
      "31"
    ]
  },
  {
    "author": [
      {
        "family": "Kleindienst",
        "given": "Richard G."
      }
    ],
    "citation-number": [
      "46."
    ],
    "note": [
      "No. 71–1299. United States Court of Appeals for the Third Circuit, 478 F.2d I; 1973 U.S. App. LEXIS 10840, decided Mar. 28, 1973, 15;",
      "accessed Sept. 24, 2005)."
    ],
    "title": [
      "The existence of these two communications was later revealed in court: Hoffmann-La Roche, Inc., Petitioner v",
      "Attorney General of the United States"
    ],
    "type": null,
    "url": [
      "http://www.web.lexis-nexis.com"
    ]
  },
  {
    "container-title": [
      "Lee Gordon (Roche) and Dr. M[atthew] J. Ellenhorn"
    ],
    "date": [
      "1963-07-31"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "note": [
      "General Subject Files, box 3568, 505.5."
    ],
    "title": [
      "If Hoffmann-La Roche had known of their existence earlier, its lawsuit, as well as the 1966 hearings that prompted it, might have had a different outcome. 47. Memorandum of telephone conversation between Dr"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "interview",
        "given": "Memorandum",
        "particle": "of"
      }
    ],
    "citation-number": [
      "48."
    ],
    "date": [
      "1963-08-22"
    ],
    "editor": [
      {
        "family": "Dr. Lee Gordon",
        "particle": "between"
      },
      {
        "family": "Ellenhorn",
        "given": "Matthew J."
      },
      {
        "family": "Egelman",
        "given": "Arthur"
      },
      {
        "family": "Moling",
        "given": "John H."
      },
      {
        "family": "Hauser",
        "given": "J."
      }
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "pages": [
      "505 5"
    ],
    "type": null,
    "volume": [
      "box 3568"
    ]
  },
  {
    "citation-number": [
      "49."
    ],
    "date": [
      "1963-12-21"
    ],
    "pages": [
      "60"
    ],
    "title": [
      "Valium advertisement, JAMA 186"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "meeting",
        "given": "Memorandum",
        "particle": "of"
      }
    ],
    "citation-number": [
      "50."
    ],
    "container-title": [
      "Apr"
    ],
    "date": [
      "1964"
    ],
    "title": [
      "present were numerous Roche executives, representatives of Roche’s advertising agency, and FDA staffers"
    ],
    "type": "article-journal",
    "volume": [
      "13"
    ]
  },
  {
    "author": [
      {
        "given": "N.A.R.A."
      }
    ],
    "container-title": [
      "UD-WW"
    ],
    "date": [
      "1966-01-18"
    ],
    "editor": [
      {
        "family": "Joseph Sadusk",
        "given": "Ed C.",
        "particle": "to"
      }
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "note": [
      "General Subject Files, box 3891, 515."
    ],
    "pages": [
      "505 51 51"
    ],
    "title": [
      "RG 88, General Subject Files"
    ],
    "type": "article-journal",
    "volume": [
      "E35"
    ]
  },
  {
    "author": [
      {
        "family": "FDA",
        "given": "H.J.Bulgerin",
        "particle": "to"
      },
      {
        "given": "Feb"
      }
    ],
    "citation-number": [
      "52."
    ],
    "date": [
      "1966"
    ],
    "genre": [
      "RG 88–74–2"
    ],
    "location": [
      "NARA"
    ],
    "note": [
      "Hearing Materials), box 50."
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Matthew J. Ellenhorn",
        "given": "John J.Jennings",
        "particle": "to"
      }
    ],
    "citation-number": [
      "53."
    ],
    "container-title": [
      "Oct"
    ],
    "date": [
      "1964"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "note": [
      "General Subject Files, box 4248, 505.53."
    ],
    "title": [
      "New Drug Surveillance Branch"
    ],
    "type": "article-journal",
    "volume": [
      "27"
    ]
  },
  {
    "author": [
      {
        "family": "A. H",
        "given": "Memorandum",
        "particle": "of telephone conversation between"
      }
    ],
    "citation-number": [
      "54."
    ],
    "date": [
      "1966-07-14"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "note": [
      "General Subject Files, box 3885, 505.5"
    ],
    "title": [
      "Pate (Case Review Branch) and Charles Llewellen (Duke University"
    ],
    "type": null
  },
  {
    "citation-number": [
      "55."
    ],
    "date": [
      "1966-07-29"
    ],
    "genre": [
      "Verhulst,",
      "NARA RG 88,"
    ],
    "note": [
      "General Subject Files, box 3891, 515."
    ],
    "title": [
      "William Goodrich (FDA assistant general counsel) to Henry L"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "James L. Goddard",
        "given": "John Finlator",
        "particle": "to"
      }
    ],
    "citation-number": [
      "56."
    ],
    "date": [
      "1966-07-29"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "pages": [
      "515 57"
    ],
    "publisher": [
      "Ibid"
    ],
    "type": null,
    "volume": [
      "box 3891"
    ]
  },
  {
    "citation-number": [
      "58."
    ],
    "date": [
      "1966-10-12"
    ],
    "pages": [
      "4340"
    ],
    "publisher": [
      "Librium-Valium Hearings"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "given": "Buttle"
      }
    ],
    "citation-number": [
      "59."
    ],
    "date": [
      "1967"
    ],
    "genre": [
      "RG 88–74–2"
    ],
    "location": [
      "NARA"
    ],
    "note": [
      "hearing material), box 51."
    ],
    "pages": [
      "111–114,"
    ],
    "title": [
      "Report"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Hearings",
        "given": "Librium-Valium"
      },
      {
        "given": "Feb"
      }
    ],
    "citation-number": [
      "60."
    ],
    "date": [
      "1967"
    ],
    "pages": [
      "5102"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Finney",
        "given": "Thomas D."
      }
    ],
    "container-title": [
      "Librium-Valium Hearings, Feb"
    ],
    "date": [
      "1967"
    ],
    "note": [
      "T. Gordon Reilly led the government’s case."
    ],
    "pages": [
      "3479 62",
      "5139–5140"
    ],
    "title": [
      "Jr., was the lead Hoffmann-La Roche lawyer"
    ],
    "type": "article-journal",
    "volume": [
      "28"
    ]
  },
  {
    "citation-number": [
      "63."
    ],
    "date": [
      "1966-10-04"
    ],
    "pages": [
      "3607–3608"
    ],
    "publisher": [
      "Librium-Valium Hearings"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Senay",
        "given": "Edward"
      }
    ],
    "citation-number": [
      "64."
    ],
    "title": [
      "an associate professor of psychiatry at the University of Chicago, said at a 1976 roundtable, “We asked 216 patients coming into the Illinois Drug Abuse program what they had used in the past 48 hours"
    ],
    "type": null
  },
  {
    "author": [
      {
        "literal": ". . ."
      }
    ],
    "container-title": [
      "See Senay in discussion",
      "Psychosomatics"
    ],
    "date": [
      "1977",
      "quote 56"
    ],
    "editor": [
      {
        "family": "Hollister",
        "given": "Leo E."
      }
    ],
    "note": [
      "The roundtable discussion was held May 20, 1976."
    ],
    "pages": [
      "44–58,"
    ],
    "title": [
      "Twenty-eight of the 216 said they had used Valium. Almost all of that use was in combination with other drugs, with heroin by far the most common",
      "Street people frequently do not know what drug they are taking",
      "Valium: A Discussion of Current Issues"
    ],
    "type": "article-journal",
    "volume": [
      "18"
    ]
  },
  {
    "author": [
      {
        "family": "Hearing Clerk",
        "given": "D.H.E.W.",
        "particle": "Hoffmann-La Roche to"
      },
      {
        "given": "Feb"
      }
    ],
    "citation-number": [
      "65."
    ],
    "date": [
      "1966"
    ],
    "note": [
      "30, table 3, NARA, RG 88–27–2 (Hearing Materials), box 48."
    ],
    "title": [
      "Comment"
    ],
    "type": null
  },
  {
    "citation-number": [
      "66."
    ],
    "date": [
      "1966-10"
    ],
    "pages": [
      "4235–4306"
    ],
    "publisher": [
      "Librium-Valium Hearings"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Hearings",
        "given": "Librium-Valium"
      },
      {
        "given": "Feb"
      }
    ],
    "citation-number": [
      "67."
    ],
    "date": [
      "1967"
    ],
    "pages": [
      "5125–5126"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Ohberg",
        "given": "Annakatri"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "68."
    ],
    "container-title": [
      "BJP"
    ],
    "date": [
      "1996"
    ],
    "note": [
      "see 77, table 3."
    ],
    "pages": [
      "75–80,"
    ],
    "title": [
      "Alcohol and Drugs in Suicides"
    ],
    "type": "article-journal",
    "volume": [
      "169"
    ]
  },
  {
    "citation-number": [
      "69."
    ],
    "date": [
      "1966-10-21"
    ],
    "pages": [
      "111–112"
    ],
    "publisher": [
      "Librium-Valium Hearings"
    ],
    "type": "book",
    "volume": [
      "4463. 70. Buttle, “Report,” 106"
    ]
  },
  {
    "citation-number": [
      "71."
    ],
    "container-title": [
      "Food and Drug Administration, “Abuse of Depressant and Stimulant Drugs Advisory Committee, Minutes of the Ninth Committee Meeting,”",
      "F-D-C Reports/Pink Sheet"
    ],
    "date": [
      "1968-06-24",
      "1968-01",
      "1968-01-23"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "pages": [
      "–9",
      "8",
      "88–79–49"
    ],
    "publisher": [
      "UD-WW"
    ],
    "title": [
      "Librium/Valium Drug Abuse Listing Decision",
      "Goddard let FDA’s relevant advisory committee know that he had as yet made no decision “as to whether he will uphold the hearing examiner’s recommendation to control these two drugs [Librium and Valium"
    ],
    "type": "article-journal",
    "volume": [
      "E9"
    ]
  },
  {
    "author": [
      {
        "given": "Finch"
      },
      {
        "family": "Disagree",
        "given": "Mitchell"
      }
    ],
    "citation-number": [
      "72."
    ],
    "container-title": [
      "F-D-C Reports/Pink Sheet June"
    ],
    "date": [
      "1969"
    ],
    "pages": [
      "34–36"
    ],
    "title": [
      ""
    ],
    "type": "article-journal",
    "volume": [
      "9"
    ]
  },
  {
    "citation-number": [
      "73."
    ],
    "date": [
      "1969-05-05"
    ],
    "genre": [
      "F-D-C Reports/Pink Sheet,"
    ],
    "note": [
      "“Proposed Rule Making. Department of Justice, Bureau of Narcotics and Dangerous Drugs, Depressant and Stimulant Drugs,” 21 CFR Part 320, Federal"
    ],
    "pages": [
      "4–5 74"
    ],
    "title": [
      "Librium, Valium & Meprobamate Deleted from BNDD’s Proposed Bill"
    ],
    "type": "report"
  },
  {
    "container-title": [
      "Register"
    ],
    "date": [
      "1969-05-21"
    ],
    "pages": [
      "7968–7974, 7973–74"
    ],
    "type": "article-journal",
    "volume": [
      "34"
    ]
  },
  {
    "author": [
      {
        "given": "F.D.A."
      }
    ],
    "citation-number": [
      "75."
    ],
    "container-title": [
      "Summary of Proceedings, Second Meeting, April 25–26, 1966: 6, NARA, RG 88, UD-WW"
    ],
    "pages": [
      "88–79–49"
    ],
    "title": [
      "Advisory Committee on Abuse of Depressant and Stimulant Drugs"
    ],
    "type": "paper-conference",
    "volume": [
      "E9"
    ]
  },
  {
    "citation-number": [
      "76."
    ],
    "container-title": [
      "Nexis Mar"
    ],
    "date": [
      "1973"
    ],
    "note": [
      "See next note."
    ],
    "pages": [
      "15"
    ],
    "title": [
      "This letter, an internal FDA communication, was mentioned in Lexis/"
    ],
    "type": "article-journal",
    "volume": [
      "28"
    ]
  },
  {
    "author": [
      {
        "family": "Roche",
        "given": "See Hoffmann-La"
      },
      {
        "family": "Inc.",
        "given": "Petitioner v Richard G.Kleindienst"
      },
      {
        "family": "United States. No",
        "given": "Attorney General",
        "particle": "of the"
      },
      {
        "family": "I",
        "given": "F2d"
      },
      {
        "literal": "U.S. App. LEXIS 10840, decided Mar."
      }
    ],
    "citation-number": [
      "77."
    ],
    "container-title": [
      "but it did not include a copy of Appendix B. 78. Ibid",
      "New York Times"
    ],
    "date": [
      "1299",
      "1973",
      "1973",
      "2005",
      "1975-06-02"
    ],
    "note": [
      "accessed Sept. 24,"
    ],
    "pages": [
      "79",
      "27 80"
    ],
    "publisher": [
      "Ibid"
    ],
    "title": [
      "United States Court of Appeals for the Third Circuit, 478",
      "The advisory committee’s actual “report” was not present in the files. We have only the minutes of what the committee decided in session. What purported to be the one-page report was reprinted in the court’s opinion, 20 of 21. This report listed the drugs claimed to be in the committee’s “Appendix B",
      "Two Tranquilizers, Librium and Valium, Face Strict Control"
    ],
    "type": "article-journal",
    "url": [
      "http://www.web.lexis-nexis.com"
    ],
    "volume": [
      "18"
    ]
  },
  {
    "citation-number": [
      "81."
    ],
    "container-title": [
      "Minutes"
    ],
    "date": [
      "1974-11-20"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "pages": [
      "88–00–03"
    ],
    "publisher": [
      "UD-WW"
    ],
    "title": [
      "FDA Controlled Substances Advisory Committee"
    ],
    "type": "article-journal",
    "volume": [
      "2",
      "E1"
    ]
  },
  {
    "citation-number": [
      "82."
    ],
    "container-title": [
      "Wellcome Witnesses to Twentieth Century Medicine"
    ],
    "date": [
      "1998"
    ],
    "editor": [
      {
        "family": "Jenner",
        "given": "Alec"
      },
      {
        "family": "discussion",
        "given": "in E.M.Tansey"
      },
      {
        "others": true
      }
    ],
    "location": [
      "London"
    ],
    "pages": [
      "152–153"
    ],
    "publisher": [
      "Wellcome Trust"
    ],
    "type": "chapter",
    "volume": [
      "2"
    ]
  },
  {
    "citation-number": [
      "83."
    ],
    "container-title": [
      "Two of the three authorities for the sentence were the animal pharmacologists Nathan Eddy and Harris Isbell in Lexington"
    ],
    "location": [
      "Kentucky"
    ],
    "title": [
      "Buried in the long “proposed rule making” was the sentence, “Librium and Valium have been taken in excessive amounts for extended periods of time by individuals to the point that they have become physically dependent on the drug"
    ],
    "type": "chapter"
  },
  {
    "container-title": [
      "Federal Register"
    ],
    "date": [
      "1969-05-21"
    ],
    "pages": [
      "7971"
    ],
    "type": "article-journal",
    "volume": [
      "34"
    ]
  },
  {
    "author": [
      {
        "family": "Katz",
        "given": "J.] L."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "84."
    ],
    "container-title": [
      "Benzodiazepines: Current Concepts"
    ],
    "date": [
      "1990"
    ],
    "editor": [
      {
        "family": "I. Hindmarch",
        "particle": "ed."
      },
      {
        "others": true
      }
    ],
    "location": [
      "Chichester"
    ],
    "pages": [
      "181–198",
      "194"
    ],
    "publisher": [
      "Wiley"
    ],
    "title": [
      "Abuse Liability of Benzodiazepines"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Brandon",
        "given": "S.]"
      }
    ],
    "citation-number": [
      "85."
    ],
    "container-title": [
      "Hindmarch, Benzodiazepines"
    ],
    "date": [
      "quote 112"
    ],
    "pages": [
      "111–139,"
    ],
    "title": [
      "Clinical Use of Benzodiazepines in Anxiety and Panic Disorders"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Hollister",
        "given": "Leo H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "86."
    ],
    "container-title": [
      "Psychopharmacologia"
    ],
    "date": [
      "1961",
      "quote 67"
    ],
    "pages": [
      "63–68,"
    ],
    "title": [
      "Withdrawal Reactions from Chlordiazepoxide (‘Librium’"
    ],
    "type": "article-journal",
    "volume": [
      "2"
    ]
  },
  {
    "citation-number": [
      "87."
    ],
    "title": [
      "Hollister apparently regretted the government’s misconstruction of his"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Covi",
        "given": "Lino"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "88."
    ],
    "container-title": [
      "Drug Abuse: Social and Psychopharmacological Aspects"
    ],
    "date": [
      "1969"
    ],
    "editor": [
      {
        "family": "Jon O. Cole",
        "particle": "ed."
      },
      {
        "others": true
      }
    ],
    "location": [
      "Springfield"
    ],
    "pages": [
      "93–108"
    ],
    "publisher": [
      "Thomas"
    ],
    "title": [
      "Factors Affecting Withdrawal Response to Certain Minor Tranquilizers"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Covi",
        "given": "L.]"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "89."
    ],
    "container-title": [
      "Acta Psychiatrica Scandinavica"
    ],
    "date": [
      "1973"
    ],
    "pages": [
      "51–64"
    ],
    "title": [
      "Length of Treatment with Anxiolytic Sedatives and Response to Their Sudden Withdrawal"
    ],
    "type": "article-journal",
    "volume": [
      "49"
    ]
  },
  {
    "author": [
      {
        "family": "to",
        "given": "Herman X."
      }
    ],
    "citation-number": [
      "90."
    ],
    "container-title": [
      "Oct"
    ],
    "date": [
      "1979"
    ],
    "genre": [
      "RG 88,"
    ],
    "note": [
      "General Subject Files, 88–85–49, box 33, 515.231; attached to Robert Wetherell (assoc."
    ],
    "title": [
      "Director",
      "NARA"
    ],
    "type": "article-journal",
    "volume": [
      "15"
    ]
  },
  {
    "author": [
      {
        "family": "commissioner",
        "given": "Legislative Affairs) to Sen Richard S.Schweiker"
      }
    ],
    "date": [
      "1979-11-06"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Lader",
        "given": "M.]"
      }
    ],
    "citation-number": [
      "91."
    ],
    "container-title": [
      "Neuroscience"
    ],
    "date": [
      "1978",
      "quote 163"
    ],
    "pages": [
      "159–165,"
    ],
    "title": [
      "Benzodiazepines—The Opium of the Masses"
    ],
    "type": "article-journal",
    "volume": [
      "3"
    ]
  },
  {
    "author": [
      {
        "family": "Tyrer",
        "given": "Peter"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "92."
    ],
    "container-title": [
      "Lancet"
    ],
    "date": [
      "1981-03-07"
    ],
    "pages": [
      "520–522"
    ],
    "title": [
      "Benzodiazepine Withdrawal Symptoms and Propanolol"
    ],
    "type": "article-journal",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "Petursson",
        "given": "H."
      },
      {
        "family": "Lader",
        "given": "M.H."
      }
    ],
    "citation-number": [
      "93."
    ],
    "container-title": [
      "BMJ"
    ],
    "date": [
      "1981-09-05",
      "quote 643"
    ],
    "pages": [
      "643–645,"
    ],
    "title": [
      "Withdrawal from Long-term Benzodiazepine Treatment"
    ],
    "type": "article-journal",
    "volume": [
      "283"
    ]
  },
  {
    "author": [
      {
        "family": "Ashton",
        "given": "Heather"
      }
    ],
    "citation-number": [
      "94."
    ],
    "container-title": [
      "BMJ"
    ],
    "date": [
      "1984-04-14"
    ],
    "pages": [
      "1135–1140"
    ],
    "title": [
      "Benzodiazepine Withdrawal: An Unfinished Story"
    ],
    "type": "article-journal",
    "volume": [
      "288"
    ]
  },
  {
    "author": [
      {
        "family": "Henry E",
        "given": "H.C.Sh",
        "particle": "to"
      }
    ],
    "citation-number": [
      "95."
    ],
    "container-title": [
      "Dec"
    ],
    "date": [
      "1972"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "note": [
      "General Subject Files, box 4867."
    ],
    "title": [
      "Simmons (FDA Bureau of Drugs"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Gordon",
        "given": "Barbara"
      }
    ],
    "citation-number": [
      "96."
    ],
    "date": [
      "1979"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "Harper & Row"
    ],
    "title": [
      "I’m Dancing As Fast As I Can"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Brady",
        "given": "James Scott"
      }
    ],
    "citation-number": [
      "97."
    ],
    "container-title": [
      "John J"
    ],
    "note": [
      "Hopper, Jr., M.D., Civil Action No."
    ],
    "title": [
      "Plaintiffs v"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "83-JM-451."
    ],
    "container-title": [
      "Supp",
      "Dist. LEXIS"
    ],
    "date": [
      "1333",
      "1983"
    ],
    "note": [
      "LexisNexis Academic, quote 2 of 5 (accessed July 29, 2005)."
    ],
    "title": [
      "United States District Court for the District of Colorado. 570 F",
      "U.S"
    ],
    "type": "article-journal",
    "volume": [
      "13755, Sept. 14"
    ]
  },
  {
    "author": [
      {
        "family": "Jones",
        "given": "Ricky"
      },
      {
        "family": "Plaintiff",
        "given": "v Nurse Ehlert"
      }
    ],
    "citation-number": [
      "98."
    ],
    "note": [
      ". defendants, Case No. 88-C-103."
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "LEXIS",
        "given": "U.S.Dist"
      }
    ],
    "container-title": [
      "Supp",
      "LexisNexis Academic"
    ],
    "date": [
      "1989",
      "1093-01-31"
    ],
    "note": [
      "accessed July 29, 2005)."
    ],
    "title": [
      "United States District Court for the Eastern District of Wisconsin. 704 F",
      "Decided"
    ],
    "type": "article-journal",
    "volume": [
      "885"
    ]
  },
  {
    "citation-number": [
      "99."
    ],
    "date": [
      "1970-10-12"
    ],
    "genre": [
      "F-D-C Reports/Pink Sheet,"
    ],
    "pages": [
      "23–24"
    ],
    "title": [
      "Librium-Valium Controls"
    ],
    "type": "report"
  },
  {
    "date": [
      "1972",
      "100",
      "1970-10-19"
    ],
    "genre": [
      "F-D-C Reports/Pink Sheet,"
    ],
    "location": [
      "New York"
    ],
    "pages": [
      "275"
    ],
    "publisher": [
      "Norton"
    ],
    "title": [
      "On Dodd’s hostility to the “tranquilizers,” see Rufus King, The Drug Hang-Up: America’s Fifty-Year Folly",
      "Sen. Dodd Describes Librium and Valium As ‘Killer’ Drugs"
    ],
    "type": "report"
  },
  {
    "citation-number": [
      "101."
    ],
    "container-title": [
      "F-D-C Reports/Pink Sheet"
    ],
    "date": [
      "1970-06-29"
    ],
    "pages": [
      "–2"
    ],
    "title": [
      "Agnew Joins Hue & Cry"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "102."
    ],
    "container-title": [
      "On Examination on the Use and Misuse of Valium, Librium, and Other Minor Tranquilizers, Sept. 10, 1979"
    ],
    "date": [
      "1980"
    ],
    "location": [
      "Washington, DC"
    ],
    "note": [
      "For the articles, see 348–416."
    ],
    "pages": [
      "1"
    ],
    "publisher": [
      "GPO"
    ],
    "title": [
      "Hearing Before the Subcommittee on Health and Scientific Research of the Committee on Labor and Human Resources, United States Senate, 96th Congress, 1st Session"
    ],
    "type": "chapter"
  },
  {
    "citation-number": [
      "103."
    ],
    "date": [
      "1990-08-13"
    ],
    "genre": [
      "F-D-C Reports/Pink Sheet,"
    ],
    "pages": [
      "8"
    ],
    "title": [
      "‘Traceable’ Prescriptions for Controlled Drugs"
    ],
    "type": "report"
  },
  {
    "author": [
      {
        "family": "Clark",
        "given": "See H.Westley"
      }
    ],
    "citation-number": [
      "104."
    ],
    "container-title": [
      "Journal of Psychoactive Drugs"
    ],
    "date": [
      "1991"
    ],
    "note": [
      "The sun figure of speech is not Dr. Clark’s."
    ],
    "pages": [
      "321–328"
    ],
    "title": [
      "Policy and Medical-Legal Issues in the Prescribing of Controlled Substances"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "citation-number": [
      "105."
    ],
    "container-title": [
      "JAMA"
    ],
    "date": [
      "1976-08-02"
    ],
    "pages": [
      "432"
    ],
    "title": [
      "Federal Agency Lists Most Widely Abused Drugs"
    ],
    "type": "article-journal",
    "volume": [
      "236"
    ]
  },
  {
    "author": [
      {
        "family": "William",
        "given": "T."
      }
    ],
    "citation-number": [
      "106."
    ],
    "container-title": [
      "District, Mar"
    ],
    "date": [
      "1963"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "note": [
      "General Subject Files, box 3578, 515."
    ],
    "title": [
      "Robinson (supervisory inspector, FDA) to Director, N.Y"
    ],
    "type": "article-journal",
    "volume": [
      "28"
    ]
  },
  {
    "citation-number": [
      "107."
    ],
    "container-title": [
      "Psychosomatics"
    ],
    "date": [
      "1977"
    ],
    "editor": [
      {
        "family": "Hollister",
        "given": "See"
      },
      {
        "family": "discussion",
        "given": "in Leo E.Hollister"
      }
    ],
    "pages": [
      "44–58, 56"
    ],
    "title": [
      "Valium: A Discussion of Current Issues"
    ],
    "type": "article-journal",
    "volume": [
      "18"
    ]
  },
  {
    "citation-number": [
      "108."
    ],
    "container-title": [
      "SuDocs J"
    ],
    "date": [
      "1975-04"
    ],
    "genre": [
      "Phase IV Report,"
    ],
    "issue": [
      "2"
    ],
    "location": [
      "Providence, R.I"
    ],
    "note": [
      "BNDD Contract No. 72–47. Submitted by IMS America, Ltd): 8;"
    ],
    "pages": [
      "84 13 975–976"
    ],
    "publisher": [
      "copy at Brown University"
    ],
    "title": [
      "Drug Abuse Warning Network"
    ],
    "type": "article-journal",
    "volume": [
      "24"
    ]
  },
  {
    "author": [
      {
        "family": "FDA",
        "given": "Bureau of Drugs"
      },
      {
        "given": "Minutes"
      }
    ],
    "citation-number": [
      "109."
    ],
    "container-title": [
      "Meeting"
    ],
    "genre": [
      "RG 88,"
    ],
    "issue": [
      "6, Feb. 5, 1980"
    ],
    "location": [
      "NARA"
    ],
    "pages": [
      "15–17,",
      "86–00–86"
    ],
    "publisher": [
      "UD-WW, E-29"
    ],
    "title": [
      "Drug Abuse Advisory Committee"
    ],
    "type": "article-journal",
    "volume": []
  },
  {
    "author": [
      {
        "family": "R",
        "given": "As Gene"
      }
    ],
    "citation-number": [
      "110."
    ],
    "container-title": [
      "Drug Enforcement Administration, wrote in 1991"
    ],
    "location": [
      "Approximately"
    ],
    "title": [
      "Haislip, deputy assistant administrator, Office of Diversion Control"
    ],
    "type": "chapter"
  },
  {
    "container-title": [
      "Impact of Prescription Drug Diversion Control Systems on Medical Practice and Patient Care, NIDA Research Monograph Series",
      "National Institute on Drug Abuse, 120–131",
      "quotes"
    ],
    "date": [
      "1993"
    ],
    "editor": [
      {
        "literal": "ed."
      }
    ],
    "issue": [
      "131"
    ],
    "location": [
      "Rockville, MD"
    ],
    "note": [
      "The conference at which the paper was presented took place in 1991."
    ],
    "pages": [
      "128"
    ],
    "publisher": [
      "NIDA"
    ],
    "title": [
      "Drug Diversion Control Systems, Medical Practice, and Patient Care"
    ],
    "type": "article-journal",
    "volume": [
      "120, 127"
    ]
  },
  {
    "citation-number": [
      "111."
    ],
    "location": [
      "Rockville, MD"
    ],
    "publisher": [
      "Department of Health and Human"
    ],
    "title": [
      "National Institute on Drug Abuse, Annual Data, 1985: Data from the Drug Abuse Warning Network"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Petursson",
        "given": "Hannes"
      },
      {
        "family": "Lader",
        "given": "Malcolm"
      }
    ],
    "citation-number": [
      "118."
    ],
    "container-title": [
      "New Psychiatric Syndromes: DSM-III and Beyond"
    ],
    "date": [
      "1983"
    ],
    "editor": [
      {
        "family": "Salman Akhtar",
        "particle": "ed."
      }
    ],
    "location": [
      "New York"
    ],
    "pages": [
      "177"
    ],
    "publisher": [
      "Aronson"
    ],
    "title": [
      "Benzodiazepine Withdrawal Syndrome",
      "177–190"
    ],
    "type": "chapter"
  },
  {
    "citation-number": [
      "119."
    ],
    "container-title": [
      "Pharmacokinetic and Clinical Aspects on Oxazepam and Related Benzodiazepines: Oxazepam Symposium"
    ],
    "date": [
      "Nov",
      "1977",
      "1978"
    ],
    "editor": [
      {
        "family": "Lader",
        "given": "Malcolm"
      },
      {
        "family": "discussion",
        "given": "in Ruth Chinnery"
      },
      {
        "others": true
      }
    ],
    "location": [
      "Stockholm",
      "Copenhagen"
    ],
    "pages": [
      "14–15,",
      "122–123"
    ],
    "publisher": [
      "Munksgaard"
    ],
    "type": "paper-conference"
  },
  {
    "author": [
      {
        "given": "Lader"
      }
    ],
    "citation-number": [
      "120."
    ],
    "container-title": [
      "quotes"
    ],
    "pages": [
      "164"
    ],
    "title": [
      "Benzodiazepines"
    ],
    "type": "article-journal",
    "volume": [
      "163"
    ]
  },
  {
    "citation-number": [
      "121."
    ],
    "container-title": [
      "“New Perspectives in Benzodiazepine Therapy—International Symposium",
      "Arzeimittelforschung/Drug Research"
    ],
    "date": [
      "1979",
      "1980",
      "quote 900"
    ],
    "editor": [
      {
        "family": "Classen",
        "given": "Hans Georg"
      },
      {
        "others": true
      }
    ],
    "location": [
      "Heidelberg"
    ],
    "pages": [
      "898–901,"
    ],
    "title": [
      "The monograph appeared in 1978. The quote is from the following source: John Marks, “The Benzodiazepines—Use and Abuse"
    ],
    "type": "article-journal",
    "volume": [
      "5a"
    ]
  },
  {
    "author": [
      {
        "family": "Marks",
        "given": "John"
      }
    ],
    "citation-number": [
      "122."
    ],
    "date": [
      "1985"
    ],
    "edition": [
      "2nd"
    ],
    "location": [
      "Lancaster"
    ],
    "pages": [
      "6–7, 48"
    ],
    "publisher": [
      "MTP Press"
    ],
    "title": [
      "The Benzodiazepines: Use, Overuse, Misuse, Abuse"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "See",
        "given": "for example"
      },
      {
        "family": "Tyrer",
        "given": "Peter"
      },
      {
        "family": "Clare",
        "given": "Anthony W."
      }
    ],
    "citation-number": [
      "123."
    ],
    "container-title": [
      "Benzodiazepines Divided: A Multidisciplinary Review",
      "BMJ"
    ],
    "date": [
      "1984-04-14"
    ],
    "editor": [
      {
        "literal": "ed."
      }
    ],
    "pages": [
      "1101–1102,"
    ],
    "title": [
      "Benzodiazepines on Trial",
      "who began his editorial with, “Anyone who believes that a drug treatment can combine sound efficacy with no adverse effects whatsoever must be due for a nasty fall",
      "Benzodiazepines, Alcohol or Nicotine?"
    ],
    "type": "article-journal",
    "volume": [
      "288"
    ]
  },
  {
    "author": [
      {
        "family": "Trimble",
        "given": "Michael R."
      }
    ],
    "date": [
      "1983"
    ],
    "location": [
      "Chichester"
    ],
    "publisher": [
      "Wiley"
    ],
    "title": [
      "1–13"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Power",
        "given": "Kevin"
      }
    ],
    "citation-number": [
      "124."
    ],
    "container-title": [
      "Benzodiazepines: The Basis for Controversy: Proceedings of an Extended Panel Discussion Held in London on"
    ],
    "date": [
      "1988-07-15",
      "1988"
    ],
    "editor": [
      {
        "family": "Hugh Freeman",
        "particle": "ed."
      }
    ],
    "location": [
      "London"
    ],
    "pages": [
      "39–43",
      "42"
    ],
    "publisher": [
      "Royal Society of Medicine"
    ],
    "title": [
      "Some Characteristics Contributing to Benzodiazepine Dependence"
    ],
    "type": "paper-conference"
  },
  {
    "author": [
      {
        "family": "David Taylor",
        "given": "On",
        "particle": "annual prescribing see"
      }
    ],
    "citation-number": [
      "125."
    ],
    "container-title": [
      "The Benzodiazepines in Current Clinical Practice"
    ],
    "date": [
      "1987"
    ],
    "editor": [
      {
        "family": "Hugh Freeman",
        "particle": "ed."
      },
      {
        "others": true
      }
    ],
    "location": [
      "London"
    ],
    "note": [
      "For a comment on the CRM guidelines, see Robert G. Priest, letter, BMJ 280 (Apr. 19, 1980): 1085."
    ],
    "pages": [
      "13–18"
    ],
    "publisher": [
      "Royal Society of Medicine Services"
    ],
    "title": [
      "Current Usage of Benzodiazepines in Britain"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Hindmarch",
        "given": "Ian"
      }
    ],
    "citation-number": [
      "126."
    ],
    "container-title": [
      "From Psychopharmacology to Neuropsychopharmacology in the 1980s",
      "Thomas Ban et al., 201–205"
    ],
    "date": [
      "2002"
    ],
    "editor": [
      {
        "literal": "ed."
      }
    ],
    "location": [
      "Budapest"
    ],
    "pages": [
      "203"
    ],
    "publisher": [
      "Animula"
    ],
    "title": [
      "A Measured Performance: Psychometrics in Psychopharmacology"
    ],
    "type": "chapter"
  },
  {
    "container-title": [
      "Great Britain. Committee on Safety of Medicines, Current Problems",
      "The Scientific Basis of Drug Therapy in Psychiatry"
    ],
    "date": [
      "1988-01"
    ],
    "editor": [
      {
        "literal": "ed."
      }
    ],
    "issue": [
      "21"
    ],
    "note": [
      "John Marks et al., 191–201 (Oxford: Pergamon, 1965), see 192, table 1."
    ],
    "pages": [
      "1–2"
    ],
    "title": [
      "The list was of drug preparations that would no longer be paid for by the NHS. 127. “Benzodiazepines",
      "In the United Kingdom 66 percent of benzos were given without a co-prescription, as opposed to 51 percent of prescriptions for imipramine and 47 percent for chlorpromazine. But this is normally seen as a psychopharmacologic plus: Benzos had such activity or so few side effects that a co-prescription was not required. See John Marks, “Interactions Involving Drugs Used in Psychiatry"
    ],
    "type": "article-journal",
    "volume": []
  },
  {
    "citation-number": [
      "128."
    ],
    "container-title": [
      "Scrip"
    ],
    "date": [
      "2003-06-11"
    ],
    "pages": [
      "6"
    ],
    "title": [
      "Significant Decline"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "interview",
        "given": "David Sheehan"
      }
    ],
    "citation-number": [
      "129."
    ],
    "container-title": [
      "The Psychopharmacologists"
    ],
    "date": [
      "2000"
    ],
    "editor": [
      {
        "family": "David Healy",
        "particle": "ed."
      }
    ],
    "location": [
      "London"
    ],
    "pages": [
      "479–503",
      "488"
    ],
    "publisher": [
      "Arnold"
    ],
    "title": [
      "Angles on Panic"
    ],
    "type": "chapter",
    "volume": [
      "3"
    ]
  },
  {
    "author": [
      {
        "family": "Leber",
        "given": "Paul"
      },
      {
        "family": "discussion",
        "given": "F.D.A."
      }
    ],
    "citation-number": [
      "130."
    ],
    "container-title": [
      "31st Meeting"
    ],
    "date": [
      "1989"
    ],
    "note": [
      "triazolam]: 9–10; obtained from FDA through Freedom of Information Act."
    ],
    "title": [
      "Psychopharmacologic Drugs Advisory Committee"
    ],
    "type": "paper-conference",
    "volume": [
      "II, Sept. 22"
    ]
  },
  {
    "author": [
      {
        "family": "Hollister",
        "given": "discussion"
      },
      {
        "family": "Hollister",
        "particle": "in"
      }
    ],
    "citation-number": [
      "131."
    ],
    "date": [
      "52"
    ],
    "title": [
      "Valium"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Rickels",
        "given": "Karl"
      },
      {
        "family": "discussion",
        "given": "in Hollister"
      }
    ],
    "citation-number": [
      "132."
    ],
    "pages": [
      "49"
    ],
    "title": [
      "Valium"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Rickels",
        "given": "Karl"
      }
    ],
    "citation-number": [
      "133."
    ],
    "container-title": [
      "Anxiety: New Research and Changing Concepts"
    ],
    "date": [
      "1981"
    ],
    "editor": [
      {
        "family": "Donald F. Klein",
        "particle": "ed."
      },
      {
        "family": "Rabkin",
        "given": "Judith G."
      }
    ],
    "location": [
      "New York"
    ],
    "note": [
      "Rickels, discussion, in Freeman, Benzodiazepines in Current Clinical Practice, 12."
    ],
    "pages": [
      "8"
    ],
    "publisher": [
      "Raven"
    ],
    "title": [
      "Benzodiazepines: Use and Misuse",
      "1–26"
    ],
    "type": "chapter"
  },
  {
    "citation-number": [
      "134."
    ],
    "date": [
      "1976",
      "1988"
    ],
    "issue": [
      ", No. 4"
    ],
    "location": [
      "Rockville, MD"
    ],
    "note": [
      "8, table"
    ],
    "publisher": [
      "NIDA, Division of Epidemiology and Statistical Analysis"
    ],
    "title": [
      "National Institute on Drug Abuse, Statistical Series: A Decade of DAWN: Benzodiazepine-Related Cases"
    ],
    "type": null,
    "volume": []
  },
  {
    "citation-number": [
      "4."
    ],
    "note": [
      "such as Xanax (alprazolam) and Ativan (lorazepam), was up. Yet the huge declines in numbers for Valium (diazepam) and Librium (chlordiazepoxide) swamped these less commonly used substances."
    ],
    "title": [
      "These data concern total number of benzo-related visits. The trend for some benzodiazepines more recently released on the market"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Weintraub",
        "given": "Michael"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "135."
    ],
    "container-title": [
      "on the basis of IMS America data",
      "JAMA"
    ],
    "date": [
      "1991"
    ],
    "pages": [
      "2392–2397,"
    ],
    "title": [
      "Consequences of the 1989 New York State Triplicate Benzodiazepine Prescription Regulations"
    ],
    "type": "article-journal",
    "volume": [
      "266"
    ]
  },
  {
    "author": [
      {
        "family": "advertisement",
        "given": "Elavil"
      }
    ],
    "citation-number": [
      "136."
    ],
    "container-title": [
      "JAMA"
    ],
    "date": [
      "1968-12-02"
    ],
    "pages": [
      "2193"
    ],
    "type": "article-journal",
    "volume": [
      "206"
    ]
  },
  {
    "author": [
      {
        "family": "Association",
        "given": "American Psychiatric"
      }
    ],
    "citation-number": [
      "137."
    ],
    "date": [
      "1990"
    ],
    "location": [
      "Washington, DC"
    ],
    "pages": [
      "56–58"
    ],
    "publisher": [
      "APA"
    ],
    "title": [
      "Benzodiazepine Dependence, Toxicity, and Abuse: A Task Force Report"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Nelson",
        "given": "Cheryl"
      }
    ],
    "citation-number": [
      "138."
    ],
    "container-title": [
      "Advance Data from Vital and Health Statistics"
    ],
    "issue": [
      "232"
    ],
    "title": [
      "Drug Utilization in Office Practice, National Ambulatory Medical Care Survey, 1990"
    ],
    "type": "article-journal",
    "volume": []
  },
  {
    "date": [
      "1993-03-25"
    ],
    "location": [
      "Hyattsville, MD"
    ],
    "pages": [
      "2"
    ],
    "publisher": [
      "National Center for Health Statistics"
    ],
    "type": "book",
    "volume": [
      "4"
    ]
  },
  {
    "citation-number": [
      "139."
    ],
    "container-title": [
      "Post of Feb"
    ],
    "date": [
      "2007"
    ],
    "title": [
      "I am anonymizing the members of the listserv psycho-pharm@psychom. net, as they did not necessarily realize they were posting for publication"
    ],
    "type": "article-journal",
    "volume": [
      "13"
    ]
  },
  {
    "citation-number": [
      "140."
    ],
    "editor": [
      {
        "family": "Hindmarch",
        "given": "Benzodiazepines"
      }
    ],
    "pages": [
      "112"
    ],
    "type": null
  },
  {
    "citation-number": [
      "141."
    ],
    "date": [
      "2005-12-05"
    ],
    "publisher": [
      "Thomas Ban"
    ],
    "type": "book"
  },
  {
    "note": [
      "Richard Crout, Nov. 12, 1997, part I: 3 of 3;",
      "accessed June 25, 2002)."
    ],
    "title": [
      "Notes to Chapter 6 1. FDA Oral History Program, Interview with J"
    ],
    "type": null,
    "url": [
      "http://www.fda.gov/oc/history/oralhistories/crout"
    ]
  },
  {
    "citation-number": [
      "2."
    ],
    "note": [
      "Yet the bulk of the work at NAS/NRC had finished at that point. See “NAS/NRC Efficacy Contract Extended One Year,”"
    ],
    "title": [
      "To be exact, the NAS/NRC contract was renewed in July 1969 for one more year to tie up loose ends"
    ],
    "type": null
  },
  {
    "date": [
      "1969-07-07"
    ],
    "genre": [
      "F-D-C Reports/Pink Sheet,"
    ],
    "pages": [
      "2"
    ],
    "type": "report"
  },
  {
    "citation-number": [
      "3."
    ],
    "date": [
      "1969"
    ],
    "location": [
      "Washington, DC"
    ],
    "pages": [
      "1"
    ],
    "publisher": [
      "National Academy of Sciences"
    ],
    "title": [
      "The Drug Amendments of 1962 are quoted in Division of Medical Sciences, National Research Council, Drug Efficacy Study: Final Report to the Commissioner of Food and Drugs, Food and Drug Administration"
    ],
    "type": "book"
  },
  {
    "citation-number": [
      "4."
    ],
    "date": [
      "1962-09-17"
    ],
    "genre": [
      "F-D-C Reports/Pink Sheet,"
    ],
    "pages": [
      "4–5"
    ],
    "title": [
      "On this conflict, see “Grandfather Clause"
    ],
    "type": "report"
  },
  {
    "author": [
      {
        "family": "Haen",
        "given": "Paul",
        "particle": "De"
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "New York State Journal of Medicine"
    ],
    "date": [
      "1969-12-15"
    ],
    "pages": [
      "3157–3162, 3159"
    ],
    "title": [
      "Quarterly Review of Drugs: Medicinal Chemistry and Synthetic Drugs"
    ],
    "type": "article-journal",
    "volume": [
      "69"
    ]
  },
  {
    "citation-number": [
      "6."
    ],
    "date": [
      "1963-03-21"
    ],
    "genre": [
      "Part 4,"
    ],
    "title": [
      "Hearings Before the Subcommittee on Reorganization and International Organizations of the Committee on Government Operations, United States Senate, 88th Congress, First Session, Agency Coordination Study"
    ],
    "type": null
  },
  {
    "date": [
      "1964",
      "1963-06-19"
    ],
    "genre": [
      "Ibid., part 5,"
    ],
    "location": [
      "Washington, DC"
    ],
    "pages": [
      "1327 7",
      "2182–2183"
    ],
    "publisher": [
      "GPO"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Ibid"
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Feb"
    ],
    "date": [
      "1964"
    ],
    "pages": [
      "2384"
    ],
    "title": [
      "part 5, reprints letter from Humphrey to Larrick"
    ],
    "type": "article-journal",
    "volume": [
      "21"
    ]
  },
  {
    "author": [
      {
        "given": "Ibid"
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Mar"
    ],
    "date": [
      "1964"
    ],
    "pages": [
      "2384–2385"
    ],
    "title": [
      "Larrick to Humphrey"
    ],
    "type": "article-journal",
    "volume": [
      "20"
    ]
  },
  {
    "citation-number": [
      "10."
    ],
    "date": [
      "1971-03-22"
    ],
    "genre": [
      "F-D-C Reports/Pink Sheet,"
    ],
    "pages": [
      "12"
    ],
    "title": [
      "FDA Reversed Position"
    ],
    "type": "report"
  },
  {
    "citation-number": [
      "11."
    ],
    "container-title": [
      "UD-WW"
    ],
    "date": [
      "1964-01-31",
      "1964"
    ],
    "genre": [
      "NARA RG 88,"
    ],
    "pages": [
      "505"
    ],
    "publisher": [
      "General Subject Files"
    ],
    "title": [
      "Memorandum of Meetings, Office of Commissioner"
    ],
    "type": "article-journal",
    "volume": [
      "E35"
    ]
  },
  {
    "author": [
      {
        "family": "Ralph G. Smith",
        "given": "Arthur Egelman",
        "particle": "to"
      }
    ],
    "citation-number": [
      "12."
    ],
    "container-title": [
      "Feb"
    ],
    "date": [
      "1964"
    ],
    "genre": [
      "file 505,"
    ],
    "note": [
      "as above."
    ],
    "type": "article-journal",
    "volume": [
      "5"
    ]
  },
  {
    "author": [
      {
        "family": "Register",
        "given": "Federal"
      },
      {
        "given": "Feb"
      }
    ],
    "citation-number": [
      "13."
    ],
    "date": [
      "1964"
    ],
    "genre": [
      "CFR Part 130,"
    ],
    "note": [
      "reprinted in Hearings Subcommittee on Reorganization, part"
    ],
    "pages": [
      "21",
      "2370–2373"
    ],
    "type": null,
    "volume": [
      "5"
    ]
  },
  {
    "citation-number": [
      "14."
    ],
    "date": [
      "1964-06",
      "2842"
    ],
    "pages": [
      "2832–2843,"
    ],
    "title": [
      "Hearings Subcommittee on Reorganizations, part 5, “Summary Memorandum of Comments by Senator Hubert H. Humphrey"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Cannan",
        "given": "R.Keith"
      }
    ],
    "citation-number": [
      "15."
    ],
    "container-title": [
      "FDA Papers"
    ],
    "date": [
      "1968-03"
    ],
    "pages": [
      "10"
    ],
    "title": [
      "NAS-NRC Background,” part of a larger article, “The Washington Briefing on FDA’s Drug Efficacy Review"
    ],
    "type": "article-journal",
    "volume": [
      "2"
    ]
  },
  {
    "citation-number": [
      "16."
    ],
    "pages": [
      "1–8"
    ],
    "publisher": [
      "National Research Council, Drug Efficacy Study"
    ],
    "title": [
      "Information in this section is largely based on Division of Medical Sciences"
    ],
    "type": "book"
  },
  {
    "citation-number": [
      "17."
    ],
    "container-title": [
      "York Times"
    ],
    "date": [
      "1967-12-31"
    ],
    "title": [
      "Statistic from the New"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "18."
    ],
    "pages": [
      "7"
    ],
    "publisher": [
      "Drug Efficacy Study"
    ],
    "type": "book"
  },
  {
    "citation-number": [
      "19."
    ],
    "container-title": [
      "Abuse of Depressant and Stimulant Drugs Advisory Committee, Minutes of the Seventh Committee Meeting"
    ],
    "date": [
      "1967-09-19"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "pages": [
      "88–79–49"
    ],
    "publisher": [
      "UD-WW"
    ],
    "type": "paper-conference",
    "volume": [
      "4",
      "E9"
    ]
  },
  {
    "citation-number": [
      "20."
    ],
    "date": [
      "1968-01-29"
    ],
    "genre": [
      "F-D-C Reports/Pink Sheet,"
    ],
    "pages": [
      "17"
    ],
    "title": [
      "PMA [Pharmaceutical Manufacturers Association] Charges"
    ],
    "type": "report"
  },
  {
    "author": [
      {
        "family": "Duke Trexler",
        "given": "Louis Lasagna",
        "particle": "to"
      }
    ],
    "citation-number": [
      "21."
    ],
    "date": [
      "1971-06-21"
    ],
    "note": [
      "correspondence; obtained through the Freedom of Information Act (FOIA)."
    ],
    "title": [
      "FDA, DESI papers, “NAS-NRC Reviews"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Smith",
        "given": "Kline"
      },
      {
        "family": "Laboratories",
        "given": "French"
      }
    ],
    "citation-number": [
      "22."
    ],
    "container-title": [
      "F-D-C Reports/Pink Sheet May"
    ],
    "date": [
      "1971",
      "1969"
    ],
    "location": [
      "Philadelphia"
    ],
    "pages": [
      "15 23",
      "22"
    ],
    "publisher": [
      "SKF",
      "“FDA Makes First Real Departure"
    ],
    "title": [
      "A Chronology and Review of the National Academy of Sciences/National Research Council Drug Efficacy Study",
      ""
    ],
    "type": "article-journal",
    "volume": [
      "5"
    ]
  },
  {
    "author": [
      {
        "family": "Joseph",
        "given": "D."
      }
    ],
    "citation-number": [
      "24."
    ],
    "container-title": [
      "Quality of Advice"
    ],
    "date": [
      "1971"
    ],
    "editor": [
      {
        "given": "Cooper"
      }
    ],
    "location": [
      "Washington, DC"
    ],
    "pages": [
      "132"
    ],
    "publisher": [
      "Interdisciplinary Communication Associates"
    ],
    "title": [
      "Cooper, discussion"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Wardell",
        "given": "William M."
      }
    ],
    "citation-number": [
      "25."
    ],
    "container-title": [
      "Regulation, Economics, and Pharmaceutical Innovation"
    ],
    "date": [
      "1973"
    ],
    "editor": [
      {
        "family": "Joseph D. Cooper",
        "particle": "ed."
      }
    ],
    "location": [
      "Washington, DC"
    ],
    "pages": [
      "235–267",
      "242"
    ],
    "publisher": [
      "American University"
    ],
    "title": [
      "Regulatory Assessment Model Reassessed"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Lasagna",
        "given": "Louis"
      }
    ],
    "citation-number": [
      "26."
    ],
    "container-title": [
      "Perspectives in Biology and Medicine"
    ],
    "date": [
      "1976",
      "quote 540"
    ],
    "pages": [
      "537–548,"
    ],
    "title": [
      "Consensus Among Experts: The Unholy Grail"
    ],
    "type": "article-journal",
    "volume": [
      "19"
    ]
  },
  {
    "citation-number": [
      "27."
    ],
    "container-title": [
      "F-D-C Reports/Pink Sheet Oct"
    ],
    "date": [
      "1971",
      "28",
      "1970"
    ],
    "editor": [
      {
        "family": "Lasagna",
        "given": "Louis"
      },
      {
        "family": "discussion",
        "given": "in Joseph D.Cooper"
      }
    ],
    "location": [
      "Washington, DC"
    ],
    "pages": [
      "41",
      "–1"
    ],
    "publisher": [
      "Interdisciplinary Communication Associates"
    ],
    "title": [
      "Decision-Making on the Efficacy and Safety of Drugs",
      "Critical Review of NAS/NRC Drug Efficacy Study"
    ],
    "type": "article-journal",
    "volume": [
      "26"
    ]
  },
  {
    "author": [
      {
        "family": "Thinking",
        "given": "Edwards’ New"
      }
    ],
    "citation-number": [
      "29."
    ],
    "container-title": [
      "F-D-C Reports/Pink Sheet May"
    ],
    "date": [
      "1971"
    ],
    "pages": [
      "28"
    ],
    "title": [
      ""
    ],
    "type": "article-journal",
    "volume": [
      "10"
    ]
  },
  {
    "citation-number": [
      "30."
    ],
    "date": [
      "2002-07-19"
    ],
    "title": [
      "Telephone interview with Sidney Merlis"
    ],
    "type": null
  },
  {
    "citation-number": [
      "31."
    ],
    "note": [
      "FDA, DESI papers, NAS/NRC reports, box 6, no. 1778 (methyprylon); obtained through FOIA."
    ],
    "title": [
      "The psychiatry panel did not necessarily evaluate all drugs used in psychiatry, even though as a rule drugs used across specialties were considered by the various specialty panels; the anesthesia panel, for example, evaluated the hypnotic methyprylon (Noludar) as an anesthetic agent. The psychiatry panel did not judge it"
    ],
    "type": "report"
  },
  {
    "author": [
      {
        "family": "interview",
        "given": "Jonathan Cole"
      }
    ],
    "citation-number": [
      "32."
    ],
    "date": [
      "2002-07-17"
    ],
    "type": null
  },
  {
    "citation-number": [
      "33."
    ],
    "container-title": [
      "Drug Efficacy Study"
    ],
    "pages": [
      "72–76"
    ],
    "title": [
      "Yet there clearly was some overall suspiciousness of combination drugs, either at NAS/NRC or FDA, for the DES final report inveighed against them"
    ],
    "type": "article-journal",
    "volume": [
      "8"
    ]
  },
  {
    "author": [
      {
        "family": "Lewis",
        "given": "R.Craigin"
      }
    ],
    "citation-number": [
      "34."
    ],
    "container-title": [
      "Medical Economics"
    ],
    "date": [
      "1972-06-19",
      "quote 30"
    ],
    "note": [
      "Italics in original."
    ],
    "pages": [
      "27–32,"
    ],
    "title": [
      "Drug Efficacy Ratings: Will They Box You In?"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "35."
    ],
    "container-title": [
      "F-D-C Reports/Pink Sheet Aug"
    ],
    "date": [
      "1969"
    ],
    "pages": [
      "10"
    ],
    "title": [
      "Nelson Witnesses Hit Ads"
    ],
    "type": "article-journal",
    "volume": [
      "4"
    ]
  },
  {
    "citation-number": [
      "36."
    ],
    "container-title": [
      "F-D-C Reports/Pink Sheet Aug"
    ],
    "date": [
      "42. 37",
      "1969"
    ],
    "editor": [
      {
        "family": "Freedman",
        "given": "Daniel"
      },
      {
        "family": "discussion",
        "given": "in Cooper"
      },
      {
        "family": "ed.",
        "given": "Decision-Making"
      }
    ],
    "note": [
      "Parentheses in original."
    ],
    "pages": [
      "10"
    ],
    "title": [
      "Nelson Witnesses Hit Ads"
    ],
    "type": "article-journal",
    "volume": [
      "4"
    ]
  },
  {
    "author": [
      {
        "family": "antineurotics",
        "given": "For",
        "particle": "details on the"
      },
      {
        "family": "Edward Shorter",
        "particle": "see"
      }
    ],
    "citation-number": [
      "38."
    ],
    "container-title": [
      "Nature Reviews Drug Discovery"
    ],
    "date": [
      "2002"
    ],
    "note": [
      "The full list of antineurotics considered by the panel that ultimately were withdrawn: mephenesin, phenaglycodol, aspartate salts, mephenoxalone, emylcamate, meparfynol"
    ],
    "pages": [
      "1003–1006"
    ],
    "title": [
      "Looking Backwards: A Possible New Path for Drug Discovery in Psychopharmacology"
    ],
    "type": "article-journal",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "methylparafynol)",
        "given": "ectylurea"
      },
      {
        "family": "hydroxyphenamate",
        "given": "oxanamide"
      },
      {
        "family": "captodiame",
        "given": "benactyzine"
      },
      {
        "given": "deanol"
      }
    ],
    "container-title": [
      "interview, in The Psychopharmacologists"
    ],
    "date": [
      "1996"
    ],
    "editor": [
      {
        "family": "David Healy",
        "particle": "ed."
      }
    ],
    "location": [
      "London"
    ],
    "pages": [
      "347"
    ],
    "publisher": [
      "Chapman and Hall"
    ],
    "title": [
      "39. Donald Klein, “Reaction Patterns to Psychotropic Drugs"
    ],
    "type": "chapter",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "Karliner",
        "given": "William"
      }
    ],
    "citation-number": [
      "40."
    ],
    "container-title": [
      "American Practitioner"
    ],
    "date": [
      "1960",
      "quote 280"
    ],
    "pages": [
      "278–281,"
    ],
    "title": [
      "Use of Psychopharmacological Agents"
    ],
    "type": "article-journal",
    "volume": [
      "11"
    ]
  },
  {
    "citation-number": [
      "41."
    ],
    "date": [
      "2002-07-17"
    ],
    "note": [
      "See, for example, the psychiatry panel’s report on chlorpromazine, FDA, DESI papers, NAS/NRC, box 2, no. 1330 tablets (liquid) and no. 1344 (injectable); obtained through FOIA. 42. Jonathan Cole, interview,"
    ],
    "type": "report"
  },
  {
    "author": [
      {
        "family": "Smith",
        "given": "Kline"
      }
    ],
    "citation-number": [
      "43."
    ],
    "container-title": [
      "Federal Register"
    ],
    "date": [
      "1980-06-17"
    ],
    "pages": [
      "41070–41074, 41073"
    ],
    "title": [
      "French continued to fight for expanding the chlorpromazine label, and in 1980 the FDA accepted several additional indications, including “severe behavioral problems in children” and the “shortterm treatment of hyperactive children"
    ],
    "type": "article-journal",
    "volume": [
      "45"
    ]
  },
  {
    "author": [
      {
        "family": "interview",
        "given": "Cole"
      }
    ],
    "citation-number": [
      "44."
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Robert J. Bazell",
        "particle": "see"
      }
    ],
    "citation-number": [
      "45."
    ],
    "container-title": [
      "Science"
    ],
    "date": [
      "1971-06-04"
    ],
    "pages": [
      "1013–1015"
    ],
    "title": [
      "The eight stimulants remaining on the market were: mephentermine, methamphetamine, phentermine, phenmetrazine, methylphenidate, diethylpropion, and benzphetamine. 46. “Over half”",
      "Drug Efficacy Study: FDA Yields on Fixed Combinations"
    ],
    "type": "article-journal",
    "volume": [
      "172"
    ]
  },
  {
    "author": [
      {
        "family": "See",
        "given": "F.D.A."
      }
    ],
    "citation-number": [
      "47."
    ],
    "container-title": [
      "Summary of Proceedings, Second Meeting, April 25–26, 1966: 7, NARA, RG 88, UD-WW"
    ],
    "pages": [
      "88–79–49"
    ],
    "title": [
      "Advisory Committee on Abuse of Depressant and Stimulant Drugs"
    ],
    "type": "paper-conference",
    "volume": [
      "E9"
    ]
  },
  {
    "author": [
      {
        "family": "FDA",
        "given": "N.A.S./N.R.C."
      }
    ],
    "citation-number": [
      "48."
    ],
    "container-title": [
      "box"
    ],
    "issue": [
      "2147"
    ],
    "type": "article-journal",
    "volume": [
      "3"
    ]
  },
  {
    "citation-number": [
      "49."
    ],
    "container-title": [
      "NAS/NRC, box"
    ],
    "issue": [
      "1729"
    ],
    "title": [
      "FDA archives"
    ],
    "type": "article-journal",
    "volume": [
      "8"
    ]
  },
  {
    "author": [
      {
        "family": "Rickels",
        "given": "Karl"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "50."
    ],
    "container-title": [
      "Diseases of the Nervous System"
    ],
    "date": [
      "1971"
    ],
    "pages": [
      "457–467"
    ],
    "title": [
      "Combination of Meprobamate and Benactyzine (Deprol) and Constituents in Neurotic Depressed Outpatients"
    ],
    "type": "article-journal",
    "volume": [
      "32"
    ]
  },
  {
    "author": [
      {
        "family": "FDA",
        "given": "N.A.S./N.R.C."
      }
    ],
    "citation-number": [
      "51."
    ],
    "container-title": [
      "box"
    ],
    "date": [
      "1308"
    ],
    "issue": [
      ""
    ],
    "title": [
      "The combo product was evidently saved by trial data resuscitated from NDA 12–042, showing Eskatrol “to be an effective anorectic agent while producing a minimum of side effects"
    ],
    "type": "article-journal",
    "volume": [
      "2"
    ]
  },
  {
    "author": [
      {
        "given": "addition"
      },
      {
        "family": "Bryan",
        "given": "See Paul A."
      },
      {
        "family": "Stern",
        "given": "Lawrence H."
      }
    ],
    "container-title": [
      "52. Louis Lasagna, discussion, in Cooper, Quality of Advice, 213. 53. Herbert Ley, discussion, in Cooper, Quality of Advice, 155. 54. See “Combination Drugs for Human Use",
      "Federal Register",
      "FDA Papers"
    ],
    "date": [
      "1971-02-18",
      "1970-10"
    ],
    "note": [
      "The authors were director and assistant director of DESI, respectively. 56. Herbert Ley, Louis Lasagna, discussion, in Cooper, Quality of Advice, 156."
    ],
    "pages": [
      "3126–3127 55",
      "14–17"
    ],
    "title": [
      "Eskatrol’ has been shown to be efficacious for the relief of the anxieties and tensions seen in the obese patient",
      "CFR Part 3",
      "The Drug Efficacy Study, 1962–1970"
    ],
    "type": "article-journal",
    "volume": [
      "21",
      "36",
      "4"
    ]
  },
  {
    "citation-number": [
      "57."
    ],
    "publisher": [
      "Letters . . .” F-D-C Reports/Pink"
    ],
    "title": [
      "FDA Plans to Revoke 1938–62 ‘Not New"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Feb",
        "given": "Sheet"
      }
    ],
    "date": [
      "1968"
    ],
    "note": [
      "the latter having been launched before 1938."
    ],
    "pages": [
      "12–13"
    ],
    "title": [
      "In this arcane FDA terminology, “not new” was not the same as “old"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Jan",
        "given": "At",
        "particle": "a meeting at the FDA on"
      }
    ],
    "citation-number": [
      "58."
    ],
    "date": [
      "1968",
      "1968"
    ],
    "note": [
      "“PMA Charges . . .,” F-D-C Reports/Pink Sheet Jan. 29,"
    ],
    "pages": [
      "14"
    ],
    "title": [
      "Chester Williams of the Department of Justice asked FDA counsel Goodrich “whether it is possible that withdrawal of an NDA for a useful drug which has some unsupported claims ‘could be used as a club to prevent a mfr. from litigating claims which he believes in, which would ordinarily be handled by seizure action and litigation in the courts?’"
    ],
    "type": "report"
  },
  {
    "citation-number": [
      "59."
    ],
    "container-title": [
      "Federal Register"
    ],
    "date": [
      "1970-05-08"
    ],
    "pages": [
      "7250–7253"
    ],
    "title": [
      "Antibiotic Drugs"
    ],
    "type": "article-journal",
    "volume": [
      "35"
    ]
  },
  {
    "author": [
      {
        "family": "paper",
        "given": "Robert Temple’s"
      },
      {
        "literal": "“. . ."
      }
    ],
    "citation-number": [
      "60."
    ],
    "container-title": [
      "Third International Conference of Drug Regulatory Agencies in Stockholm"
    ],
    "date": [
      "June 11–14, 1984"
    ],
    "location": [
      "Sweden"
    ],
    "note": [
      "a reason for demanding two controlled trials. FDA, NAS/NRC."
    ],
    "pages": [
      "21"
    ],
    "title": [
      "Reevaluation of Marketed Drugs: the DESI Program",
      "We have from time to time found that the published results did not in fact reflect the data collected by the investigator"
    ],
    "type": "paper-conference"
  },
  {
    "citation-number": [
      "61."
    ],
    "note": [
      "See the remarks of Vincent Kleinfeld, a Washington regulatory lawyer in Cooper, Decision-Making, 28–29."
    ],
    "title": [
      "It was also widely held among insiders that the courts never reversed FDA decisions; hence, struggle was pointless"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Temple"
      }
    ],
    "citation-number": [
      "62."
    ],
    "pages": [
      "15"
    ],
    "title": [
      "Reevaluation of Marketed Drugs"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Goodrich",
        "given": "William W."
      }
    ],
    "citation-number": [
      "63."
    ],
    "container-title": [
      "FDA Papers"
    ],
    "date": [
      "1968-03"
    ],
    "pages": [
      "12–15"
    ],
    "title": [
      "Legislative Background,” in “The Washington Briefing on FDA’s Drug Efficacy Review"
    ],
    "type": "article-journal",
    "volume": [
      "2"
    ]
  },
  {
    "citation-number": [
      "64."
    ],
    "container-title": [
      "this document was, in turn, attached to acting director, Bureau of Drugs to Morton Fromer",
      "Dec"
    ],
    "date": [
      "1974",
      "1977-12-19"
    ],
    "note": [
      "in NARA, RG 88, General Subject Files, box 5031, 505."
    ],
    "title": [
      "See “Summary Authority to Suspend Drug Marketing,” attached to Linda Horton (chief, Legislative Services Staff) to Morton Fromer (consumer safety officer"
    ],
    "type": "article-journal",
    "volume": [
      "3"
    ]
  },
  {
    "author": [
      {
        "family": "Lasagna",
        "given": "Louis"
      }
    ],
    "citation-number": [
      "65."
    ],
    "container-title": [
      "Science"
    ],
    "date": [
      "quote 872"
    ],
    "issue": [
      "May 26, 1978"
    ],
    "note": [
      "The actual DESI unit had been"
    ],
    "pages": [
      "871–873,"
    ],
    "title": [
      "The Development and Regulation of New Medications"
    ],
    "type": "article-journal",
    "volume": [
      "200"
    ]
  },
  {
    "author": [
      {
        "family": "in",
        "particle": "dismantled"
      },
      {
        "family": "Wardell",
        "given": "William M."
      }
    ],
    "container-title": [
      "Agents and Actions"
    ],
    "date": [
      "1972",
      "1972-12-04",
      "1972-12-01",
      "1978"
    ],
    "note": [
      "On the administrative shuffling of the DESI Task Force within the FDA, see “FDA Concentrates Responsibility"
    ],
    "pages": [
      "67",
      "421–422"
    ],
    "title": [
      "See Marion Finkel to Director, Bureau of Drugs",
      "together with attached Position Paper, DESI Project Office",
      "RG 88, General Subject Files, box 4647, 505.52. 66. Bryan and Stern, “The Drug Efficacy Study",
      "The U.S. Drug Efficacy Study and Its Implication (DESI"
    ],
    "type": "article-journal",
    "volume": [
      "15",
      "8"
    ]
  },
  {
    "author": [
      {
        "literal": ". ."
      }
    ],
    "container-title": [
      "F-D-C Reports/Pink Sheet",
      "F-D-C Reports/Pink Sheet"
    ],
    "date": [
      "1969-06-23",
      "1971-01-18",
      "2002-07-17"
    ],
    "note": [
      "Federal Register 36 (Apr. 28, 1971): 7989. 70. Edwin Ortiz (director, Division of Metabolic and Endocrine Drug Products) to Hoffmann-La Roche, Dec. 8, 1972, FDA, NAS/NRC reports, NDA 12–750/S-010. 71. Jonathan Cole interview,"
    ],
    "pages": [
      "7– 8 69"
    ],
    "title": [
      "",
      "New Procedure for Handling NAS/NRC Review"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Marplan",
        "given": "Roche’s"
      }
    ],
    "citation-number": [
      "72."
    ],
    "container-title": [
      "F-D-C Reports/Pink Sheet Apr"
    ],
    "date": [
      "1975"
    ],
    "pages": [
      "8"
    ],
    "title": [
      ""
    ],
    "type": "article-journal",
    "volume": [
      "28"
    ]
  },
  {
    "citation-number": [
      "73."
    ],
    "container-title": [
      "Federal Register"
    ],
    "date": [
      "1976-10-05"
    ],
    "pages": [
      "43938–43940"
    ],
    "type": "article-journal",
    "volume": [
      "41"
    ]
  },
  {
    "author": [
      {
        "family": "J. Neyman",
        "particle": "by"
      },
      {
        "family": "Pearson",
        "given": "E.S."
      }
    ],
    "citation-number": [
      "74."
    ],
    "note": [
      "this classical essay is reprinted in Neyman and Pearson, Joint Statistical Papers (Cambridge: Cambridge University Press, 1967), 186–202, see"
    ],
    "title": [
      "Having too few subjects to show a result at a certain level of effect is called “type II” error and it was first described in 1933"
    ],
    "type": null
  },
  {
    "container-title": [
      "Federal Register"
    ],
    "date": [
      "190, 201",
      "1979-08-28",
      "1985"
    ],
    "edition": [
      "39th"
    ],
    "location": [
      "Physicians",
      "Oradell, NJ"
    ],
    "pages": [
      "50409–50410 76",
      "1690"
    ],
    "publisher": [
      "Desk Reference",
      "Medical Economics Company"
    ],
    "title": [
      "But only in the 1970s did it start to become common coin within the trialist community. 75"
    ],
    "type": "article-journal",
    "volume": [
      "44"
    ]
  },
  {
    "author": [
      {
        "family": "Cole",
        "given": "Jonathan"
      },
      {
        "given": "interview"
      }
    ],
    "citation-number": [
      "77."
    ],
    "date": [
      "2002-07-17"
    ],
    "note": [
      "Alertonic was NAS/NRC box 2, file no. 1322."
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Temple"
      }
    ],
    "citation-number": [
      "78."
    ],
    "date": [
      "quote 19"
    ],
    "genre": [
      "statistics from table 3,"
    ],
    "title": [
      "Reevaluation of Marketed Drugs"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Robert",
        "given": "L."
      }
    ],
    "citation-number": [
      "79."
    ],
    "container-title": [
      "Smith Kline & French Laboratories, discussion, in Cooper, Quality of Advice"
    ],
    "pages": [
      "176–177"
    ],
    "title": [
      "Dean, director of regulatory affairs"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "John Young",
        "given": "William C.Triplett",
        "particle": "to"
      }
    ],
    "citation-number": [
      "80."
    ],
    "date": [
      "1972-07-10"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "note": [
      "General Subject Files, box 4647, 505.52. Italics in original."
    ],
    "type": null
  },
  {
    "title": [
      "chlorpromazine.) In 1979 Ciba-Geigy acquired Tutag, its generics arm becoming “Geneva Generics"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Director",
        "given": "Albert Lavender",
        "particle": "to"
      }
    ],
    "citation-number": [
      "82."
    ],
    "date": [
      "1973-01-17"
    ],
    "note": [
      "NARA, RG 88, General Subject Files, box 4863, 505.52."
    ],
    "title": [
      "Office of Compliance"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Durward",
        "given": "G."
      }
    ],
    "citation-number": [
      "83."
    ],
    "container-title": [
      "Edwards"
    ],
    "date": [
      "1972-12-15"
    ],
    "location": [
      "Edwards"
    ],
    "title": [
      "Hall to Charles C"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Dec",
        "particle": "responded with a boilerplate letter on"
      },
      {
        "family": "Schmidt",
        "given": "Alexander M."
      },
      {
        "given": "interview"
      }
    ],
    "container-title": [
      "NARA RG 88, General Subject Files"
    ],
    "date": [
      "1985"
    ],
    "genre": [
      "Mar. 8–9,"
    ],
    "note": [
      "part 3: 4 of 9 (accessed June 25, 2002)."
    ],
    "pages": [
      "505 52 84"
    ],
    "title": [
      "29, 1972, to “Dear Mr. Hall",
      "FDA Oral History Program"
    ],
    "type": "chapter",
    "url": [
      "http://www.fda.gov/oc/history/oralhistories/schmidt/default/htm,"
    ],
    "volume": [
      "box 4647"
    ]
  },
  {
    "author": [
      {
        "family": "Havighurst",
        "given": "Clark"
      },
      {
        "family": "discussion",
        "given": "in Cooper"
      }
    ],
    "citation-number": [
      "85."
    ],
    "container-title": [
      "Italics in original"
    ],
    "title": [
      "Quality of Advice, 167"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "FDA",
        "given": "Goodwin interview"
      }
    ],
    "citation-number": [
      "86."
    ],
    "container-title": [
      "part"
    ],
    "pages": [
      "10 12"
    ],
    "type": "article-journal",
    "volume": [
      "2"
    ]
  },
  {
    "author": [
      {
        "family": "Administering",
        "given": "Havoc",
        "particle": "in"
      }
    ],
    "citation-number": [
      "87."
    ],
    "container-title": [
      "F-D-C Reports/Pink Sheet"
    ],
    "date": [
      "1970-06-22"
    ],
    "pages": [
      "21"
    ],
    "title": [
      ""
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Quirk",
        "given": "Paul J."
      }
    ],
    "citation-number": [
      "88."
    ],
    "container-title": [
      "The Politics of Regulation",
      "191–235"
    ],
    "date": [
      "1980"
    ],
    "editor": [
      {
        "family": "James Q. Wilson",
        "particle": "ed."
      }
    ],
    "location": [
      "New York"
    ],
    "pages": [
      "210–211"
    ],
    "publisher": [
      "Basic Books"
    ],
    "title": [
      "Food and Drug Administration"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "given": "F.D.A."
      }
    ],
    "citation-number": [
      "89."
    ],
    "date": [
      "1760"
    ],
    "title": [
      "NAS/NRC, box 8, file no",
      "A notice in the Federal Register of"
    ],
    "type": null
  },
  {
    "date": [
      "1970-06-25"
    ],
    "note": [
      "declared it lacking in efficacy (see 10395)."
    ],
    "title": [
      "on “Oxanamide and Certain Other Drugs"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "F.D.A."
      }
    ],
    "citation-number": [
      "90."
    ],
    "container-title": [
      "Federal Register"
    ],
    "date": [
      "1730",
      "1978-04-28"
    ],
    "issue": [
      "1744"
    ],
    "pages": [
      "91",
      "18256–18257"
    ],
    "title": [
      "NAS/NRC, box 8, file no",
      "Methylphendiate Hydrochloride for Oral Use"
    ],
    "type": "article-journal",
    "volume": [
      "43"
    ]
  },
  {
    "citation-number": [
      "92."
    ],
    "container-title": [
      "Federal Register"
    ],
    "date": [
      "1974-06-05"
    ],
    "pages": [
      "19973"
    ],
    "title": [
      "Pfizer Laboratories"
    ],
    "type": "article-journal",
    "volume": [
      "39"
    ]
  },
  {
    "citation-number": [
      "93."
    ],
    "date": [
      "1975"
    ],
    "edition": [
      "29th"
    ],
    "location": [
      "Physicians",
      "Oradell, NJ"
    ],
    "pages": [
      "1571"
    ],
    "publisher": [
      "Desk Reference",
      "Medical Economics Co"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "FDA",
        "given": "N.A.S./N.R.C."
      }
    ],
    "citation-number": [
      "94."
    ],
    "container-title": [
      "box"
    ],
    "date": [
      "1284"
    ],
    "edition": [
      "57th"
    ],
    "issue": [
      " "
    ],
    "location": [
      "Physicians"
    ],
    "publisher": [
      "Desk Reference"
    ],
    "type": "article-journal",
    "volume": [
      "2"
    ]
  },
  {
    "date": [
      "2003"
    ],
    "location": [
      "Montvale, NJ"
    ],
    "pages": [
      "1602"
    ],
    "publisher": [
      "Thomson"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "FDA",
        "given": "N.A.S./N.R.C."
      }
    ],
    "citation-number": [
      "95."
    ],
    "container-title": [
      "box"
    ],
    "issue": [
      "1330"
    ],
    "type": "article-journal",
    "volume": [
      "2"
    ]
  },
  {
    "citation-number": [
      "96."
    ],
    "container-title": [
      "Federal Register"
    ],
    "date": [
      "1970-08-26"
    ],
    "pages": [
      "13608–13609"
    ],
    "type": "article-journal",
    "volume": [
      "35"
    ]
  },
  {
    "author": [
      {
        "family": "interview",
        "given": "Cole"
      }
    ],
    "citation-number": [
      "97."
    ],
    "date": [
      "2002-07-17"
    ],
    "note": [
      "Notes to Chapter 7"
    ],
    "pages": [
      "25"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Leo Hollister",
        "given": "Frank Berger",
        "particle": "interview by"
      }
    ],
    "citation-number": [
      "1."
    ],
    "date": [
      "1995-12"
    ],
    "title": [
      "16, American College of Neuropsychopharmacology (ACNP), Oral History Project; I am grateful to Thomas Ban for sharing this transcript with me"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Michael Alan Taylor",
        "given": "This",
        "particle": "paragraph is based on"
      },
      {
        "family": "Fink",
        "given": "Max"
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Acta Psychiatrica Scandinavica"
    ],
    "date": [
      "2006"
    ],
    "editor": [
      {
        "family": "Bolwig",
        "given": "Tom G."
      },
      {
        "family": "Shorter",
        "given": "Edward"
      }
    ],
    "issue": [
      "433"
    ],
    "location": [
      "New York",
      "Copenhagen"
    ],
    "note": [
      "Blackwell/Munksgaard, 2007); Conrad M. Swartz and Edward Shorter, Psychotic Depression (New York: Cambridge University Press., 2007)."
    ],
    "publisher": [
      "Cambridge University Press"
    ],
    "title": [
      "Melancholia: The Diagnosis, Pathophysiology, and Treatment of Depressive Illness",
      "Melancholia: Beyond DSM, Beyond Neurotransmitters"
    ],
    "type": "article-journal",
    "volume": [
      "115"
    ]
  },
  {
    "author": [
      {
        "family": "Wetherill",
        "given": "Henry M.",
        "suffix": "Jr"
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "American Journal of Insanity"
    ],
    "date": [
      "1889",
      "quote 28"
    ],
    "pages": [
      "28–47,"
    ],
    "title": [
      "The Modern Hypnotics"
    ],
    "type": "article-journal",
    "volume": [
      "46"
    ]
  },
  {
    "author": [
      {
        "family": "Goodwin",
        "given": "Donald W."
      },
      {
        "family": "Guze",
        "given": "Samuel B."
      }
    ],
    "citation-number": [
      "4."
    ],
    "edition": [
      "4th"
    ],
    "title": [
      "Psychiatric Diagnosis"
    ],
    "type": null
  },
  {
    "citation-number": [
      "1974;"
    ],
    "date": [
      "1989"
    ],
    "location": [
      "New York"
    ],
    "pages": [],
    "publisher": [
      "Oxford University Press"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Robert Spitzer",
        "given": "Daniel Greenwald",
        "particle": "to"
      },
      {
        "given": "undated"
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "American Psychiatric Association Archives"
    ],
    "date": [
      "1978"
    ],
    "location": [
      "Arlington, VA"
    ],
    "note": [
      "Hereafter cited as APA Archives.) Dr. Greenwald’s note was apparently preserved for reconsideration in the drafting of the revised edition of the manual, DSM-III-R, which began soon after DSM-III appeared in 1980."
    ],
    "title": [
      "on the basis of internal evidence), Janet Williams Papers, DSM-III-R, box 1, DSM-III files, “Affective comments in notebook"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Max Fink",
        "given": "Robert Spitzer",
        "particle": "interview by"
      },
      {
        "family": "Shorter",
        "given": "Edward"
      },
      {
        "given": "Mar"
      }
    ],
    "citation-number": [
      "6."
    ],
    "note": [
      "14, 2007, at Irvington, New York, 7."
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Walter",
        "given": "E."
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Mar"
    ],
    "date": [
      "1973"
    ],
    "note": [
      "Spitzer at this point had not yet been appointed."
    ],
    "title": [
      "Barton (medical director) to Sidney Malitz (chair, APA Council on Research and Development",
      "APA Archives, Professional Affairs, box 17, folder 188, “Origins of the Task Force on Nomenclature and Statistics"
    ],
    "type": "article-journal",
    "volume": [
      "20"
    ]
  },
  {
    "citation-number": [
      "8."
    ],
    "note": [
      "Spitzer interview, 22."
    ],
    "type": "interview"
  },
  {
    "author": [
      {
        "family": "Hoenig",
        "given": "J.]"
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Canadian Journal of Psychiatry"
    ],
    "date": [
      "1981",
      "quote 240"
    ],
    "pages": [
      "240–243,"
    ],
    "title": [
      "Nosology and Statistical Classification"
    ],
    "type": "article-journal",
    "volume": [
      "26"
    ]
  },
  {
    "citation-number": [
      "10."
    ],
    "note": [
      "Spitzer interview, 7."
    ],
    "type": "interview"
  },
  {
    "citation-number": [
      "11."
    ],
    "note": [
      "Spitzer interview, 7."
    ],
    "type": "interview"
  },
  {
    "citation-number": [
      "12."
    ],
    "note": [
      "Spitzer interview, 21."
    ],
    "type": "interview"
  },
  {
    "author": [
      {
        "family": "Robins",
        "given": "Eli"
      },
      {
        "family": "Guze",
        "given": "Samuel B."
      }
    ],
    "citation-number": [
      "13."
    ],
    "container-title": [
      "AJP"
    ],
    "date": [
      "1970"
    ],
    "pages": [
      "983–987"
    ],
    "title": [
      "Establishment of Diagnostic Validity in Psychiatric Illness: Its Application to Schizophrenia"
    ],
    "type": "article-journal",
    "volume": [
      "126"
    ]
  },
  {
    "author": [
      {
        "family": "Feighner",
        "given": "John P."
      },
      {
        "family": "Robins",
        "given": "Eli"
      },
      {
        "family": "Guze",
        "given": "Samuel B."
      },
      {
        "family": "Robert A. Woodruff",
        "given": "George Winokur",
        "suffix": "Jr."
      },
      {
        "family": "Muñoz",
        "given": "Rodrigo"
      }
    ],
    "citation-number": [
      "14."
    ],
    "container-title": [
      "Archives of General Psychiatry"
    ],
    "date": [
      "1972"
    ],
    "pages": [
      "57–63"
    ],
    "title": [
      "Diagnostic Criteria for Use in Psychiatric Research"
    ],
    "type": "article-journal",
    "volume": [
      "26"
    ]
  },
  {
    "author": [
      {
        "family": "Spitzer",
        "given": "Robert"
      },
      {
        "family": "Endicott",
        "given": "Jean"
      },
      {
        "family": "Robins",
        "given": "Eli"
      }
    ],
    "citation-number": [
      "15."
    ],
    "container-title": [
      "Archives of General Psychiatry"
    ],
    "date": [
      "1978"
    ],
    "pages": [
      "773–782"
    ],
    "title": [
      "Research Diagnostic Criteria"
    ],
    "type": "article-journal",
    "volume": [
      "35"
    ]
  },
  {
    "citation-number": [
      "16."
    ],
    "container-title": [
      "May"
    ],
    "date": [
      "1979"
    ],
    "publisher": [
      "DSM-III files"
    ],
    "title": [
      "Spitzer to “Fellow Deans of the Invisible College",
      "APA Archives, Williams Papers, Research DSM-III-R, box 3, misc"
    ],
    "type": "article-journal",
    "volume": [
      "10"
    ]
  },
  {
    "citation-number": [
      "17."
    ],
    "date": [
      "2006-12-04"
    ],
    "location": [
      "Hollywood, FL"
    ],
    "title": [
      "Paula Clayton interview, by Max Fink and Edward Shorter"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Nomenclature",
        "given": "A.P.A.Task Force",
        "particle": "on"
      },
      {
        "family": "Statistics",
        "given": "meeting of Sept"
      }
    ],
    "citation-number": [
      "18."
    ],
    "genre": [
      "box 17,"
    ],
    "location": [
      "New York"
    ],
    "pages": [
      "188"
    ],
    "publisher": [
      "APA Archives, Professional Affairs"
    ],
    "title": [
      "4–5, 1974"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Spitzer",
        "given": "Robert"
      }
    ],
    "citation-number": [
      "19."
    ],
    "container-title": [
      "10–11, APA Archives, Professional Affairs, box 17, folder",
      "Spitzer interview"
    ],
    "issue": [
      "70, no. 3"
    ],
    "pages": [
      "20"
    ],
    "title": [
      "Progress Report on the Preparation of DSM-III"
    ],
    "type": "article-journal",
    "volume": [
      "8",
      "193"
    ]
  },
  {
    "author": [
      {
        "family": "Organization",
        "given": "World Health"
      }
    ],
    "citation-number": [
      "21."
    ],
    "container-title": [
      "Injuries, and Causes of Death, Based on the Recommendations of the Ninth Revision Conference, 1975, and Adopted by the Twenty-ninth World Health Assembly"
    ],
    "date": [
      "1977"
    ],
    "location": [
      "Geneva"
    ],
    "pages": [
      "191–193"
    ],
    "publisher": [
      "WHO"
    ],
    "title": [
      "International Classification of Diseases: Manual of the International Statistical Classification of Diseases"
    ],
    "type": "paper-conference",
    "volume": [
      "1"
    ]
  },
  {
    "citation-number": [
      "22."
    ],
    "container-title": [
      "Committee on Nomenclature and Statistics of the American Psychiatric Association, DSM-II: Diagnostic and Statistical Manual of Mental Disorders"
    ],
    "date": [
      "1968"
    ],
    "edition": [
      "2nd"
    ],
    "location": [
      "Washington, DC"
    ],
    "pages": [
      "8"
    ],
    "publisher": [
      "APA"
    ],
    "type": "chapter"
  },
  {
    "citation-number": [
      "23."
    ],
    "note": [
      "Spitzer interview, 34."
    ],
    "type": "interview"
  },
  {
    "citation-number": [
      "24."
    ],
    "container-title": [
      "interview, in The Psychopharmacologists"
    ],
    "date": [
      "2000"
    ],
    "editor": [
      {
        "family": "David Healy",
        "particle": "ed."
      }
    ],
    "location": [
      "London"
    ],
    "pages": [
      "395–414",
      "408"
    ],
    "publisher": [
      "Arnold"
    ],
    "title": [
      "The phrase “Chinese menu” for the lists of diagnostic criteria was Gerald Klerman’s. See Samuel Guze, “The Neo-Kraepelinian Revolution"
    ],
    "type": "chapter",
    "volume": [
      "3"
    ]
  },
  {
    "author": [
      {
        "family": "Spitzer",
        "given": "Robert L."
      },
      {
        "family": "Endicott",
        "given": "Jean"
      },
      {
        "family": "Robins",
        "given": "Eli"
      },
      {
        "family": "Kuriansky",
        "given": "Judith"
      },
      {
        "family": "Gurland",
        "given": "Barry"
      }
    ],
    "citation-number": [
      "25."
    ],
    "container-title": [
      "Predictability in Psychopharmacology: Preclinical and Clinical Correlations",
      "Abraham Sudilovsky et al., 1–47"
    ],
    "date": [
      "1975"
    ],
    "editor": [
      {
        "literal": "ed."
      }
    ],
    "location": [
      "New York"
    ],
    "pages": [
      "23–29"
    ],
    "publisher": [
      "Raven"
    ],
    "title": [
      "Preliminary Report of the Reliability of Research Diagnostic Criteria Applied to Psychiatric Case Records"
    ],
    "type": "chapter"
  },
  {
    "citation-number": [
      "26."
    ],
    "date": [
      "1975"
    ],
    "note": [
      "attached"
    ],
    "title": [
      "Initial Draft Version of DSM-III Classification of Aug"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Lissy F. Jarvik",
        "particle": "to Bernard Stotsky to"
      }
    ],
    "date": [
      "1976-11-08",
      "1957"
    ],
    "location": [
      "Nashville, TN",
      "Berlin"
    ],
    "note": [
      "27. Karl Leonhard, Die Aufteilung der endogenen Psychosen"
    ],
    "publisher": [
      "Vanderbilt University Medical Center",
      "Akademie-Verlag"
    ],
    "title": [
      "Paula Clayton Papers, box 30, folder 13, International Neuropsychopharmacology Archives, Eskind Biomedical Library"
    ],
    "type": null
  },
  {
    "citation-number": [
      "28."
    ],
    "container-title": [
      "June"
    ],
    "date": [
      "1976"
    ],
    "location": [
      "Range"
    ],
    "publisher": [
      "APA Archives, Medical Director’s Office"
    ],
    "title": [
      "See “Final General Session [of meeting in St. Louis",
      "Donald Klein remarks, 1"
    ],
    "type": "article-journal",
    "volume": [
      "10"
    ]
  },
  {
    "author": [
      {
        "literal": "box C-1, “Summary of Conference . . . DSM-III in Mid-stream"
      }
    ],
    "citation-number": [
      "37,"
    ],
    "container-title": [
      "APA Archives, Williams Papers, DSM-III-R, box 1, DSM-III files, major depressive disorder. The March 1976 draft was attached to Task Force on Nomenclature and Statistics, “Progress Report on the Preparation of DSM-III,” March 1976, APA Archives, Professional Affairs, box 17, folder"
    ],
    "date": [
      "1976",
      "2005",
      "36. 30"
    ],
    "issue": [
      "70, no. 3"
    ],
    "location": [
      "New York"
    ],
    "note": [
      "This draft also made mention of demoralization disorder, the only point in the DSM-III process at which this interesting diagnosis seems to have been officially considered."
    ],
    "pages": [
      "83 29"
    ],
    "publisher": [
      "Oxford University Press",
      "Spitzer interview"
    ],
    "title": [
      "On the history of “endogenous” depression, see Shorter, Historical Dictionary of Psychiatry",
      "Later evidence suggests that Spitzer disliked “minor” because of the problem of insurance reimbursement for clinicians. Yet he may be just accommodating others’ opinions, without himself, a researcher, fearing this problem. See Rachel Gittelman to Robert Spitzer, Feb. 18, 1976: ”I am not too clear what would replace the major/minor heading"
    ],
    "type": "article-journal",
    "volume": [
      "193"
    ]
  },
  {
    "citation-number": [
      "31."
    ],
    "date": [
      "1976-08-19"
    ],
    "title": [
      "The draft of",
      "was attached to Spitzer to Organic Mental"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Subcommittee",
        "given": "Disorders"
      },
      {
        "given": "Sept"
      }
    ],
    "date": [
      "1976"
    ],
    "genre": [
      "Clayton Papers, box 30,"
    ],
    "pages": [
      "13"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Task Force",
        "given": "Robert Spitzer",
        "particle": "to"
      }
    ],
    "citation-number": [
      "32."
    ],
    "container-title": [
      "Clayton Papers, box"
    ],
    "date": [
      "1976-11-05"
    ],
    "pages": [
      "13"
    ],
    "type": "article-journal",
    "volume": [
      "30"
    ]
  },
  {
    "author": [
      {
        "family": "See",
        "given": "A.P.A."
      }
    ],
    "citation-number": [
      "33."
    ],
    "container-title": [
      "minutes of meeting of May 1"
    ],
    "date": [
      "1977"
    ],
    "location": [
      "Toronto"
    ],
    "title": [
      "re “Task Force on Nomenclature & Statistics"
    ],
    "type": "paper-conference"
  },
  {
    "citation-number": [
      "34."
    ],
    "container-title": [
      "Jan",
      "Clayton Papers, box"
    ],
    "date": [
      "1978"
    ],
    "pages": [
      "15"
    ],
    "title": [
      "Draft of Axes I and II of DSM-III Classification"
    ],
    "type": "article-journal",
    "volume": [
      "16",
      "30"
    ]
  },
  {
    "author": [
      {
        "family": "text",
        "given": "D.S.M.-I.I.I.",
        "particle": "draft"
      }
    ],
    "citation-number": [
      "35."
    ],
    "container-title": [
      "APA, DSM-III"
    ],
    "date": [
      "1979-08",
      "1980"
    ],
    "location": [
      "Washington, DC"
    ],
    "pages": [
      "377"
    ],
    "publisher": [
      "APA"
    ],
    "title": [
      "Comparative Listing of DSM-II and DSM-III, undated [c",
      "Appendix C: Annotated Comparative Listing of DSM-II and DSM-III”; APA Archives, Williams Papers, Research—DSM-III-R, box 3. The sentence about chronic equaling neurasthenia was edited out of the published version, which stated simply of neurasthenia, “This DSM-II category was rarely used"
    ],
    "type": "chapter"
  },
  {
    "citation-number": [
      "36."
    ],
    "container-title": [
      "Clayton Papers, box"
    ],
    "date": [
      "1977-06-06"
    ],
    "pages": [
      "12"
    ],
    "title": [
      "Robert Spitzer to Task Force"
    ],
    "type": "article-journal",
    "volume": [
      "30"
    ]
  },
  {
    "author": [
      {
        "literal": "“Draft of Axes I and II . ."
      }
    ],
    "citation-number": [
      "37."
    ],
    "container-title": [
      "Jan",
      "Clayton Papers, box"
    ],
    "date": [
      "1978"
    ],
    "note": [
      "Spitzer interview, 34."
    ],
    "pages": [
      "15 38"
    ],
    "title": [
      ""
    ],
    "type": "article-journal",
    "volume": [
      "16",
      "30"
    ]
  },
  {
    "citation-number": [
      "39."
    ],
    "container-title": [
      "Mar",
      "Apr"
    ],
    "date": [
      "1977",
      "1977"
    ],
    "note": [
      "Professional Affairs, box 16, folder 176, DSM-III draft (1)."
    ],
    "title": [
      "Draft of Axes I and II of DSM-III Classification",
      "attached to “DSM-III Draft, Table of Contents",
      "APA Archives"
    ],
    "type": "article-journal",
    "volume": [
      "30",
      "15"
    ]
  },
  {
    "author": [
      {
        "family": "Robert Spitzer",
        "given": "John Racy",
        "particle": "to"
      },
      {
        "given": "Mar"
      }
    ],
    "citation-number": [
      "40."
    ],
    "date": [
      "1978"
    ],
    "title": [
      "APA Archives, Williams Papers, Research—DSM-III-R, box 1, DSM-III files, folder “misc. affective"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "John Racy",
        "given": "Robert Spitzer",
        "particle": "to"
      }
    ],
    "citation-number": [
      "41."
    ],
    "container-title": [
      "Mar"
    ],
    "date": [
      "1978"
    ],
    "title": [
      "Williams Papers, Research—DSM-III-R, box 1, DSM-III files, folder “misc. affective"
    ],
    "type": "article-journal",
    "volume": [
      "31"
    ]
  },
  {
    "citation-number": [
      "42."
    ],
    "date": [
      "1978-07-10"
    ],
    "title": [
      "Robert Spitzer to “Affective Disorder Mavens",
      "APA Archives, Williams Papers, Research—DSM-III-R, DSM-III files, “misc. affective"
    ],
    "type": null
  },
  {
    "citation-number": [
      "43."
    ],
    "container-title": [
      "Atlanta, the minutes note, “In the Affective Disorders section, consideration is being given to renaming the Chronic Affective Disorders, Chronic Minor Affective Disorders. The Episodic Disorders"
    ],
    "note": [
      "then, would become the Major Affective Disorders.”"
    ],
    "title": [
      "This point was brought out even before the renaming occurred. At a meeting of the task force on May 7, 1978"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "W",
        "given": "Janet B."
      }
    ],
    "date": [
      "1978-05-25",
      "box 31"
    ],
    "location": [
      "Clayton Papers"
    ],
    "title": [
      "Forman to Members of the Task Force"
    ],
    "type": null
  },
  {
    "citation-number": [
      "44."
    ],
    "container-title": [
      "Apr"
    ],
    "date": [
      "1979"
    ],
    "location": [
      "Williams Papers"
    ],
    "note": [
      "DSM-III-R, loose DSM-III files, “neurosis” folder."
    ],
    "title": [
      "Spitzer to “Dear Colleagues"
    ],
    "type": "article-journal",
    "volume": [
      "30"
    ]
  },
  {
    "author": [
      {
        "family": "Alex H. Kaplan",
        "given": "See John J.McGrath",
        "particle": "to"
      }
    ],
    "citation-number": [
      "45."
    ],
    "container-title": [
      "Mar"
    ],
    "date": [
      "1979"
    ],
    "title": [
      "American Psychoanalytic Association",
      "Williams Papers, Research—DSM-III-R, loose DSM-III files"
    ],
    "type": "article-journal",
    "volume": [
      "12"
    ]
  },
  {
    "citation-number": [
      "46."
    ],
    "note": [
      "Spitzer interview, 20."
    ],
    "type": "interview"
  },
  {
    "citation-number": [
      "47."
    ],
    "container-title": [
      "Apr"
    ],
    "date": [
      "1979",
      "box 31"
    ],
    "location": [
      "Clayton Papers"
    ],
    "title": [
      "Spitzer to task force members, memo entitled “Neurotic Depression Once Again"
    ],
    "type": "article-journal",
    "volume": [
      "27"
    ]
  },
  {
    "author": [
      {
        "family": "Donald",
        "given": "F."
      }
    ],
    "citation-number": [
      "48."
    ],
    "container-title": [
      "Mar"
    ],
    "date": [
      "1979"
    ],
    "pages": [
      "31"
    ],
    "title": [
      "Klein to Task Force",
      "Clayton Papers"
    ],
    "type": "article-journal",
    "volume": [
      "30"
    ]
  },
  {
    "author": [
      {
        "given": "D.S.M.-I.I.I."
      }
    ],
    "citation-number": [
      "49."
    ],
    "title": [
      "214, 223. The diagnostic criteria for a major depressive episode"
    ],
    "type": null
  },
  {
    "author": [
      {
        "literal": "III-R, published in"
      }
    ],
    "date": [
      "1987",
      "1993"
    ],
    "location": [
      "New York"
    ],
    "pages": [
      "57"
    ],
    "publisher": [
      "Brunner"
    ],
    "title": [
      "Herman van Praag, “Make-Believes” in Psychiatry or The Perils of Progress"
    ],
    "type": "book",
    "volume": [
      "53"
    ]
  },
  {
    "author": [
      {
        "given": "In"
      }
    ],
    "citation-number": [
      "51."
    ],
    "date": [
      "2005"
    ],
    "genre": [
      "(For internal medicine, by contrast, it was 82.3"
    ],
    "note": [
      "percent; the average for all specialties was 70.5 percent."
    ],
    "title": [
      "90.1 percent of all visits to psychiatrists ended with a prescription, making psychiatry the highest-prescribing specialty"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Cherry",
        "given": "D.K."
      },
      {
        "others": true
      }
    ],
    "date": [
      "2007"
    ],
    "location": [
      "Hyattsville, MD"
    ],
    "pages": [
      "24"
    ],
    "publisher": [
      "National Center for Health Statistics"
    ],
    "title": [
      "National Ambulatory Medical Care Survey: 2005 Summary, Advance Data from Vital and Health Statistics 387"
    ],
    "type": "book",
    "volume": [
      "33"
    ]
  },
  {
    "author": [
      {
        "family": "Robert Spitzer",
        "given": "Arthur Rifkin",
        "particle": "to"
      }
    ],
    "citation-number": [
      "52."
    ],
    "container-title": [
      "Mar"
    ],
    "date": [
      "1978"
    ],
    "title": [
      "Williams Papers, Research—DSM-III-R, box 2; “DSM-III- unfiled"
    ],
    "type": "article-journal",
    "volume": [
      "30"
    ]
  },
  {
    "author": [
      {
        "family": "Keller",
        "given": "Martin B."
      },
      {
        "family": "Hanks",
        "given": "Diane L."
      }
    ],
    "citation-number": [
      "53."
    ],
    "container-title": [
      "Journal of Clinical Psychiatry"
    ],
    "date": [
      "1994"
    ],
    "pages": [
      "25–33"
    ],
    "title": [
      "The Natural History and Heterogeneity of Depressive Disorders: Implications for Rational Antidepressant Therapy"
    ],
    "type": "article-journal",
    "volume": [
      "55, suppl. A"
    ]
  },
  {
    "author": [
      {
        "family": "Robert Spitzer",
        "given": "Bernard J.Carroll",
        "particle": "to"
      },
      {
        "given": "Feb"
      }
    ],
    "citation-number": [
      "54."
    ],
    "date": [
      "1979"
    ],
    "note": [
      "Williams papers, DSM-III-R, box 1, DSM-III files, major depressive disorder."
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Robert Spitzer",
        "given": "Donald Klein",
        "particle": "to"
      }
    ],
    "citation-number": [
      "55."
    ],
    "container-title": [
      "Mar"
    ],
    "date": [
      "1979"
    ],
    "genre": [
      "Clayton Papers, box 31."
    ],
    "type": "article-journal",
    "volume": [
      "6"
    ]
  },
  {
    "author": [
      {
        "family": "Robert Spitzer",
        "given": "Donald Klein",
        "particle": "to"
      }
    ],
    "citation-number": [
      "56."
    ],
    "date": [
      "1984-08-31"
    ],
    "location": [
      "Williams Papers, Research"
    ],
    "note": [
      "DSM-III-R, box 2, loose DSM-III-R papers."
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Compton",
        "given": "Wilson M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "57."
    ],
    "container-title": [
      "AJP"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "2141–2147"
    ],
    "title": [
      "Changes in the Prevalence of Major Depression and Comorbid Substance Use Disorders in the United States Between 1991–1992 and 2001–2002"
    ],
    "type": "article-journal",
    "volume": [
      "163"
    ]
  },
  {
    "author": [
      {
        "family": "Andrews",
        "given": "Gavin"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "58."
    ],
    "container-title": [
      "BJP"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "495–496"
    ],
    "title": [
      "Lifetime Risk of Depression: Restricted to a Minority or Waiting for Most?"
    ],
    "type": "article-journal",
    "volume": [
      "187"
    ]
  },
  {
    "author": [
      {
        "family": "Parker",
        "given": "Gordon"
      }
    ],
    "citation-number": [
      "59."
    ],
    "container-title": [
      "Journal of Nervous and Mental Disease"
    ],
    "date": [
      "2006",
      "quote 156"
    ],
    "pages": [
      "155–157,"
    ],
    "title": [
      "Editorial: Commentary on Diagnosing Major Depressive Disorder"
    ],
    "type": "article-journal",
    "volume": [
      "194"
    ]
  },
  {
    "author": [
      {
        "family": "Robert Spitzer",
        "given": "Donald Klein",
        "particle": "to"
      }
    ],
    "citation-number": [
      "60."
    ],
    "container-title": [
      "Apr",
      "Affective.”"
    ],
    "date": [
      "1978"
    ],
    "pages": [
      "36–37"
    ],
    "title": [
      "Williams Papers, Research, DSM-III-R, box 1, DSM-III files, folder “Misc"
    ],
    "type": "article-journal",
    "volume": [
      "24",
      "61. Spitzer interview"
    ]
  },
  {
    "author": [
      {
        "family": "Olfson",
        "given": "Mark"
      },
      {
        "family": "Klerman",
        "given": "Gerald L."
      }
    ],
    "citation-number": [
      "62."
    ],
    "container-title": [
      "AJP",
      "table"
    ],
    "date": [
      "1993"
    ],
    "pages": [
      "571–577,",
      "572"
    ],
    "title": [
      "Trends in the Prescription of Antidepressants by Office-Based Psychiatrists"
    ],
    "type": "article-journal",
    "volume": [
      "150",
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "Max Fink",
        "given": "Ross Baldessarini",
        "particle": "interview with"
      },
      {
        "family": "Shorter",
        "given": "Edward"
      }
    ],
    "citation-number": [
      "63."
    ],
    "container-title": [
      "Feb"
    ],
    "date": [
      "2006"
    ],
    "location": [
      "Belmont, MA"
    ],
    "type": "article-journal",
    "volume": [
      "17"
    ]
  },
  {
    "author": [
      {
        "family": "Parker",
        "given": "Gordon"
      }
    ],
    "citation-number": [
      "64."
    ],
    "container-title": [
      "Psychological Medicine"
    ],
    "date": [
      "2005",
      "quote 471"
    ],
    "pages": [
      "467–474,"
    ],
    "title": [
      "Beyond Major Depression"
    ],
    "type": "article-journal",
    "volume": [
      "35"
    ]
  },
  {
    "citation-number": [
      "65."
    ],
    "title": [
      "According to an ABC News Report"
    ],
    "type": null,
    "url": [
      "http://abcnews.go.com/GMA/"
    ]
  },
  {
    "citation-number": [
      "OnCall/story?id=2640591&page=1"
    ],
    "note": [
      "accessed May 15, 2007)."
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Bernstein",
        "given": "Fred A."
      }
    ],
    "citation-number": [
      "66."
    ],
    "container-title": [
      "New York Times, Feb"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "7"
    ],
    "title": [
      "The New Kitchen Is Done"
    ],
    "type": "article-journal",
    "volume": [
      "22"
    ]
  },
  {
    "citation-number": [
      "67."
    ],
    "note": [
      "Spitzer interview, 48. Notes to Chapter 8"
    ],
    "type": "interview"
  },
  {
    "author": [
      {
        "family": "Raofi",
        "given": "S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "National Center for Health Statistics, Vital Health Statistics"
    ],
    "issue": [
      "163"
    ],
    "title": [
      "Medication Therapy in Ambulatory Medical Care: United States, 2003–04"
    ],
    "type": "article-journal",
    "volume": [
      "13"
    ]
  },
  {
    "author": [
      {
        "family": "D. K. Cherry",
        "particle": "so on down the list."
      },
      {
        "others": true
      },
      {
        "literal": "Arvid Carlsson interview by David Healy and Edward Shorter, part II, Gothenburg, Sweden"
      },
      {
        "family": "Bowman",
        "given": "Robert L."
      },
      {
        "others": true
      },
      {
        "given": "al"
      }
    ],
    "container-title": [
      "Feb",
      "Medical Hypotheses",
      "Science",
      "Biochemical Pharmacology"
    ],
    "date": [
      "2006",
      "2007",
      "2007",
      "1957-06-24",
      "2006",
      "1955-07-01",
      "1965"
    ],
    "genre": [
      "F-T-C Reports/Pink Sheet,"
    ],
    "issue": [
      "387"
    ],
    "location": [
      "Hyattsville, MD"
    ],
    "note": [
      "Solomon H. Snyder, Julius Axelrod et"
    ],
    "pages": [
      "25 2",
      "4",
      "689–690 5",
      "32–33",
      "831–835"
    ],
    "publisher": [
      "National Center for Health Statistics",
      "Einar Hellbom"
    ],
    "title": [
      "27, table 10. In 2005, antidepressants led drugs in all other therapeutic classes in percent of mentions in office visits: Antidepressants constituted 5.3 percent of all drug mentions, antihypertensive agents 5.2 percent",
      "National Ambulatory Medical Care Survey: 2005 Summary, Advance Data from Vital and Health Statistics",
      "On the repositioning of phenyltoloxamine, see “Bristol Lab Tranquilizer",
      "Chlorpheniramine, Selective Serotonin-Reuptake Inhibitors (SSRIs) and Over-the-Counter Treatment",
      "Spectrophotofluormetric Assay in the Visible and Ultraviolet",
      "A Sensitive and Specific Fluorescence Assay for Tissue Serotonin"
    ],
    "type": "article-journal",
    "volume": [
      "34",
      "28",
      "25–26. 3",
      "17",
      "66",
      "122",
      "14"
    ]
  },
  {
    "author": [
      {
        "family": "Arvid Carlsson",
        "particle": "see"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "For the 1960 paper and the conference",
      "Ciba Foundation Symposium Jointly With Committee for Symposia on Drug Action on Adrenergic",
      "Bioscience Reports"
    ],
    "date": [
      "1999-12-08",
      "2001-12"
    ],
    "pages": [
      "691–710"
    ],
    "title": [
      "Arvid Carlsson tells this story in his Nobel Lecture",
      "A Half-Century of Neurotransmitter Research: Impact on Neurology and Psychiatry",
      "On the Biochemistry and Possible Functions of Dopamine and Noradrenaline in Brain"
    ],
    "type": "article-journal",
    "volume": [
      "21"
    ]
  },
  {
    "date": [
      "1960"
    ],
    "editor": [
      {
        "family": "Mechanisms",
        "given": "ed J.R.Vane"
      },
      {
        "others": true
      }
    ],
    "location": [
      "Boston"
    ],
    "pages": [
      "432–439"
    ],
    "publisher": [
      "Little and Brown"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Coppen",
        "given": "Alec"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Lancet"
    ],
    "date": [
      "1963-01-12"
    ],
    "pages": [
      "79–81"
    ],
    "title": [
      "Potentiation of the Antidepressive Effect of a Monoamine-Oxidase Inhibitor by Tryptophan"
    ],
    "type": "article-journal",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "B. Falck",
        "given": "The",
        "particle": "seminal contribution is"
      },
      {
        "family": "Hillarp",
        "given": "N.-A."
      },
      {
        "family": "Thieme",
        "given": "G."
      },
      {
        "family": "Torp",
        "given": "A."
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Journal of Histochemistry and Cytochemistry"
    ],
    "date": [
      "1962"
    ],
    "pages": [
      "348–354"
    ],
    "title": [
      "Fluorescence of Catechol Amines and Related Compounds Condensed with Formaldehyde"
    ],
    "type": "article-journal",
    "volume": [
      "10"
    ]
  },
  {
    "author": [
      {
        "family": "Kielholz",
        "given": "P.]"
      },
      {
        "family": "Pöldinger",
        "given": "W.]"
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Deutsche Medizinische Wochenschrift"
    ],
    "issue": [
      "Apr. 5, 1968"
    ],
    "pages": [
      "701–704"
    ],
    "title": [
      "Die Behandlung endogener Depressionen mit Psychopharmaka"
    ],
    "type": "article-journal",
    "volume": [
      "93"
    ]
  },
  {
    "citation-number": [
      "10."
    ],
    "container-title": [
      "interview), in Psychopharmacologists"
    ],
    "date": [
      "1996"
    ],
    "editor": [
      {
        "family": "David Healy",
        "particle": "ed."
      }
    ],
    "location": [
      "London"
    ],
    "note": [
      "Carlsson reinforced the importance of the Kielholz article in the Healy–Shorter interview, Feb. 27, 2007: 72."
    ],
    "pages": [
      "51–80",
      "60"
    ],
    "publisher": [
      "Chapman and Hall"
    ],
    "title": [
      "In his published work, Carlsson makes virtually no reference to this Kielholz article. Yet he told David Healy in 1996 that Kielholz’s data were the reason that he, Carlsson, did the experiment. Arvid Carlsson, “Rise of Neuropsychopharmacology"
    ],
    "type": "chapter",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "Carlsson",
        "given": "Arvid"
      },
      {
        "family": "Corrodi",
        "given": "Hans"
      },
      {
        "family": "Fuxe",
        "given": "Kjell"
      },
      {
        "family": "Hökfelt",
        "given": "Tomas"
      }
    ],
    "citation-number": [
      "11."
    ],
    "container-title": [
      "European Journal of Pharmacology"
    ],
    "date": [
      "1969"
    ],
    "pages": [
      "357–366"
    ],
    "title": [
      "Effect of Antidepressant Drugs on the Depletion of Intraneuronal Brain 5-Hydroxytryptramine Stores Caused by 4-Methyl-alpha-Ethyl-Meta-Tyramine"
    ],
    "type": "article-journal",
    "volume": [
      "5"
    ]
  },
  {
    "author": [
      {
        "family": "Carlsson",
        "given": "Arvid"
      },
      {
        "family": "Corrodi",
        "given": "Hans"
      },
      {
        "family": "Fuxe",
        "given": "Kjell"
      },
      {
        "family": "Hökfelt",
        "given": "Tomas"
      }
    ],
    "citation-number": [
      "12."
    ],
    "container-title": [
      "European Journal of Pharmacology"
    ],
    "date": [
      "1969"
    ],
    "pages": [
      "367–373"
    ],
    "title": [
      "Effect of Antidepressant Drugs on the Depletion of Intraneuronal Brain Catecholamine Stores Caused by 4, alpha- Dimethyl-Meta-Tyramine"
    ],
    "type": "article-journal",
    "volume": [
      "5"
    ]
  },
  {
    "author": [
      {
        "family": "Carlsson",
        "given": "Arvid"
      },
      {
        "family": "Lindqvist",
        "given": "Margit"
      }
    ],
    "citation-number": [
      "13."
    ],
    "container-title": [
      "Journal of Pharmacy and Pharmacology"
    ],
    "date": [
      "1969"
    ],
    "pages": [
      "460–464"
    ],
    "title": [
      "Central and Peripheral Monoaminergic Membrane-Pump Blockage by Some Addictive Analgesics and Antihistamines"
    ],
    "type": "article-journal",
    "volume": [
      "21"
    ]
  },
  {
    "citation-number": [
      "14."
    ],
    "date": [
      "2004"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "New York University Press"
    ],
    "title": [
      "For a fluent overview of these events, see David Healy, Let Them Eat Prozac: The Unhealthy Relationship Between the Pharmaceutical Industry and Depression",
      "Some observers consider early research on clomipramine as touching off the SSRI era. Yet clomipramine metabolizes in the body to a norepinephrine reuptake inhibitor"
    ],
    "type": "book"
  },
  {
    "citation-number": [
      "15."
    ],
    "date": [
      "1973-11-12"
    ],
    "issue": [
      "h patent no. 361 663"
    ],
    "type": null,
    "volume": []
  },
  {
    "citation-number": [
      "16."
    ],
    "date": [
      "1995"
    ],
    "location": [
      "Stockholm"
    ],
    "pages": [
      "101–110"
    ],
    "publisher": [
      "Swedish Pharmaceutical Press"
    ],
    "title": [
      "These details are mainly from Ivan Oestholm [Ostholm], Drug Discovery: A Pharmacist’s Story"
    ],
    "type": "book"
  },
  {
    "citation-number": [
      "17."
    ],
    "container-title": [
      "BJP"
    ],
    "date": [
      "1982-03"
    ],
    "title": [
      "Zelmid advertisement"
    ],
    "type": "article-journal",
    "volume": [
      "140"
    ]
  },
  {
    "citation-number": [
      "18."
    ],
    "container-title": [
      "Recent Advances in the Treatment of Depression: Proceedings of an International Symposium, Corfu",
      "Acta Psychiatrica Scandinavica"
    ],
    "date": [
      "April 16–18, 1980"
    ],
    "editor": [
      {
        "family": "Carlsson",
        "given": "Arvid"
      },
      {
        "others": true
      }
    ],
    "issue": [
      "290"
    ],
    "location": [
      "Greece"
    ],
    "title": [
      "See the two big symposia"
    ],
    "type": "article-journal",
    "volume": [
      "63"
    ]
  },
  {
    "container-title": [
      "The Treatment of Depression: Proceedings of a Symposium in Laxenburg",
      "Acta Psychiatrica Scandinavica"
    ],
    "date": [
      "1981",
      "1983-07-09",
      "1983"
    ],
    "editor": [
      {
        "family": "Gottfries",
        "given": "Carl-Gerhard"
      }
    ],
    "issue": [
      "308"
    ],
    "location": [
      "Copenhagen",
      "Austria",
      "Copenhagen"
    ],
    "publisher": [
      "Munksgaard",
      "Munksgaard"
    ],
    "title": [
      "Recent Advances with Zimeldine, the 5-HT Reuptake Blocker"
    ],
    "type": "article-journal",
    "volume": [
      "68"
    ]
  },
  {
    "author": [
      {
        "given": "F.D.A."
      }
    ],
    "citation-number": [
      "19."
    ],
    "date": [
      "1981-12-04"
    ],
    "pages": [
      "–164"
    ],
    "title": [
      "Psychopharmacologic Drugs Advisory Committee"
    ],
    "type": null,
    "volume": [
      "2"
    ]
  },
  {
    "author": [
      {
        "family": "interview",
        "given": "Arvid Carlsson"
      },
      {
        "given": "Feb"
      }
    ],
    "citation-number": [
      "20."
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "69"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Iversen",
        "given": "Leslie"
      }
    ],
    "citation-number": [
      "21."
    ],
    "container-title": [
      "interview), in The Psychopharmacologists"
    ],
    "date": [
      "1998",
      "quote 343"
    ],
    "editor": [
      {
        "family": "David Healy",
        "particle": "ed."
      }
    ],
    "location": [
      "London"
    ],
    "pages": [
      "325–350",
      "325–350,"
    ],
    "publisher": [
      "Altman"
    ],
    "title": [
      "Neuroscience and Drug Development"
    ],
    "type": "chapter",
    "volume": [
      "2"
    ]
  },
  {
    "citation-number": [
      "22."
    ],
    "container-title": [
      "Sept"
    ],
    "date": [
      "1983",
      "box 28"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "pages": [
      "88–89–16,"
    ],
    "publisher": [
      "UD-04W"
    ],
    "title": [
      "Robert Temple to Director, Division of Neuropharmacological Drug Products [Paul Leber"
    ],
    "type": "article-journal",
    "volume": [
      "15",
      "E3"
    ]
  },
  {
    "author": [
      {
        "family": "Langlois",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "23."
    ],
    "container-title": [
      "European Journal of Clinical Pharmacology"
    ],
    "date": [
      "1985"
    ],
    "pages": [
      "67–71"
    ],
    "title": [
      "High Incidence of Multisystemic Reactions to Zimeldine"
    ],
    "type": "article-journal",
    "volume": [
      "28"
    ]
  },
  {
    "citation-number": [
      "24."
    ],
    "note": [
      "Carlsson interview, 69."
    ],
    "type": "interview"
  },
  {
    "author": [
      {
        "family": "Bech",
        "given": "P.]"
      }
    ],
    "citation-number": [
      "25."
    ],
    "container-title": [
      "Advances in Biological Psychiatry"
    ],
    "date": [
      "1988"
    ],
    "pages": [
      "58–69, 64"
    ],
    "title": [
      "A Review of the Antidepressant Properties of Serotonin Reuptake Inhibitors"
    ],
    "type": "article-journal",
    "volume": [
      "17"
    ]
  },
  {
    "citation-number": [
      "26."
    ],
    "date": [
      "1988"
    ],
    "location": [
      "Richmond, Surrey"
    ],
    "pages": [
      "109–120"
    ],
    "publisher": [
      "PJB Publications"
    ],
    "title": [
      "For a comprehensive list of SSRIs in development in the late 1980s, see Scrip’s Serotonin Report"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Claassen",
        "given": "V."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "27."
    ],
    "container-title": [
      "British Journal of Pharmacology"
    ],
    "date": [
      "1977"
    ],
    "pages": [
      "505–516"
    ],
    "title": [
      "Fluvoxamine, a Specific 5-Hydroxytryptamine Uptake Inhibitor"
    ],
    "type": "article-journal",
    "volume": [
      "60"
    ]
  },
  {
    "author": [
      {
        "family": "Fur",
        "given": "Gérard Le"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "28."
    ],
    "container-title": [
      "Life Sciences"
    ],
    "date": [
      "1978"
    ],
    "note": [
      "Claude Gueremy et al., “3-(4-iperidinylalkyl)indoles, Selective Inhibitors of Neuronal 5-"
    ],
    "pages": [
      "1959–1966"
    ],
    "title": [
      "On the Regional and Specific Serotonin Uptake Inhibition by LM 5008"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Eli Lilly",
        "given": "Date",
        "particle": "given in"
      },
      {
        "family": "Barr Laboratories",
        "given": "Company",
        "particle": "v."
      },
      {
        "others": true
      },
      {
        "family": "Dist",
        "given": "U.S."
      },
      {
        "given": "Jick"
      },
      {
        "others": true
      },
      {
        "given": "Henry"
      }
    ],
    "container-title": [
      "FDA, Psychopharmacologic Drugs Advisory Committee, 28th Meeting",
      "Journal of Medicinal Chemistry",
      "Scrip, Feb",
      "Supp",
      "Susan S",
      "BMJ",
      "Acta Psychiatrica Scandinavica"
    ],
    "date": [
      "1980",
      "30",
      "1991",
      "1999",
      "1999-01-12",
      "1985-10-10",
      "1995-01-28",
      "1989"
    ],
    "genre": [
      "LEXIS 21852;"
    ],
    "issue": [
      "354"
    ],
    "note": [
      "See Klaus Bogeso’s account ”Drug Hunting” (interview), in Healy, Psychopharmacologists,",
      "fluoxetine]: 140–141; obtained through the Freedom of Information Act (FOIA). 32. See Iversen interview, in Healy, Psychopharmacologists,",
      "For data indicting the tricyclics as highly dangerous to suicidal patients, see John A.",
      "All such studies are bedeviled by not knowing the actual cause of death, as opposed to the coincidental presence of a given drug. 34. A[ndré] Uzan, discussion, in “Colloque international sur ‘Approches biologiques de l’anxiété et des troubles de l’humeur,’ Sousse (Tunisie), 16–17"
    ],
    "pages": [
      "1306–1310 29",
      "561–579, 569",
      "22 31",
      "344 33",
      "215–218",
      "37–45"
    ],
    "title": [
      "Hydroxytryptamine Uptake",
      "Citalopram Launched",
      "IP 96–0491-C-B/S, United States District Court for the Southern District of Indiana, Indianapolis Division, 100 F",
      "On Benadryl, see the testimony of Lilly scientist Louis Lemberger, who explained that to get nisoxetine, a norepinephrine-reuptakeinhibitor, Lilly reversed the oxygen and the carbon on the Benadryl side chain; they then tweaked nisoxetine to get fluoxetine",
      "One study with a database of over 172,000 patients on antidepressants found that fluoxetine had an unusually high suicide rate per 10,000 person years of use; the classic tricyclic antidepressants by contrast had suicide rates rather lower than average (taking dothiepin as the “average”",
      "Antidepressants and Suicide",
      "A Fatal Toxicity Index for Antidepressant Poisoning"
    ],
    "type": "article-journal",
    "volume": [
      "23",
      "2",
      "13",
      "2d 917",
      "2",
      "310",
      "80"
    ]
  },
  {
    "date": [
      "1981-10",
      "1982",
      "1988-10-03",
      "1984-12-17"
    ],
    "genre": [
      "NDA 18–936,"
    ],
    "issue": [
      "ale, n.s., 8"
    ],
    "note": [
      "FDA Archives. 36. Carlsson interview, 73. 37. For a list of co-prescribed drugs, see Dorothy S. Dobbs to FDA,",
      "accessed June 22, 2006)."
    ],
    "pages": [
      "324–325",
      "33"
    ],
    "title": [
      "Uzan was an industry scientist associated with the discovery of indalpine (Upstène). 35. This list of side effects is from FDA, “Summary Basis of Approval: Fluoxetine Hydrochloride"
    ],
    "type": "interview",
    "url": [
      "http://www.healyprozac.com/trials/criticaldocs/dobbsexhibits.pdf"
    ],
    "volume": []
  },
  {
    "citation-number": [
      "38."
    ],
    "title": [
      "Lilly’s Gary Tollefson waffled in answering a question about this but made it clear that a certain number were indeed recruited in advertisements"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "FDA",
        "given": "Psychopharmacologic Drugs Advisory Committee"
      },
      {
        "given": "Sept"
      }
    ],
    "date": [
      "1991"
    ],
    "genre": [
      "[antidepressants and suicide], 251–253"
    ],
    "note": [
      "accessed Oct. 23, 2006)."
    ],
    "type": null,
    "url": [
      "http://www.fda.gov/ohrms/dockets/"
    ]
  },
  {
    "author": [
      {
        "family": "Cohn",
        "given": "J.B."
      },
      {
        "others": true
      },
      {
        "family": "Stark",
        "given": "Paul"
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Journal of Clinical Psychiatry",
      "Journal of Clinical Psychiatry",
      "Imipramine and Placebo in Outpatients with Major Depressive Disorder,” Journal of Clinical Psychiatry"
    ],
    "date": [
      "1985",
      "1985"
    ],
    "issue": [
      "1985"
    ],
    "pages": [
      "20–25",
      "26–31",
      "53–58"
    ],
    "title": [
      "Depressive Disorder",
      "A Comparison of Fluoxetine, Imipramine, and Placebo in Patients with Major Depressive Disorder",
      "A Review of Multicenter Controlled Studies of Fluoxetine vs"
    ],
    "type": "article-journal",
    "volume": [
      "46",
      "46",
      "46"
    ]
  },
  {
    "citation-number": [
      "40."
    ],
    "date": [
      "1988-06-03"
    ],
    "pages": [
      "309 –"
    ],
    "title": [
      "Prozac advertisement, JAMA 259"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Weringer",
        "given": "See Elora"
      }
    ],
    "citation-number": [
      "41."
    ],
    "container-title": [
      "Reflections on Twentieth-Century Psychopharmacology. ed. Thomas Ban et al., 58–64"
    ],
    "date": [
      "2004"
    ],
    "location": [
      "Budapest"
    ],
    "publisher": [
      "Animula"
    ],
    "title": [
      "The History of Psychotropic Drugs at Pfizer"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Welch",
        "given": "Willard M."
      }
    ],
    "citation-number": [
      "42."
    ],
    "container-title": [
      "Advances in Medicinal Chemistry"
    ],
    "date": [
      "1995"
    ],
    "pages": [
      "113–148"
    ],
    "title": [
      "Discovery and Preclinical Development of the Serotonin Reuptake Inhibitor Sertraline"
    ],
    "type": "article-journal",
    "volume": [
      "3"
    ]
  },
  {
    "author": [
      {
        "family": "See",
        "given": "F.D.A."
      }
    ],
    "citation-number": [
      "43."
    ],
    "container-title": [
      "33rd Meeting"
    ],
    "date": [
      "1990-11-19"
    ],
    "note": [
      "sertraline], 83–86, 93, obtained through FOIA."
    ],
    "title": [
      "Psychopharmacologic Drugs Advisory Committee (PDAC"
    ],
    "type": "paper-conference"
  },
  {
    "author": [
      {
        "family": "Lassen",
        "given": "Jorgen Buus"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "44."
    ],
    "container-title": [
      "European Journal of Pharmacology"
    ],
    "date": [
      "1975"
    ],
    "pages": [
      "108–115"
    ],
    "publisher": [
      "Buus Lassen, “Potent and Long-Lasting Potentiation of Two"
    ],
    "title": [
      "Comparative Studies of a New 5HT-Uptake Inhibitor and Some Tricyclic Thymoleptics"
    ],
    "type": "article-journal",
    "volume": [
      "32"
    ]
  },
  {
    "citation-number": [
      "5-Hydroxytryptophan-Induced"
    ],
    "container-title": [
      "European Journal of Pharmacology",
      "Carlsson interview, Feb"
    ],
    "date": [
      "1978",
      "2007"
    ],
    "note": [
      "For the facts in this paragraph, see SmithKline Beecham v. Apotex Corp., 98 C 3952, United States District Court for the Northern District of Illinois, Eastern Division, 286 F. Supp. 2d 925; 2001 U.S. Dist. LEXIS 19766; decided Nov. 30, 2001."
    ],
    "pages": [
      "351–358",
      "74 45"
    ],
    "title": [
      "Effects in Mice by Three Selective 5-HT Uptake Inhibitors",
      "Arvid Carlsson remembers that Buus Lassen prompted the synthesis after a conversation with Carlsson"
    ],
    "type": "article-journal",
    "volume": [
      "47",
      "27"
    ]
  },
  {
    "citation-number": [
      "46."
    ],
    "container-title": [
      "AJP"
    ],
    "date": [
      "1993-03"
    ],
    "note": [
      "advertisement section."
    ],
    "title": [
      "Paxil advertisement"
    ],
    "type": "article-journal",
    "volume": [
      "150"
    ]
  },
  {
    "author": [
      {
        "family": "FDA",
        "given": "P.D.A.C."
      },
      {
        "given": "Feb"
      }
    ],
    "citation-number": [
      "47."
    ],
    "date": [
      "2004"
    ],
    "genre": [
      "[adolescent suicide and antidepressants], 171;"
    ],
    "note": [
      "accessed March 12, 2004)."
    ],
    "type": null,
    "url": [
      "http://www.fda.gov./ohrms/dockets/ac/04/transcripts/4006T1.pdf"
    ]
  },
  {
    "citation-number": [
      "48."
    ],
    "date": [
      "2002-07-17"
    ],
    "pages": [
      "15"
    ],
    "title": [
      "Jonathan Cole interview by Edward Shorter"
    ],
    "type": null
  },
  {
    "citation-number": [
      "49."
    ],
    "date": [
      "1994-04-26"
    ],
    "location": [
      "Leber, FDA, PDAC"
    ],
    "note": [
      "fluoxetine for treatment of bulimia], 284, obtained through FOIA."
    ],
    "type": null
  },
  {
    "author": [
      {
        "literal": "For Detre and Leber, see FDA, PDAC, 23rd Meeting, Feb."
      }
    ],
    "citation-number": [
      "50."
    ],
    "date": [
      "1983"
    ],
    "note": [
      "obtained through FOIA."
    ],
    "pages": [
      "165–166"
    ],
    "type": null,
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "FDA",
        "given": "P.D.A.C."
      }
    ],
    "citation-number": [
      "51."
    ],
    "date": [
      "1980-11-06"
    ],
    "note": [
      "antidepressant guidelines], 192; obtained through FOIA."
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "FDA",
        "given": "P.D.A.C."
      }
    ],
    "citation-number": [
      "52."
    ],
    "container-title": [
      "Apr"
    ],
    "note": [
      "venlafaxine], 207; obtained through FOIA."
    ],
    "pages": [
      "1993"
    ],
    "title": [
      "38th Meeting"
    ],
    "type": "article-journal",
    "volume": [
      "30"
    ]
  },
  {
    "author": [
      {
        "family": "FDA",
        "given": "P.D.A.C."
      },
      {
        "given": "Feb"
      }
    ],
    "citation-number": [
      "53."
    ],
    "date": [
      "1983"
    ],
    "note": [
      "nomifensine], 2: 141; obtained through FOIA."
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "FDA",
        "given": "P.D.A.C."
      }
    ],
    "citation-number": [
      "54."
    ],
    "date": [
      "1982-06-10"
    ],
    "note": [
      "alprazolam], 1: 135; obtained through FOIA."
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "FDA",
        "given": "P.D.A.C."
      },
      {
        "given": "Apr"
      }
    ],
    "citation-number": [
      "55."
    ],
    "date": [
      "1994"
    ],
    "note": [
      "fluoxetine for treatment of bulimia], 284; obtained through FOIA."
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "FDA",
        "given": "P.D.A.C."
      }
    ],
    "citation-number": [
      "56."
    ],
    "date": [
      "1981-12-04"
    ],
    "note": [
      "obtained through FOIA."
    ],
    "pages": [
      "168–169"
    ],
    "type": null,
    "volume": [
      "2"
    ]
  },
  {
    "container-title": [
      "57. FDA, PDAC, 32nd Meeting"
    ],
    "date": [
      "1989-12-01"
    ],
    "note": [
      "clomipramine in OCD]; obtained through FOIA. 58. On the subject of possibly carcinogenic elevations of prolactin in the drug"
    ],
    "pages": [
      "131"
    ],
    "title": [
      "The day previously nomifensine had been under discussion"
    ],
    "type": "paper-conference"
  },
  {
    "author": [
      {
        "family": "FDA",
        "particle": "studies.”"
      },
      {
        "given": "P.D.A.C."
      }
    ],
    "date": [
      "1993-07-19"
    ],
    "note": [
      "nefazodone, risperidone], 242–244, 260; obtained through FOIA."
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "FDA",
        "given": "P.D.A.C."
      }
    ],
    "citation-number": [
      "59."
    ],
    "date": [
      "1982-06-10"
    ],
    "note": [
      "alprazolam, bupropion], 1: 141; obtained through FOIA. 60. Ibid., 271."
    ],
    "type": null
  },
  {
    "author": [
      {
        "literal": "FDA, PDAC, 23rd Meeting, Feb."
      },
      {
        "family": "FOIA",
        "particle": "obtained through"
      }
    ],
    "citation-number": [
      "61."
    ],
    "container-title": [
      "Archives of General Psychiatry"
    ],
    "date": [
      "1983",
      "1974"
    ],
    "pages": [
      "137,",
      "447–454"
    ],
    "title": [
      "Donald Klein coined the term “endogenomorphic depression,” by which he meant any depression with the features of retardation, agitation, and dysphoria, regardless of whether precipitated or not; he saw such depressions as eminently drug responsive. Klein, “Endogenomorphic Depression"
    ],
    "type": "article-journal",
    "volume": [
      "1",
      "31"
    ]
  },
  {
    "citation-number": [
      "62."
    ],
    "container-title": [
      "F-D-C Reports/Pink Sheet Jan"
    ],
    "date": [
      "1968"
    ],
    "pages": [
      "14"
    ],
    "title": [
      "PMA [Pharmaceutical Manufacturers Association] Charges FDA ‘Numbers Game’ in Efficacy Review"
    ],
    "type": "article-journal",
    "volume": [
      "29"
    ]
  },
  {
    "citation-number": [
      "63."
    ],
    "location": [
      "Edwards"
    ],
    "title": [
      "Peter Barton Hutt (general counsel) to Charles C"
    ],
    "type": null
  },
  {
    "container-title": [
      "box"
    ],
    "date": [
      "1972-10-24"
    ],
    "pages": [
      "505 52"
    ],
    "title": [
      "NARA, RG 88, General Subject Files"
    ],
    "type": "article-journal",
    "volume": [
      "4647"
    ]
  },
  {
    "author": [
      {
        "family": "Richard J. Pierce",
        "given": "Charles C.Edwards",
        "particle": "to"
      }
    ],
    "citation-number": [
      "64."
    ],
    "date": [
      "Aug",
      "1972"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "note": [
      "General Subject Files, box 4647."
    ],
    "type": null,
    "volume": [
      "18"
    ]
  },
  {
    "author": [
      {
        "family": "J. B. Roerig",
        "given": "Joseph Sadusk",
        "particle": "to"
      },
      {
        "given": "Company"
      }
    ],
    "citation-number": [
      "65."
    ],
    "date": [
      "1965-07-27"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "note": [
      "General Subject Files, box 3751, 505.2."
    ],
    "type": null
  },
  {
    "citation-number": [
      "66."
    ],
    "container-title": [
      "Louis Lasagna, discussion, in Decision-Making on the Efficacy and Safety of Drugs [1970 conference"
    ],
    "date": [
      "1971"
    ],
    "editor": [
      {
        "family": "Joseph D. Cooper",
        "particle": "ed."
      }
    ],
    "location": [
      "Washington, DC"
    ],
    "pages": [
      "180 67"
    ],
    "publisher": [
      "Interdisciplinary Communication Associates",
      "“PMA Tries Again for FDA Reply on Relative Effectiveness Policy,”"
    ],
    "type": "paper-conference"
  },
  {
    "container-title": [
      "copy in NARA, RG 88, General Subject Files",
      "Washington Drug and Devices Newsletter"
    ],
    "date": [
      "1972-07-14"
    ],
    "pages": [
      "4647"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "68."
    ],
    "date": [
      "1974-08-08"
    ],
    "genre": [
      "RG 88,"
    ],
    "location": [
      "NARA"
    ],
    "pages": [
      "88–89–16, 27"
    ],
    "publisher": [
      "General Subject Files, UD-04W"
    ],
    "title": [
      "Memo of OSE Rounds"
    ],
    "type": null,
    "volume": [
      "E3"
    ]
  },
  {
    "author": [
      {
        "family": "FDA",
        "given": "P.D.A.C."
      }
    ],
    "citation-number": [
      "69."
    ],
    "date": [
      "1983-02-24"
    ],
    "genre": [
      "[antidepressant labeling],"
    ],
    "note": [
      "obtained through FOIA."
    ],
    "pages": [
      "143–144"
    ],
    "type": null,
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "FDA",
        "given": "P.D.A.C."
      }
    ],
    "citation-number": [
      "70."
    ],
    "date": [
      "1981-12-04"
    ],
    "note": [
      "dothiepin], 59–61; obtained through FOIA."
    ],
    "type": null,
    "volume": [
      "2"
    ]
  },
  {
    "author": [
      {
        "family": "FDA",
        "given": "P.D.A.C."
      }
    ],
    "citation-number": [
      "71."
    ],
    "date": [
      "1985-10-11"
    ],
    "note": [
      "haloperidol decanoate], 2: 62; obtained through FOIA."
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "FDA",
        "given": "P.D.A.C."
      }
    ],
    "citation-number": [
      "72."
    ],
    "container-title": [
      "Apr"
    ],
    "date": [
      "1989"
    ],
    "note": [
      "clozapine], 17, obtained through"
    ],
    "title": [
      "30th Meeting"
    ],
    "type": "article-journal",
    "volume": [
      "26"
    ]
  },
  {
    "author": [
      {
        "family": "FDA",
        "given": "P.D.A.C."
      }
    ],
    "citation-number": [
      "75."
    ],
    "date": [
      "1993-07-19"
    ],
    "note": [
      "nefazodone], 164; obtained through FOIA."
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Laughren",
        "given": "T.] P."
      }
    ],
    "citation-number": [
      "76."
    ],
    "container-title": [
      "European Psychiatry"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "418–423, 419"
    ],
    "title": [
      "The Scientific and Ethical Basis for Placebo-Controlled Trials in Depression and Schizophrenia: An FDA Perspective"
    ],
    "type": "article-journal",
    "volume": [
      "16"
    ]
  },
  {
    "author": [
      {
        "family": "FDA",
        "given": "P.D.A.C."
      },
      {
        "given": "Feb"
      }
    ],
    "citation-number": [
      "77."
    ],
    "date": [
      "2001"
    ],
    "note": [
      "olanzapine IM], 207; obtained through FOIA."
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "FDA",
        "given": "P.D.A.C."
      }
    ],
    "citation-number": [
      "78."
    ],
    "date": [
      "1993-10-18"
    ],
    "note": [
      "fluvoxamine], 92; obtained through FOIA. 79. Ibid., 106."
    ],
    "type": null
  },
  {
    "citation-number": [
      "80."
    ],
    "container-title": [
      "Sept"
    ],
    "date": [
      "2004"
    ],
    "issue": [
      "108–125"
    ],
    "note": [
      "accessed Feb. 10, 2006)."
    ],
    "pages": [
      "58–61,"
    ],
    "title": [
      "FDA’s Role in Protecting the Public Health: Examining FDA’s Review of Safety and Efficacy Concerns in Antidepressant Use By Children. Hearing Before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, 108th Congress, 2nd Session"
    ],
    "type": "article-journal",
    "url": [
      "http://www.access.gpo.gov/congress/house"
    ],
    "volume": [
      "23",
      "l"
    ]
  },
  {
    "author": [
      {
        "family": "Dobbs",
        "given": "Dorothy S."
      },
      {
        "family": "FDA",
        "particle": "to"
      }
    ],
    "citation-number": [
      "81."
    ],
    "date": [
      "1982-06-16"
    ],
    "note": [
      "accessed June 22, 2006)."
    ],
    "type": null,
    "url": [
      "http://www.healyprozac.com/trials/criticaldocs/dobbsexhibits."
    ]
  },
  {
    "author": [
      {
        "family": "FDA",
        "given": "P.D.A.C."
      }
    ],
    "citation-number": [
      "82."
    ],
    "date": [
      "1985-10-10"
    ],
    "note": [
      "fluoxetine], 39–40; obtained through FOIA. 83. Ibid., 127–128."
    ],
    "type": null
  },
  {
    "citation-number": [
      "84."
    ],
    "container-title": [
      "In the meeting on sertraline, see Thomas Laughren’s comment that Prozac as well lacked effectiveness in inpatients. FDA, PDAC, 33rd Meeting"
    ],
    "date": [
      "1990-11-19"
    ],
    "note": [
      "sertraline], 73; obtained through FOIA."
    ],
    "type": "paper-conference"
  },
  {
    "author": [
      {
        "given": "P.D.A.C."
      }
    ],
    "citation-number": [
      "85."
    ],
    "container-title": [
      "Oct",
      "Ibid"
    ],
    "date": [
      "1985"
    ],
    "pages": [
      "87",
      "133–134"
    ],
    "type": "article-journal",
    "volume": [
      "10",
      "118. 86. Ibid., 129",
      "87. 88. Ibid"
    ]
  },
  {
    "author": [
      {
        "given": "P.D.A.C."
      }
    ],
    "citation-number": [
      "89."
    ],
    "date": [
      "1990-11-19"
    ],
    "pages": [
      "97"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "F.D.A."
      }
    ],
    "citation-number": [
      "90."
    ],
    "container-title": [
      "Oct"
    ],
    "date": [
      "1988"
    ],
    "pages": [
      "48"
    ],
    "publisher": [
      "FDA Archives"
    ],
    "title": [
      "Summary Basis of Approval, NDA 18–936, Drug Generic Name: fluoxetine hydrochloride"
    ],
    "type": "article-journal",
    "volume": [
      "3"
    ]
  },
  {
    "author": [
      {
        "family": "Healy",
        "given": "D.]"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "91."
    ],
    "container-title": [
      "Journal of Psychopharmacology"
    ],
    "date": [
      "1999"
    ],
    "pages": [
      "94–99"
    ],
    "title": [
      "Suicide in the Course of the Treatment of Depression"
    ],
    "type": "article-journal",
    "volume": [
      "13"
    ]
  },
  {
    "author": [
      {
        "given": "Healy"
      }
    ],
    "citation-number": [
      "92."
    ],
    "title": [
      "Let Them Eat Prozac, 133"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Dolan",
        "given": "See Jack"
      },
      {
        "family": "Altimari",
        "given": "Dave"
      }
    ],
    "citation-number": [
      "93."
    ],
    "container-title": [
      "Hartford Courant Sept"
    ],
    "date": [
      "2003"
    ],
    "note": [
      "See Susan K. Forsyth v. Eli Lilly and Company, Civil No."
    ],
    "title": [
      "Memos Display Drug Firms’ Optimism",
      "There is, however, considerable evidence that Lilly suppressed negative trial data regarding Prozac"
    ],
    "type": "article-journal",
    "url": [
      "http://www.ctnow.com."
    ],
    "volume": [
      "21"
    ]
  },
  {
    "author": [
      {
        "given": "A.C.K."
      }
    ],
    "citation-number": [
      "95–00185"
    ],
    "container-title": [
      "Dist. LEXIS"
    ],
    "date": [
      "1998-01-05"
    ],
    "title": [
      "United States District Court for the District of Hawaii, 1998 U.S"
    ],
    "type": "article-journal",
    "volume": [
      "541"
    ]
  },
  {
    "author": [
      {
        "family": "New York",
        "given": "See Alexander Glassman",
        "particle": "interview by Edward Shorter in"
      }
    ],
    "citation-number": [
      "94."
    ],
    "date": [
      "2004-10-05"
    ],
    "pages": [
      "23–25"
    ],
    "title": [
      "Lilly ultimately did get its combo of Prozac and Zyprexa approved as Symbyax for “bipolar depression"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Khan",
        "given": "Arif"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "95."
    ],
    "container-title": [
      "International Journal of Neuropsychopharmacology"
    ],
    "date": [
      "2002",
      "see 194, table 1"
    ],
    "pages": [
      "193–197,"
    ],
    "title": [
      "Are Placebo Controls Necessary to Test New Antidepressants and Anxiolytics?"
    ],
    "type": "article-journal",
    "volume": [
      "5"
    ]
  },
  {
    "author": [
      {
        "family": "Guy",
        "given": "William"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "96."
    ],
    "container-title": [
      "Drug Development Research"
    ],
    "date": [
      "1986"
    ],
    "pages": [
      "267–272"
    ],
    "title": [
      "Double-Blind Dose Determination Study of a New Antidepressant—Sertraline"
    ],
    "type": "article-journal",
    "volume": [
      "9"
    ]
  },
  {
    "author": [
      {
        "family": "Babyak",
        "given": "Michael"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "97."
    ],
    "container-title": [
      "Psychosomatic Medicine"
    ],
    "date": [
      "2000"
    ],
    "pages": [
      "633–638"
    ],
    "title": [
      "Exercise Treatment for Major Depression: Maintenance of Therapeutic Benefit at 10 Months"
    ],
    "type": "article-journal",
    "volume": [
      "62"
    ]
  },
  {
    "author": [
      {
        "family": "Thomas E. Donnelly",
        "given": "memorandum",
        "suffix": "Jr."
      }
    ],
    "citation-number": [
      "98."
    ],
    "date": [
      "1990-11-19"
    ],
    "title": [
      "FDA Conversation Record",
      "I am grateful to David Healy for sharing this document with me"
    ],
    "type": null
  },
  {
    "citation-number": [
      "99."
    ],
    "container-title": [
      "Dec"
    ],
    "date": [
      "2004"
    ],
    "note": [
      "posted by Chris Gupta, Dec. 8, 2004, at"
    ],
    "title": [
      "Quoted in a web communication by Karen Barth Menzies (a partner at Baum Hedlund, a law firm representing plaintiffs in drug litigation"
    ],
    "type": "article-journal",
    "url": [
      "http://www.newmediaexplorer."
    ],
    "volume": [
      "1"
    ]
  },
  {
    "citation-number": [
      "101."
    ],
    "note": [
      "Ibid., 40."
    ],
    "type": null
  },
  {
    "citation-number": [
      "102."
    ],
    "note": [
      "Ibid., 54."
    ],
    "type": null
  },
  {
    "citation-number": [
      "103."
    ],
    "note": [
      "Ibid., 59."
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Ibid"
      }
    ],
    "citation-number": [
      "104."
    ],
    "container-title": [
      "Ibid"
    ],
    "pages": [
      "75–76"
    ],
    "title": [
      "54–55. 105"
    ],
    "type": "article-journal",
    "volume": [
      "64. 106. Ibid., 66. 107. Ibid"
    ]
  },
  {
    "author": [
      {
        "family": "advertisement",
        "given": "Zoloft"
      }
    ],
    "citation-number": [
      "108."
    ],
    "date": [
      "1992-03"
    ],
    "title": [
      "AJP 149",
      "This was the first Zoloft ad in that journal"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Khan"
      }
    ],
    "citation-number": [
      "109."
    ],
    "date": [
      "194"
    ],
    "title": [
      "Are Placebo Controls Necessary?"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "FDA",
        "given": "P.D.A.C."
      }
    ],
    "citation-number": [
      "110."
    ],
    "date": [
      "1992-10-05"
    ],
    "note": [
      "paroxetine], 38; obtained through FOIA. 111. Ibid., 127."
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Group",
        "given": "Danish University Antidepressant"
      }
    ],
    "citation-number": [
      "112."
    ],
    "container-title": [
      "Journal of Affective Disorders"
    ],
    "date": [
      "1990",
      "quote 297"
    ],
    "pages": [
      "289–299,"
    ],
    "title": [
      "Paroxetine: A Selective Serotonin Reuptake Inhibitor Showing Better Tolerance, but Weaker Antidepressant Effect than Clomipramine in a Controlled Multicenter Study"
    ],
    "type": "article-journal",
    "volume": [
      "18"
    ]
  },
  {
    "citation-number": [
      "113."
    ],
    "date": [
      "1996-08-26"
    ],
    "genre": [
      "NDA 18–140/S-003;"
    ],
    "note": [
      "accessed July 16, 2002)."
    ],
    "title": [
      "Paul Leber to Wyeth-Ayerst Laboratories",
      "FDA, Center for Drug Evaluation and Research, Approval package for Ativan (lorazepam"
    ],
    "type": null,
    "url": [
      "http://www.fda.gov/cder/foi/nda/97/018140ap_s003."
    ]
  },
  {
    "author": [
      {
        "family": "Gavrus",
        "given": "Delia"
      }
    ],
    "citation-number": [
      "114."
    ],
    "container-title": [
      "Proceedings of the 15th Annual History of Medicine Days"
    ],
    "date": [
      "2006"
    ],
    "editor": [
      {
        "family": "W. A. Whitelaw",
        "particle": "ed."
      }
    ],
    "location": [
      "Calgary"
    ],
    "pages": [
      "138–156"
    ],
    "publisher": [
      "University of Calgary Faculty of Medicine"
    ],
    "title": [
      "The Gatekeepers of American Psychiatry: The FDA and the Approval of SSRIs for Depression, 1985–1992"
    ],
    "type": "paper-conference"
  },
  {
    "author": [
      {
        "family": "FDA",
        "given": "P.D.A.C."
      }
    ],
    "citation-number": [
      "115."
    ],
    "date": [
      "1983-02-24",
      "1990-11-19"
    ],
    "note": [
      "antidepressant labeling], 1: 158; obtained through FOIA. 116."
    ],
    "pages": [
      "95–96"
    ],
    "publisher": [
      "PDAC"
    ],
    "type": null
  },
  {
    "citation-number": [
      "117."
    ],
    "note": [
      "See Edward Shorter, “The Liberal State and the Rogue Agency: FDA’s Regulation of Drugs for Mood Disorders, 1950s-1970s,”"
    ],
    "title": [
      "Readers are reminded that the PDAC transcripts on which this chapter heavily relies were obtained through requests to the FDA on the basis of the Freedom of Information Act (FOIA). FDA document transfers to the National Archives and Records Administration of the federal government, as of this writing, go little beyond 1982"
    ],
    "type": null
  },
  {
    "container-title": [
      "International Journal of Law and Psychiatry"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "126–135"
    ],
    "type": "article-journal",
    "volume": [
      "31"
    ]
  },
  {
    "citation-number": [
      "118."
    ],
    "date": [
      "1990-11-19"
    ],
    "pages": [
      "98"
    ],
    "publisher": [
      "PDAC"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Lasagna",
        "given": "Louis"
      }
    ],
    "citation-number": [
      "119."
    ],
    "container-title": [
      "Perspectives in Biology and Medicine"
    ],
    "date": [
      "1989",
      "quote 337"
    ],
    "pages": [
      "322–343,"
    ],
    "title": [
      "Congress, the FDA, and New Drug Development: Before and After 1962"
    ],
    "type": "article-journal",
    "volume": [
      "32"
    ]
  },
  {
    "author": [
      {
        "family": "Quirk",
        "given": "Paul J."
      }
    ],
    "citation-number": [
      "120."
    ],
    "container-title": [
      "The Politics of Regulation",
      "191–235"
    ],
    "date": [
      "1980"
    ],
    "editor": [
      {
        "family": "James Q. Wilson",
        "particle": "ed."
      }
    ],
    "location": [
      "New York"
    ],
    "pages": [
      "211"
    ],
    "publisher": [
      "Basic Books"
    ],
    "title": [
      "Food and Drug Administration"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "update",
        "given": "For",
        "particle": "an"
      },
      {
        "family": "Gardiner Harris",
        "particle": "see"
      }
    ],
    "citation-number": [
      "121."
    ],
    "container-title": [
      "New York Times"
    ],
    "date": [
      "2007-06-11"
    ],
    "title": [
      "Potentially Incompatible Goals at F.D.A"
    ],
    "type": "article-journal",
    "volume": [
      "A16"
    ]
  },
  {
    "citation-number": [
      "122."
    ],
    "date": [
      "2006-05-31"
    ],
    "genre": [
      "Thomas Ban, personal communication,"
    ],
    "type": "personal_communication"
  },
  {
    "author": [
      {
        "family": "Sheehan",
        "given": "David"
      }
    ],
    "citation-number": [
      "123."
    ],
    "container-title": [
      "interview, in The Psychopharmacologists"
    ],
    "date": [
      "2000"
    ],
    "editor": [
      {
        "family": "David Healy",
        "particle": "ed."
      }
    ],
    "location": [
      "London"
    ],
    "pages": [
      "479–503",
      "487"
    ],
    "publisher": [
      "Arnold"
    ],
    "title": [
      "Angles on Panic"
    ],
    "type": "chapter",
    "volume": [
      "3"
    ]
  },
  {
    "citation-number": [
      "124."
    ],
    "container-title": [
      "Newsweek"
    ],
    "date": [
      "1990-03-26"
    ],
    "pages": [
      "39"
    ],
    "title": [
      "The Promise of Prozac"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "125."
    ],
    "container-title": [
      "Scrip"
    ],
    "date": [
      "1992-05-22"
    ],
    "pages": [
      "26"
    ],
    "title": [
      "Psychotropic Sales $7.6 Bill by 1996?"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "126."
    ],
    "container-title": [
      "Scrip"
    ],
    "date": [
      "1990-03-14"
    ],
    "pages": [
      "14"
    ],
    "title": [
      "‘Another Excellent Year’ for Lilly"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "given": "Editorial"
      }
    ],
    "citation-number": [
      "127."
    ],
    "container-title": [
      "Lancet"
    ],
    "date": [
      "1991-03-16"
    ],
    "pages": [
      "650–651"
    ],
    "title": [
      "If at First You Do Succeed"
    ],
    "type": "article-journal",
    "volume": [
      "337"
    ]
  },
  {
    "citation-number": [
      "128."
    ],
    "container-title": [
      "Scrip"
    ],
    "date": [
      "1991-01-23"
    ],
    "title": [
      "US Oral Antidepressant Market"
    ],
    "type": "article-journal",
    "volume": [
      "30"
    ]
  },
  {
    "citation-number": [
      "129."
    ],
    "container-title": [
      "Scrip, Mar"
    ],
    "date": [
      "1993"
    ],
    "pages": [
      "7"
    ],
    "title": [
      "SmithKline Beecham Stresses New Product Growth"
    ],
    "type": "article-journal",
    "volume": [
      "2"
    ]
  },
  {
    "citation-number": [
      "130."
    ],
    "container-title": [
      "Scrip, Feb"
    ],
    "date": [
      "1994"
    ],
    "pages": [
      "10–11"
    ],
    "title": [
      "Pfizer’s Jump in World Rankings"
    ],
    "type": "article-journal",
    "volume": [
      "18"
    ]
  },
  {
    "citation-number": [
      "131."
    ],
    "container-title": [
      "Wall Street Journal, Mar"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "3"
    ],
    "title": [
      "National Institute for Health Care Management data; see “Drug Spending Jumps 17%"
    ],
    "type": "article-journal",
    "volume": [
      "29"
    ]
  },
  {
    "author": [
      {
        "family": "Stagnitti",
        "given": "Marie N."
      }
    ],
    "citation-number": [
      "132."
    ],
    "location": [
      "Rockville, MD"
    ],
    "note": [
      "Feb. 2007);",
      "accessed March 13, 2007)."
    ],
    "publisher": [
      "Agency for Healthcare Research and Quality"
    ],
    "title": [
      "Trends in the Use and Expenditures for the Therapeutic Class Prescribed Psychotherapeutic Agents and All Subclasses, 1997 and 2004, Statistical Brief 163"
    ],
    "type": null,
    "url": [
      "http://www.meps.ahrq.gov/mepsweb/data_files/"
    ]
  },
  {
    "citation-number": [
      "133."
    ],
    "container-title": [
      "Psychiatric News"
    ],
    "date": [
      "2003-01-03"
    ],
    "pages": [
      "1"
    ],
    "title": [
      "Decision Resources data, “Antidepressant Market to Decline Slightly"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Olfson",
        "given": "Mark"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "134."
    ],
    "container-title": [
      "JAMA"
    ],
    "date": [
      "Jan"
    ],
    "note": [
      "9, 2002): 203–209, see 207, table 3."
    ],
    "title": [
      "National Trends in the Outpatient Treatment of Depression"
    ],
    "type": "article-journal",
    "volume": [
      "287"
    ]
  },
  {
    "author": [
      {
        "family": "Brett",
        "given": "K.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "135."
    ],
    "container-title": [
      "Vital Health Statistics"
    ],
    "date": [
      "2001"
    ],
    "issue": [
      "149"
    ],
    "pages": [
      "14"
    ],
    "title": [
      "Utilization of Ambulatory Medical Care by Women: United States, 1997–98, National Center for Health Statistics"
    ],
    "type": "article-journal",
    "volume": [
      "13",
      "38"
    ]
  },
  {
    "author": [
      {
        "family": "Mallick",
        "given": "Heather"
      }
    ],
    "citation-number": [
      "136."
    ],
    "container-title": [
      "Globe and Mail [Toronto], Jan"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "7"
    ],
    "title": [
      "As If"
    ],
    "type": "article-journal",
    "volume": [
      "5"
    ]
  },
  {
    "author": [
      {
        "given": "F.D.A."
      }
    ],
    "citation-number": [
      "137."
    ],
    "container-title": [
      "Sept"
    ],
    "date": [
      "2004"
    ],
    "genre": [
      "[antidepressants and pediatric suicide],"
    ],
    "pages": [
      "57–58"
    ],
    "title": [
      "Psychopharmacologic Drugs Advisory Committee"
    ],
    "type": "article-journal",
    "volume": [
      "13"
    ]
  },
  {
    "author": [
      {
        "given": "F.D.A."
      }
    ],
    "citation-number": [
      "138."
    ],
    "container-title": [
      "Sept"
    ],
    "date": [
      "2004"
    ],
    "note": [
      "day II], 338–339;",
      "accessed March 30, 2005)."
    ],
    "title": [
      "Joint Meeting of the PDAC and the Pediatric Advisory Committee"
    ],
    "type": "article-journal",
    "url": [
      "http://www.fda.gov/ohrms/dockets/ac/04/"
    ],
    "volume": [
      "14"
    ]
  },
  {
    "author": [
      {
        "family": "Thase",
        "given": "Michael E."
      }
    ],
    "citation-number": [
      "139."
    ],
    "container-title": [
      "Journal of Clinical Psychiatry"
    ],
    "date": [
      "1999",
      "quote 23"
    ],
    "issue": [
      "4"
    ],
    "pages": [
      "23–31,"
    ],
    "title": [
      "How Should Efficacy Be Evaluated in Randomized Clinical Trials of Treatments for Depression?"
    ],
    "type": "article-journal",
    "volume": [
      "60"
    ]
  },
  {
    "citation-number": [
      "140."
    ],
    "container-title": [
      "Pink Sheet"
    ],
    "date": [
      "1999-01-25"
    ],
    "pages": [
      "17"
    ],
    "title": [
      "Relapse Prevention Trials for Long Term Depression Advocated in EU"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Healy",
        "given": "David"
      },
      {
        "family": "Stone",
        "given": "Marc B."
      },
      {
        "family": "Jones",
        "given": "M.Lisa"
      }
    ],
    "citation-number": [
      "141."
    ],
    "date": [
      "2007-07-06"
    ],
    "genre": [
      "personal communication,"
    ],
    "title": [
      "He based his calculation on data in",
      "Clinical Review: Relationship Between Antidepressant Drugs and Suicidality in Adults"
    ],
    "type": "personal_communication"
  },
  {
    "container-title": [
      "Nov"
    ],
    "date": [
      "2006-11-17",
      "2006"
    ],
    "note": [
      "accessed Jan. 20, 2007). The Stone and Jones data concerned all currently marketed antidepressant drugs, not just SSRIs."
    ],
    "title": [
      "FDA internal document, attached to Thomas P. Laughren to Members of PDAC",
      "re “Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee”"
    ],
    "type": "article-journal",
    "url": [
      "www.fda.gov/ohrms/ dockets/ac/06/briefing/2006–427261–01-FDA.pdf"
    ],
    "volume": [
      "16"
    ]
  },
  {
    "citation-number": [
      "142."
    ],
    "container-title": [
      "Feb"
    ],
    "date": [
      "2003"
    ],
    "title": [
      "Thomas Ban, personal communication"
    ],
    "type": "article-journal",
    "volume": [
      "25"
    ]
  },
  {
    "author": [
      {
        "family": "Kirsch",
        "given": "Irving"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "143."
    ],
    "date": [
      "2002-07-15"
    ],
    "genre": [
      "Prevention & Treatment 5, article 23,"
    ],
    "note": [
      "accessed Oct. 27, 2002)."
    ],
    "title": [
      "The Emperor’s New Drugs: An Analysis of Antidepressant Medication Data Submitted to the U.S. Food and Drug Administration"
    ],
    "type": null,
    "url": [
      "http://"
    ]
  },
  {
    "author": [
      {
        "given": "F.D.A."
      }
    ],
    "citation-number": [
      "144."
    ],
    "container-title": [
      "Feb"
    ],
    "date": [
      "2004"
    ],
    "note": [
      "pediatric suicide], 173,"
    ],
    "title": [
      "Joint meeting of PDAC with the Pediatric Subcommittee of the Anti-Infective Drugs Advisory Committee"
    ],
    "type": "article-journal",
    "volume": [
      "2"
    ]
  },
  {
    "author": [
      {
        "family": "J. R. Geddes",
        "particle": "see"
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "The Cochrane Library"
    ],
    "date": [
      "2002"
    ],
    "issue": [
      "ue 3"
    ],
    "location": [
      "Oxford"
    ],
    "publisher": [
      "Update Software"
    ],
    "title": [
      "classes are virtually identical. For a definitive opinion",
      "Selective Serotonin Reuptake Inhibitors (SSRIs) for Depression (Cochrane Review"
    ],
    "type": "article-journal",
    "volume": []
  },
  {
    "author": [
      {
        "family": "Gram",
        "given": "Lars F."
      }
    ],
    "citation-number": [
      "146."
    ],
    "container-title": [
      "NEJM"
    ],
    "date": [
      "1994-11-17",
      "1359"
    ],
    "pages": [
      "1354–1361,"
    ],
    "title": [
      "Fluoxetine"
    ],
    "type": "article-journal",
    "volume": [
      "331"
    ]
  },
  {
    "author": [
      {
        "family": "Fawcett",
        "given": "Jan"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "147."
    ],
    "container-title": [
      "Journal of Clinical Psychiatry"
    ],
    "date": [
      "1997",
      "see 35, table 2"
    ],
    "issue": [
      "6"
    ],
    "pages": [
      "32–39,"
    ],
    "title": [
      "Efficacy Issues with Antidepressants"
    ],
    "type": "article-journal",
    "volume": [
      "58"
    ]
  },
  {
    "author": [
      {
        "family": "interview",
        "given": "Alan Schatzberg"
      }
    ],
    "citation-number": [
      "148."
    ],
    "date": [
      "2001-12-12"
    ],
    "publisher": [
      "ACNP, Oral History Project"
    ],
    "type": "book",
    "volume": [
      "11"
    ]
  },
  {
    "author": [
      {
        "family": "Healy",
        "given": "David"
      }
    ],
    "citation-number": [
      "149."
    ],
    "container-title": [
      "History of Psychiatry"
    ],
    "date": [
      "2000",
      "quote 398"
    ],
    "pages": [
      "393–412,"
    ],
    "title": [
      "Some Continuities and Discontinuities in the Pharmacotherapy of Nervous Conditions Before and After Chlorpromazine and Imipramine"
    ],
    "type": "article-journal",
    "volume": [
      "11"
    ]
  },
  {
    "author": [
      {
        "family": "Hollon",
        "given": "Steven"
      }
    ],
    "citation-number": [
      "150."
    ],
    "date": [
      "2002-07-15"
    ],
    "genre": [
      "Prevention & Treatment 5, article 28,"
    ],
    "title": [
      "The Emperor’s New Drugs: Effect Size and Moderation Effects"
    ],
    "type": null,
    "url": [
      "http://"
    ]
  },
  {
    "author": [
      {
        "family": "K",
        "given": "P."
      },
      {
        "given": "Gillman"
      }
    ],
    "citation-number": [
      "151."
    ],
    "container-title": [
      "British Journal of Pharmacology"
    ],
    "date": [
      "2007"
    ],
    "note": [
      "Confidence intervals in the original have been omitted here.",
      "quote 739."
    ],
    "pages": [
      "737–748,"
    ],
    "title": [
      "Gillman places the supposed dangerousness of the tricyclics in some perspective. “The mortality from nortriptyline in overdose (5.5 deaths per million scripts is similar to that from SSRIs, and better than both dothiepin (53.3) and venlafaxine (13.2 deaths per million scripts",
      "Tricyclic Antidepressant Pharmacology and Therapeutic Drug Interactions Updated"
    ],
    "type": "article-journal",
    "volume": [
      "151"
    ]
  },
  {
    "author": [
      {
        "family": "Donoghue",
        "given": "John"
      }
    ],
    "citation-number": [
      "152."
    ],
    "container-title": [
      "Clinical Drug Investigation"
    ],
    "date": [
      "1998"
    ],
    "pages": [
      "453–462"
    ],
    "title": [
      "Selective Serotonin Reuptake Inhibitor Use in Primary Care: A 5-Year Naturalistic Study"
    ],
    "type": "article-journal",
    "volume": [
      "16"
    ]
  },
  {
    "author": [
      {
        "family": "Trindade",
        "given": "Evelinda"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "153."
    ],
    "container-title": [
      "Canadian Medical Association Journal"
    ],
    "date": [
      "1998"
    ],
    "pages": [
      "1245–1252"
    ],
    "title": [
      "Adverse Effects Associated with Selective Serotonin Reuptake Inhibitors and Tricyclic Antidepressants: A Meta-analysis"
    ],
    "type": "article-journal",
    "volume": [
      "159"
    ]
  },
  {
    "author": [
      {
        "family": "Clayton",
        "given": "Anita H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "154."
    ],
    "container-title": [
      "Journal of Clinical Psychiatry"
    ],
    "date": [
      "2002",
      "quote 363"
    ],
    "pages": [
      "357–366,"
    ],
    "title": [
      "Prevalence of Sexual Dysfunction Among Newer Antidepressants"
    ],
    "type": "article-journal",
    "volume": [
      "63"
    ]
  },
  {
    "citation-number": [
      "155."
    ],
    "container-title": [
      "Pink Sheet Aug"
    ],
    "date": [
      "1998"
    ],
    "pages": [
      "15"
    ],
    "title": [
      "Glaxo’s Wellbutrin/Zyban U.S. Half-Year Sales More Than Double"
    ],
    "type": "article-journal",
    "volume": [
      "3"
    ]
  },
  {
    "author": [
      {
        "family": "FDA",
        "given": "P.D.A.C."
      }
    ],
    "citation-number": [
      "156."
    ],
    "date": [
      "1997-12-04"
    ],
    "note": [
      "triazolam], 58; obtained through FOIA."
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Kuhn",
        "given": "Roland"
      }
    ],
    "citation-number": [
      "157."
    ],
    "container-title": [
      "Healy, Psychopharmacologists"
    ],
    "note": [
      "This is the only one of Healy’s published interviews that I sat in on, simply because Kuhn wished to be interviewed in German, which I speak but David doesn’t."
    ],
    "pages": [
      "93–118, 114"
    ],
    "title": [
      "From Imipramine to Levoprotiline: The Discovery of Antidepressants"
    ],
    "type": "chapter",
    "volume": [
      "2"
    ]
  },
  {
    "citation-number": [
      "158."
    ],
    "container-title": [
      "AJP"
    ],
    "date": [
      "1982-04"
    ],
    "pages": [
      "51– 58"
    ],
    "title": [
      "Desyrel advertisement"
    ],
    "type": "article-journal",
    "volume": [
      "139"
    ]
  },
  {
    "author": [
      {
        "family": "Carroll",
        "given": "B.] J."
      }
    ],
    "citation-number": [
      "159."
    ],
    "container-title": [
      "The Origins of Depression: Current Concepts and Approaches",
      "the conference occurred Oct"
    ],
    "date": [
      "1983",
      "1982"
    ],
    "editor": [
      {
        "family": "J] Angst",
        "particle": "ed."
      }
    ],
    "location": [
      "Berlin"
    ],
    "pages": [
      "163–186",
      "164–165",
      "31–"
    ],
    "publisher": [
      "Springer"
    ],
    "title": [
      "Neurobiologic Dimensions of Depression and Mania"
    ],
    "type": "paper-conference"
  },
  {
    "citation-number": [
      "160."
    ],
    "container-title": [
      "Antidepressants and Receptor Function, Ciba Foundation Symposium 123"
    ],
    "date": [
      "1986"
    ],
    "editor": [
      {
        "family": "Porter",
        "given": "Ruth"
      }
    ],
    "location": [
      "Chichester"
    ],
    "pages": [
      "275"
    ],
    "publisher": [
      "Wiley"
    ],
    "title": [
      "Torgny Svensson, discussion"
    ],
    "type": "paper-conference"
  },
  {
    "author": [
      {
        "family": "Whitton",
        "given": "P.S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "161."
    ],
    "container-title": [
      "Neuropharmacology"
    ],
    "date": [
      "1991"
    ],
    "pages": [
      "1–4"
    ],
    "title": [
      "The Effect of the Novel Antidepressant Tianeptine on the Concentration of 5-Hydroxytryptamine in Rat Hippocampal Dialysates in Vivo"
    ],
    "type": "article-journal",
    "volume": [
      "30"
    ]
  },
  {
    "citation-number": [
      "162."
    ],
    "container-title": [
      "Reflections on Twentieth-Century Psychopharmacology"
    ],
    "date": [
      "2004"
    ],
    "editor": [
      {
        "family": "Thomas Ban",
        "particle": "ed."
      },
      {
        "others": true
      }
    ],
    "location": [
      "Budapest"
    ],
    "pages": [
      "299–307",
      "304"
    ],
    "publisher": [
      "Animula"
    ],
    "title": [
      "For a summary of this research, see Fridolin Sulser, “My Becoming a Psychopharmacologist"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Evenden",
        "given": "J.]"
      },
      {
        "family": "Peroutka",
        "given": "S.] J."
      }
    ],
    "citation-number": [
      "163."
    ],
    "date": [
      "1991"
    ],
    "editor": [
      {
        "family": "Sandler",
        "given": "Merton"
      },
      {
        "others": true
      }
    ],
    "location": [
      "Oxford"
    ],
    "pages": [
      "20"
    ],
    "publisher": [
      "Oxford University Press"
    ],
    "title": [
      "discussion",
      "5-Hydroxytryptamine in Psychiatry: A Spectrum of Ideas"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Beaumont",
        "given": "George"
      },
      {
        "family": "discussion",
        "given": "in E.M.Tansey"
      },
      {
        "family": "Christie",
        "given": "D.A."
      }
    ],
    "citation-number": [
      "164."
    ],
    "container-title": [
      "Wellcome Witnesses to Twentieth Century Medicine",
      "Tansey et al"
    ],
    "date": [
      "1997-03-11",
      "1998"
    ],
    "editor": [
      {
        "literal": "ed."
      }
    ],
    "location": [
      "London",
      "London"
    ],
    "pages": [
      "133–204,",
      "196"
    ],
    "publisher": [
      "Wellcome Trust"
    ],
    "title": [
      "Drugs in Psychiatric Practice: The Transcript of a Witness Seminar Held at the Wellcome Institute for the History of Medicine"
    ],
    "type": "article-journal",
    "volume": [
      "2"
    ]
  },
  {
    "citation-number": [
      "165."
    ],
    "container-title": [
      "“CINP Meeting with the Nobels",
      "Collegium Internationale Neuro-Psychopharmacologicum Newsletter"
    ],
    "date": [
      "2002-06-25",
      "2003-03"
    ],
    "location": [
      "Montreal, Canada"
    ],
    "pages": [
      "5"
    ],
    "title": [
      "Speaker’s Notes—Dr. Arvid Carlsson"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Lacasse",
        "given": "See Jeffrey R."
      },
      {
        "family": "Leo",
        "given": "Jonathan"
      }
    ],
    "citation-number": [
      "166."
    ],
    "container-title": [
      "PloS Medicine"
    ],
    "date": [
      "2005-12"
    ],
    "doi": [
      "10.1371/journal.pmed.0020392."
    ],
    "issue": [
      "12"
    ],
    "pages": [
      "392"
    ],
    "title": [
      "Serotonin and Depression: A Disconnect Between the Advertisements and the Scientific Literature"
    ],
    "type": "article-journal",
    "volume": [
      "2"
    ]
  },
  {
    "author": [
      {
        "family": "Lasagna",
        "given": "Louis"
      }
    ],
    "citation-number": [
      "167."
    ],
    "container-title": [
      "Clinical Pharmacology and Therapeutics"
    ],
    "date": [
      "1975",
      "quote 632"
    ],
    "pages": [
      "629–633,"
    ],
    "title": [
      "Clinical Trials of Drugs from the Viewpoint of the Academic Investigator (A Satire"
    ],
    "type": "article-journal",
    "volume": [
      "18"
    ]
  },
  {
    "author": [
      {
        "family": "Reidy",
        "given": "Jamie"
      }
    ],
    "citation-number": [
      "168."
    ],
    "date": [
      "2005"
    ],
    "location": [
      "Kansas City"
    ],
    "pages": [
      "49–50"
    ],
    "publisher": [
      "Andrews McMeel"
    ],
    "title": [
      "Hard Sell: The Evolution of a Viagra Salesman"
    ],
    "type": "book"
  },
  {
    "citation-number": [
      "169."
    ],
    "date": [
      "2005-07-27"
    ],
    "title": [
      "Personal communication of a physician who wished to remain anonymous to Edward Shorter"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Petersen",
        "given": "Melody"
      }
    ],
    "citation-number": [
      "170."
    ],
    "container-title": [
      "New York Times"
    ],
    "date": [
      "2002-08-11"
    ],
    "issue": [
      "1"
    ],
    "pages": [
      "14"
    ],
    "title": [
      "Heartfelt Advice, Hefty Fees: Companies Pay Stars to Mention Prescription Drugs"
    ],
    "type": "article-journal",
    "volume": [
      "3"
    ]
  },
  {
    "citation-number": [
      "1."
    ],
    "date": [
      "2007"
    ],
    "title": [
      "See psycho-pharm@psycom.net, posts of May 17"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Charlton",
        "given": "Bruce G."
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Medical Hypotheses"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "1–2"
    ],
    "title": [
      "Editorial: Boom or Bubble? Is Medical Research Thriving or About to Crash?"
    ],
    "type": "article-journal",
    "volume": [
      "65"
    ]
  },
  {
    "author": [
      {
        "family": "Hoenig",
        "given": "J.]"
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Canadian Journal of Psychiatry"
    ],
    "date": [
      "1981"
    ],
    "pages": [
      "85"
    ],
    "title": [
      "Psychiatric Nosology"
    ],
    "type": "article-journal",
    "volume": [
      "26"
    ]
  },
  {
    "author": [
      {
        "family": "Rush",
        "given": "A.John"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "NEJM"
    ],
    "date": [
      "2006-03-23"
    ],
    "pages": [
      "1231–1242"
    ],
    "title": [
      "Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression"
    ],
    "type": "article-journal",
    "volume": [
      "354"
    ]
  },
  {
    "author": [
      {
        "family": "Feinstein",
        "given": "Ivan"
      },
      {
        "family": "discussion",
        "given": "in Joseph D.Cooper"
      }
    ],
    "citation-number": [
      "5."
    ],
    "date": [
      "1973"
    ],
    "location": [
      "Washington, DC"
    ],
    "pages": [
      "146"
    ],
    "publisher": [
      "Interdisciplinary Communication Associates"
    ],
    "title": [
      "The Efficacy of Self-Medication, Philosophy and Technology of Drug Assessment"
    ],
    "type": "book",
    "volume": [
      "4"
    ]
  },
  {
    "author": [
      {
        "family": "Kuhn",
        "given": "Roland"
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "The Psychopharmacologists"
    ],
    "date": [
      "1998"
    ],
    "editor": [
      {
        "family": "David Healy",
        "particle": "ed."
      }
    ],
    "location": [
      "London"
    ],
    "pages": [
      "93–118",
      "99"
    ],
    "publisher": [
      "Chapman & Hall"
    ],
    "title": [
      "From Imipramine to Levoprotiline: The Discovery of Antidepressants"
    ],
    "type": "chapter",
    "volume": [
      "2"
    ]
  },
  {
    "author": [
      {
        "family": "Tansey",
        "given": "E.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "7."
    ],
    "date": [
      "1998"
    ],
    "location": [
      "London"
    ],
    "note": [
      "The group discussion in which Sandler made the comment occurred in 1997."
    ],
    "pages": [
      ", 171"
    ],
    "publisher": [
      "Wellcome Trust"
    ],
    "title": [
      "Wellcome Witnesses to Twentieth Century Medicine"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Cole",
        "given": "Jonathan O."
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Depression in the 1970’s: Modern Theory and Research",
      "The conference took place in"
    ],
    "date": [
      "1971",
      "1970"
    ],
    "editor": [
      {
        "family": "Ronald R. Fieve",
        "particle": "ed."
      }
    ],
    "location": [
      "Amsterdam"
    ],
    "pages": [
      "81–86"
    ],
    "publisher": [
      "Excerpta Medica"
    ],
    "title": [
      "The Future of Psychopharmacology"
    ],
    "type": "paper-conference"
  },
  {
    "author": [
      {
        "family": "Roy",
        "given": "Mario"
      },
      {
        "family": "Bernier",
        "given": "Jacques"
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Canadian Journal of Psychiatry"
    ],
    "date": [
      "1999",
      "quote 283"
    ],
    "pages": [
      "283–284,"
    ],
    "title": [
      "A Rapid Response with Psychostimulants in the Treatment of Depressed Persons with Medical Illnesses"
    ],
    "type": "article-journal",
    "volume": [
      "44"
    ]
  },
  {
    "author": [
      {
        "family": "Sulser",
        "given": "Fridolin"
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "interview), in The Psychopharmacologists"
    ],
    "date": [
      "2000"
    ],
    "editor": [
      {
        "family": "David Healy",
        "particle": "ed."
      }
    ],
    "location": [
      "London"
    ],
    "pages": [
      "239–258",
      "247"
    ],
    "publisher": [
      "Arnold"
    ],
    "title": [
      "From the Presynaptic Neurone to the Receptor to the Nucleus"
    ],
    "type": "chapter",
    "volume": [
      "3"
    ]
  },
  {
    "citation-number": [
      "11."
    ],
    "note": [
      "25, 2007, to psychopharm@psycom.net, on the grounds that he did not realize he was speaking for publication."
    ],
    "title": [
      "I am anonymizing the author of this post of Mar"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Temin",
        "given": "See Peter"
      }
    ],
    "citation-number": [
      "12."
    ],
    "date": [
      "1980"
    ],
    "location": [
      "Cambridge"
    ],
    "pages": [
      "42–44"
    ],
    "publisher": [
      "Harvard University Press"
    ],
    "title": [
      "Taking Your Medicine: Drug Regulation in the United States"
    ],
    "type": "book"
  },
  {
    "container-title": [
      "the Social Sciences and Humanities Council of Canada (SSHRC), and the Scion Natural Science Association"
    ],
    "title": [
      "This page intentionally left blank Ac k n o w l e d g m e n t I gratefully acknowledge financial support of this research from the Canadian Institutes of Health Research (CIHR"
    ],
    "type": "chapter"
  }
]
